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1 Introduction
During development, embryonic tissues are formed in a specific manner resulting in highly 
ordered organisms, in which different organs take over pivotal tasks concerning metabolism 
and homoeostasis. Once the three germ layers are established, cells start to interact with 
each other and rearrange themselves to produce a variety of tissues and organs. Different 
procedures of tissue remodeling occur, such as tissue infolding and tissue elongation; the 
spatio-temporal control of these morphogenetic processes is responsible for the organisation 
of different body plans, as well as for organogenesis (Pilot and Lecuit, 2005). 
The central problem of organogenesis is the specification of a correct cell behaviour in the 
appropriate group of cells. First, groups of cells are specified such that they follow a given 
morphogenetic pathway; second, the morphogenetic process is executed through changes in 
the cell architecture and/or polarity  (Pilot and Lecuit,  2005). To ensure that all processes, 
which are necessary for the formation of a specialised tissue or organ are executed in a 
precise spatio-temporal manner, a complicated network of cell communication and signalling 
is  required.  This network integrates all  single processes into a coordinated program that 
guarantees proper function of the developing organ. 
1.1 Mechanisms of cell-cell communication
Cell  communication mechanisms are strongly dependent on the synthesis of extracellular 
and  intracellular  molecules  which  are  produced  by  cells  to  inform  or  signal  to  their 
neighbouring cells, or to cells that are further away. The perception of those molecules by 
other  cells  premises  the  existence  of  appliances  that  enable  further  processing  of  the 
information and in addition enable response to the signal. Appliances that take over those 
roles are first of all cell-surface receptor proteins, which bind extracellular molecules. Upon 
binding of the signal molecule to the receptor (= perception of the signal), the information is 
processed  by  a  number  of  intracellular  proteins  that  forward  the  message  to  the 
corresponding part of the cell where the response initiated. Response can be given in terms 
of  alterations  in  gene  expression  profiles,  ion  channel  permeability,  metabolism,  or 
rearrangements of the cytoskeleton. 
1 Introduction 2
A distinction is made on whether the signal molecules remain bound to the surface of a 
neighbouring  cell  (juxtacrine  signaling)  or  whether  the  molecule  is  secreted  (paracrine 
signalling). Propagation of signals by juxtacrine signalling is only possible when cells are in 
direct contact with each other. Secreted molecules induce paracrine signalling resulting in 
processing of the information by a responding cell in the vicinity of the emitting cell.
Fig. 1-1 Major mechanisms of cell communication.  Schematic drawing of the five major 
signalling pathways that cells use for short-range and long distance communication. Synaptic 
and endocrine pathways enable cell communication over great distances within an organism, 
whereas  juxtacrine,  gap  junctional  and  paracrine  signalling  enable  direct  or  short  range 
communication. (Modified after Alberts et al., 2004)
Long distance communication within an organism is mediated via synaptic and endocrine 
signalling.  The signals  mediated by  hormones  or  an  action-potentials  are  transmitted  to 
different locations within an organism where they are further processed, for example by the 
release of neurotransmitters at the synapse between a neuronal cell and a target cell.
Another way to coordinate the activities of neighbouring cells is the usage of gap junctions. 
These specialised intercellular  channels directly connect  the cytoplasms of  two cells and 
enable the exchange of small intracellular mediators, second messenger, like calcium and 
cyclic AMP. Gap junctions are one of the three major junctional complexes between epithelial 
cells (Fig. 1-1; Alberts et al., 2004).
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1.1.1 Cross talk between cell communication mechanisms
Mechanisms of cell communication described in the previous section do normally not take 
place isolated from each other but instead, can be influenced by each other. Many examples 
for an elaborate interplay of signalling pathways has been elucidated so far. One example is 
the  influence  of  the  well  conserved  paracrine  Wnt/Wingless  signalling  pathway  on  the 
expression of gap junction proteins in various tissues. The activation of the Wnt/wingless 
cascade  by ligand  binding had been shown to  activate  the  transcription  of  gap  junction 
constituting proteins in vertebrates and invertebrates (Fig. 1-2; Ai et al., 2000; Bauer et al., 
2004; van der Heyden et al., 1998). Another example is the cross regulatory effect of the 
paracrine  signalling  pathways  wingless  and  hedgehog  which  act  in  cooperation  with  the 
juxtacrine Notch and epidermal growth factor (EGF) signalling pathways in the epidermal 
differentiation of segment specification in  Drosophila melanongaster  (Sanson, 2001).  With 
the potential of a regulatory dependency among different signalling pathways, information 
processing  is  improved  and  becomes  more  complex,  resulting  in  refined  patterns  within 
organs and tissues.
Fig. 1-2 Cross talk between cell communication mechanisms. Wnt/wingless signalling 
has  an  effect  on  gap  junction  protein  expression.  Activation  of  the  conserved  paracrine 
Wnt/wingless signaling pathway results in transcriptional activation of gap junction protein 
expression, leading to an enhanced direct intracellular communication within a  specialised 
tissue. (After Bauer et al., 2005)
1 Introduction 4
1.2 Epithelia and polarity
Cell communication networks program the formation of specialised tissues and organs within 
an  organism  resulting  in  the  existence of  many  different  cell  types  that  enable  crucial 
procedures including homoeostasis, which are needed to survive. One class of cells that is 
important for the separation of tissues and organs against the body cavity, providing a kind of 
barrier function, are the epithelial cells (Giepmans et al., 2008). They arise from the different 
germ  layers  during  embryonic  development.  For  instance,  epithelia  deriving  from  the 
ectoderm form the epidermis, endodermal epithelia (and ectodermal epithelia in Drosophila) 
are needed for lining of the gastrointestinal tract, whereas mesodermal cells form epithelia 
that line the inner body cavity. One characteristic of all epithelial cells is their highly organised 
architecture along the apico-basal  axis.  Cell  polarity is  defined as the asymmetry in  cell 
shape,  protein distribution and cell  function.  This architecture is set via different kinds of 
cellular junctions that guarantee the unique properties of those cells (Bryant and Mostov, 
2008).
1.2.1 Epithelial junctions 
The segregation of apical from basal plasma membrane constituents is widely believed to be 
mediated and controlled by lateral  cell–cell  adhesion junctions,  which are therefore often 
considered to be the primary epithelial polarity landmark (Yeaman et al., 1999).
In general, cellular junctions equip epithelial cells with various specialised features, which 
make the epithelium to one of the most robust tissue layers (Fig. 1-3).
The initially mentioned adherens junctions serve for instance as cellular anchors that connect 
the  cells  within  an  organ  or  specialized  tissue.  They  are  associated  with  the  actin 
cytoskeleton  and  are  involved  in  adhesion  (sticking  cells  together  or  sticking  cells  to 
surfaces).  Conversely,  members  of  a  family  of  calcium  ion-dependent  cell  adhesion 
molecules called cadherins, mediate the attachment between cells at  adherens junctions. 
Adherens junctions  also  transduce signals  into  and out  of  the  cell  thereby influencing a 
variety  of  cellular  behaviours  including  proliferation  and  differentiation.  Some  protein 
components of this type of junctions can shuttle to and from the nucleus, where they are 
thought to play a role in regulating gene expression (Niessen, 2007). 
A second type of  epithelial  junctions  are  the  tight  junctions  of  the  vertebrates  and  their 
invertebrate counterparts,  the septate junctions.  This essential  type of  cellular  junction is 
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required  in  differentiated  epithelial  cells  for  polarised  transport  of  proteins,  intercellular 
integrity and signalling. Additionally, it provides fence function against the surrounding tissues 
(Eckert et al., 2008). 
The third group of  epithelial  junctions which enables cellular  communication are the gap 
junctions. They are established by proteins of the pannexin, innexin or connexin family of 
proteins in the animal kingdom.
Fig.  1-3  Overview  of  epithelial  junctions.  Three  types  of  epithelial  junctions  are 
established  between  two  epithelial  cells.  Tight  juctions  (vertebrates)  or  septate  junctions 
(invertebrates) provide fence function. Adherens junctions with intermediate filaments (only in 
vertebrates) are the anchoring junctions and gap junctions are the communicating junctions. 
(Campell et al., 1999; after Orci and Perrelet, 1975).
Whereas vertebrates express connexins and pannexins, the invertebrate gap junctions are 
build by the protein family of innexins. Gap junctions assure direct cell to cell communication 
via the exchange of ions and small metabolites within a tissue, an important  prerequisite 
during development and homoeostasis. The pores of connexin channels have been studied 
extensively over the time and seem to be sufficiently wide (nominally 12Å) to be permeable∼  
to a variety of  cytoplasmic molecules.  There is evidence for  permeation through at  least 
some types of connexin channels of virtually all soluble second messengers, amino acids, 
nucleotides, calcium ions, glucose and its metabolites (Harris et al., 2007). 
1.2.1.1 Connexins
Connexin proteins construct intercellular gap junction channels that connect the cytoplasms 
of  adjacent  cells  by the formation  of  two hemichannels,  each consisting of  a  hexameric 
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assembly of  connexin proteins.  The composition of  a hemichannel and the resulting gap 
junction channel is highly mutable. Homomeric hemichannels consist of six connexin protein 
subunits of  one isoform, whereas heteromeric  hemichannels  exhibit  the presence of  two 
different connexin isoforms in one hemichannel. Finally, homotypic gap junction channels are 
constructed by two homomeric hemichannels of  the same type and heterotypic channels 
form by combinations of different hemichannel types (Fig. 1-4; Mese et al., 2007). The variety 
of  possible  hemichannel  arrangements is  provided by the plurality of  connexin isoforms. 
Meanwhile, 20 connexin isoforms have been isolated in mice and 21 isoforms in humans 
(Söhl and Willecke, 2004). Various connexin proteins are expressed in overlapping patterns 
throughout tissues and organs, whereas others are found only in specialised tissues. This 
enables a specification of gap junction channel permeability needed in different tissues.
Fig.  1-4 Assembly of vertebrate gap junction channels.  Hexameric  hemichannels  are 
formed by connexins.  Two hemichannels  build  an intercellular  gap junction  channel  that 
connects the cytoplasms of two adjacent cells. Nomenclature divides hemichannels that are 
constructed  by  one  connexin  isoform  only  as  homomeric,  hemichannels  consisting  of 
different connexin isoforms heteromeric. Gap junction channels are called homotypic when 
both hemichannels have the same composition, heterotypic,  when it  assembles from two 
different hemichannel subsets. (After Mese et al., 2007)
1.2.1.2 Innexins
Whereas connexins are the building blocks for gap junctions in vertebrates, innexins are the 
gap junction constituting proteins of the invertebrates (innexin, invertebrate connexin). They 
were first identified in the Caenorhabditis elegans and Drosophila melanogaster. Meanwhile, 
their existence has been proven in several other invertebrate species (Bauer et al., 2005) 
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with different  amounts of  isoforms in  each species.  The protein super  family of  innexins 
comprises eight members in Drosophila (Fig. 1-5). 
Fig.1-5 Conserved topology of gap junction proteins. Innexins and connexins show the 
same overall protein topology, although both families do not exhibit sequence homologies. 
The topology of the eight members of the innexin gap junction protein family are depicted in 
(A) compared to the topology of connexin43, as representative isoform for connexins (B). 
Both  families  exhibit  topologies  containing  four  transmembrne  membranes  (red),  two 
extracellular loops with conserved cysteines (three cysteine residues for connexins and two 
in innexin sequence (green; exception inx4 with three residues) and cytoplasmic located N- 
and C-termini. Potential phosphorylation sites and protein interactions sites of C-termini are 
marked with different symbols, see legend. (After Bauer et al., 2005)
Despite of lacking sequence homology to the vertebrate connexins, all innexin proteins share 
a gap junction common architecture with four transmembrane domains, two extra-cellular 
loops, cytoplasmic located amino- and carboxy-termini as well as two, conserved cysteine-
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residues in their  extracellular loops;  exception to the rule provides the germ line specific 
innexin4, which contains three cysteine residues (Fig. 1-5; Bauer et al., 2005). So far, no 
biochemical  data  exist  concerning  the  oligomerisation  process  and  nature  of  innexin 
hemichannels. Both of these issues are subject to the present thesis.
Nevertheless, innexins as gap junction constituting proteins have been found indispensible 
for a number of  developmental  processes, for instance the establishment of  the left-right 
neuronal asymmetry in C.elegans (Chuang et al., 2007), the development of the embryonic 
nervous system and the formation of the posterior foregut of Drosophila (Bauer et al., 2004, 
Lechner et al., 2007, Ostrowski et al., 2008).
1.2.1.3 Pannexins
Connexins were considered for a long time to be the only class of the vertebrate proteins 
capable  of  gap  junction  formation,  until  additional  candidates  for  this  function  with  no 
homology to connexins, termed pannexins, were discovered in vertebrates (Panchin, 2005). 
In  contrast,  vertebrate  pannexins  and  invertebrate  innexins  reveal  partial  sequence 
homology (Baranova et al., 2004).
Both, the human and the mouse genomes contain three pannexin-encoding genes. A first 
evidence that  vertebrate  pannexins  may serve as  gap junction  constituting  proteins  was 
provided by Bruzzone and coworkers (Bruzzone et al., 2003), when they demonstrated that 
in paired oocytes, rodent pannexin1 alone and in combination with pannexin2, induced the 
formation of intercellular channels. Meanwhile, biochemical studies also provide evidence for 
a hexameric composition of pannexin hemichannels (Boassa et al., 2007). Functional assays 
in  cultured  cells,  transiently  expressing  panx1  and  panx3,  were  incapable  of  forming 
intercellular channels, but assembled into functional cell  surface channels (Penuela, et al 
2007).  These  proteins  probably  play  an  important  biological  role  as  single  membrane 
channels. Pannexin function is only poorly understood. Initial expression analyses have been 
shown that they are expressed in neuronal structures of the mouse brain (Meier et al., 2006).
1.2.2 Vertebrate gap junction life cycle
Vertebrate gap junction protein biosynthesis and assembly are strictly regulated processes 
for the reason that the half life of intercellular junctions is with only a few hours relatively 
short and must be therefore processed in a highly ordered fashion (Musil  et al., 2000). For 
instance, connexin43 the best-studied connexin isoform has a half-life of only 1.5-5 hours 
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(Leithe  and  Rivedal,  2007).  Most  connexins  are  cotranslationally  integrated  into  the 
endoplasmic reticulum (ER) membrane. Misfolded connexins are targeted for ER associated 
degradation (ERAD). The oligomerisation of six connexins into a hemichannel is thought to 
be accomplished in an advancing manner starting in the endoplasmic reticulum and ending 
in the trans-Golgi network (Musil and Goodenough, 1993; Sarma et al., 2002; Laird, 2006). 
Some members of the connexin family show that complete oligomerisation is delayed until 
the connexin passes through the intermediate compartment and reaches the distal elements 
of  the  Golgi  apparatus,  namely  trans-Golgi  network  (TGN;  Laird,  2006).  Hexameric 
hemichannels (= connexons) are subsequently transported to the targeting membrane via 
vesicles, which are transported through microtubules (Shaw et al., 2007).  Connexons may 
function as hemichannels or laterally diffuse in a closed state to sites of cell-cell apposition 
where they dock with connexons from an opposing cell. In conjunction with cadherin-based 
cell  adhesion,  gap-junction channels cluster  into plaques,  open and exchange secondary 
messengers.  Connexin-binding  proteins  have  been  identified,  and  it  is  likely  that  these 
binding proteins regulate plaque formation and stability,  possibly by acting as scaffolds to 
cytoskeletal  elements  (Laird,  2006).  After  having  functioned  as  intercellular  channels  or 
hemichannels,  gap junctions are degraded by formation of annular junctions (Piehl et al., 
2007),  which  either  fuse with  the lysosome or  are targeted to  the proteosomal  pathway 
(Leithe et al., 2007). Whole gap junction plaques and fragments of those are internalised into 
one of two adjacent cells as a double-membrane structure commonly referred to as annular 
junction.  Other  pathways  for  connexin  internalisation  may  exist  in  which  connexons 
disassemble and enter the cell by classical endocytic pathways (Fig. 1-6).
Fig. 1-6 Life cycle of vertebrate gap junctions. For details, see text. (After Laird, 2006).
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The continuous synthesis and degradation of connexins through these processes serve as 
mechanisms for the quick adaptation of tissues to changing environmental conditions. 
1.3 Regulation of membrane trafficking in epithelial cells
As presented in the previous section, gap junction proteins that take over their function at the 
plasma membrane of  epithelial  cells,  have to travel  along the secretory pathway to their 
place of destination.
In general, polarized epithelial cells are exposed to mechanical stress frequently and need to 
assure that protein turnover at the different membrane domains takes place in highly ordered 
fashion  because  of  the  perpetually  ongoing  cycles  of  protein  delivery  and  degradation. 
Therefore, different pathways are established in those cells to ensure an adequate protein 
delivery to the different domains. This is achieved mainly by the existence of two delivery 
pathways, one that ensures trafficking of membrane proteins to the apical site of the cell and 
one that enables transport of proteins to baso-lateral plasma membrane domains. Proteins 
determined tor the targeting to different domains of the plasma membrane have to undergo a 
sorting  process  before membrane trafficking,  which  is  accomplished within  a specialised 
organelle, the trans-Golgi-network.
1.3.1 Sorting of cargo in the trans-Golgi network
The  Golgi  apparatus  is  know as  the  most  important  organelle  for  the  selective  sorting 
process of proteins. The delivery of most proteins to their place of destination within a cell is 
mediated by transport vesicles, so called post-Golgi-carriers, which arise from membranes of 
the trans-Golgi-network (TGN) that do not contain Golgi-resident enzymes. Because of their 
different  size  and  shape,  the  resulting  protein  transporters  differ,  therefore  also  called 
pleiomorphic structures. Post Golgi carriers emerge after initial separation of cargo proteins 
from Golgi resident proteins from the last cisternae of the Golgi-complex and are most likely 
formed by a pulling force mediated by microtubule-base motors like kinesin (Luini  et  al., 
2008). The resulting curvature of the emerging vesicles is not completely understood yet. 
Two hypotheses try to explain the shaping of the vesicles. One claims that additional proteins 
are  involved  (Antonny,  2006),  the  other  mechanism  argues  for  alterations  in  the  lipid 
composition  of  those  membrane  in  vesicle  bending  (De  Matteis  and  Godi,  2004).  A 
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combination of both mechanisms is also conceivable. Fission of the carrier from the cisternal 
membrane finally takes place at the thinnest part  of  the vesicle precursor. Movements of 
motor proteins along the cytoskeleton towards the periphery of the cell provide the necessary 
tension to induce fission and separation of the post Golgi transporter from the TGN (Fig. 1-7)
Fig. 1-7 Fission of transport vesicles from the TGN.  Membranes from the trans-Golgi 
cisterna are pulled along microtubules (green line) by kinesin (red dot). Fission of the vesicle 
takes place at the thinnest part of the stretched membrane (red line). Fission close to the tip 
leads to the formation of smaller carriers (1), whereas fission at the bottom of the emerging 
structure results in larger vesicles (2). (After Luini et al., 2008).
Allocation  of  the  right  delivery  pathway  (apical  or  baso-lateral)  for  the  cargo,  which  is 
appointed to different domains of polarised cells, requires different characteristics within the 
composition of the transported protein.
1.3.2 Apical transport
Proteins  that  are  designated  for  apical  membrane  insertion  usually  contain  ectodomain 
signals like N- or O-linked glycans, a special organisation of trans membrane domains or are 
equipped with glycosylphosophatidylinositol-anchors (GPI-anchored proteins). One or more 
of  these attributes are recognised by the delivery machinery of  the cell  and transport  is 
initiated after exit of proteins from the trans Golgi network (TGN). A common mechanism 
here  is  the  clustering  of  proteins  within  glycolipid  raft  domains  or  other  carriers,  that 
recognise attached glycans via lectins (Fölsch, 2008). Lectins are named after their role in 
the recognition and selection of carbohydrate moieties of proteins (lectin derives from the 
latin word legere, meaning to select). They are grouped into two different types with a one 
group localising mainly in intracellularly in luminal compartments, which is responsible for 
sorting and trafficking of glycoproteins in the secretory and other pathways. The other group 
of  lectins  is  found  outside  of  the  cell  and  is  either  secreted  or  localised  to  the  plasma 
membrane (Dodd et al., 2001).
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1.3.3 Baso-lateral transport
Transport of proteins to the baso-lateral membrane domain of epithelial cells is accomplished 
at the initial phase by the recognition of a signal sequence encoded in the cytoplasmic tail of 
transmembrane proteins. This motif has been found to be either tyrosine or di-leucine based 
and seems to be dominant over apical transport mechanism information. Cytosolic adaptor 
proteins (AP-1, AP-3, AP-4) are bound to this motif in the TGN and build, once they arrived at 
the plasma membrane a hetero-tetrameric complex by binding AP-2. This complex is also 
interacting  with  clathrin  during  endocytosis  later  on  (Ellis  et  al.,  2006).  Two  potential 
trafficking routes to the baso-lateral membrane domain are discussed, first an indirect route 
which is executed via recycling endosomes and a direct route. Less is known about the direct 
sorting at the TGN, because many baso-lateral proteins travel through the TGN only once, 
while they are typically recycled many times (Fölsch, 2008).
The idea of the recycling endosome as a new type of cargo sorter for baso-lateral proteins 
came up in the recent years. Little is known so far about the trafficking between TGN and the 
recycling endosome. It is known that polarised columnar epithelial cells express the epithelial 
cell-specific adaptor complex AP-1B (Ohno et al., 1999). AP-1B plays an important role  in 
baso-lateral sorting from recycling endosomes. On the one hand it interacts directly with the 
baso-lateral cargo, and on the other hand facilitates membrane recruitment of subunits of the 
exocyst complex for incorporation in the AP-1B vesicle.
1.3.3.1 Exocyst complex
The  exocyst  is  an  octameric  protein  complex  being  involved  in  vesicular  trafficking, 
specifically in tethering and spatial targeting of post-Golgi vesicles to the plasma membrane 
prior to vesicle fusion. Subunits are sec3, sec5, sec6, sec8, sec10, sec15, exo70 and exo84. 
Mutations of each member have been shown to prevent exocytosis and to arrest growth of 
the daughter cell and cytokinesis. The resulting phenotypes of all subunits were similar and 
biochemical studies led to the assumption that they act in concert to mediate exocytosis of 
baso-lateral proteins (Murthy et al., 2004).
The complex is implicated in a number of cell processes, including exocytosis and also cell 
migration and growth. It was discovered initially in yeast during a screen for regulators of 
exocytosis (TerBrush et al., 1996; Novick et al., 1980) and was later on found in various other 
species  from  invertebrates,  like  Drosophila, to  mammals.  Components  of  the  exocyst 
complex are localised to sites of active exocytosis, where they mediate the targeting and 
tethering of post-Golgi secretory vesicles for subsequent membrane fusion (Murthy et al., 
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2003).
Targeting  of  LDL-receptors  to  the  baso-lateral  membrane  was  the  first  functional  study 
showing the involvement  of  the  exocyst  complex in  anterograde trafficking  of  membrane 
proteins (Grindstaff et al., 1998). Fusion activity of exocyst complex mediated protein delivery 
is observed only in the upper third of the basolateral membrane domain immediately below 
the tight junctions (Kreizer et al., 2003). Assembly of the exocyst complex at the fusion site 
might be regulated by ralA, a small GTPase that seems to directly interact with the exocyst 
subunits sec5 and exo84.
Two possible mechanisms exist by which the exocyst complex may mediate vesicle tethering 
or docking at the plasma membrane. In the first mechanism, the exocyst complex may exist 
as two subcomplexes.  One subcomplex interacts with  secretory vesicles,  while the other 
subcomplex is recruited to specific plasma membrane domains. Interaction between these 
two  halves  of  the  complex  enables  vesicle  docking  at  the  plasma membrane.A second 
mechanism  suggests  that  the  entire  exocyst  complex  may  be  recruited  to  the  plasma 
membrane where it mediates vesicle docking. Exocyst subunit positive vesicles have been 
shown to colocalise with microtubuli, arguing for a microtubule dependent trafficking to the 
membrane.  In  addition,  members  of  the  exocyst  complex  may take over  the  transfer  of 
vesicles  from the  microtubule  to  cortical  the  actin-network  to  enable  vesicle  fusion  with 
plasma membrane.  It  is  not  clear  how many events  take place  between the  transfer  of 
secretory vesicles from microtubules, at the vicinity of the plasma membrane, to the fusion of 
these  vesicles  at  the  plasma  membrane  (Wang  and  Hu,  2006).  Evidence  exists  that 
secretory vesicles have to go through both microtubule and actin  networks to reach the 
plasma membrane (Langford, 1995, Goode et al., 2000).
Cargo vesicles are transported along the microtubule-network and the actin cytoskeleton by 
motor proteins to reach their target membranes or compartments within the cell. Selection of 
specific  cargo  proteins  by  motor  proteins  is  accomplished  either  by  a  direct  interaction 
between the the cargo protein and the motor protein or is mediated, as mentioned above, via 
binding of adaptor proteins to the cargo protein.
1.4 Actin and microtubule dependent transport of vesicles
The  transport  of  secretory  vesicles,  organelles  and  protein  complexes  is  an  essential 
intracellular process. Disturbance of the machinery by mutations of motor proteins that are 
necessary for the accomplishment of trafficking along the cytoskeleton leads in humans to 
severe diseases like amyotrophic lateral sclerosis, parapalegia and Griscelli syndrome type 1 
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(Ross  et  al.,  2008).  Whereas  microtubules  serve  as  trafficking  routes  for  long  distance 
travelling of cargo to the plasma membrane, actin filaments are mainly involved in transport 
processes that occur beneath the plasma membrane (Fig. 1-8; Rogers et al., 2000).
Fig.1-8 Motor proteins and vesicular cargo transport in the cell. Actin filaments (red) and 
microtubules (green) provide a network within the cytoplasm of a cell that is used to traffic 
vesicles from one place to another within the cell. Motor proteins assure these movements. 
Kinesin (yellow) enables transport along microtubules to the plus end, Dynein (blue) to the 
minus end. Myosin motor proteins allow movements of vesicles along actin filaments. Myosin 
Va directs cargo in plus direction, Myosin VI directs cargo in minus direction. Actin filament 
plus ends are oriented to the plasma membrane and microtubule plus ends orient to the cell 
cortex. (After Ross et al., 2008).
1.4.1 Microtubule organisation
Microtubules are polymers of subunits from α-and ß-tubulin proteins. The smallest subunit of 
a microtubule itself is a heterodimer formed by both tubulin isoforms. Both tubulin proteins 
contain GTP binding sites. The resulting microtubule is a hollow and stiff cylindrical structure 
formed by 13 parallel protofilaments, each composed of the above mentioned heterodimers 
in an alternating order. Each protofilament is assembled from subunits that all point in one 
direction resulting in  a structural  polarity with  α-tubulins directed to the one end,  termed 
minus end and ß-tubulins oriented to the other end, termed plus end (Fig.1-9). Nucleation, as 
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the initial step in the biogenesis of microtubules, paraphrases a spontaneous process where 
short oligomers are composed of subunits, that remain unstable as long it is not stabilised by 
additional subunits (Desai and Mitchison, 1997).
Microtubule  nucleation  begins  at  the  minus ends,  whereas the plus  end is  growing end 
orients  towards  the  cell  periphery.  The  minus  end  of  microtubules  is  anchored  to  the 
microtubule-organisation center (MOTC), the centrosome, which located near the nucleus of 
the cell, in most animal cells (Fig. 1-8). A γ-tubulin ring complex, which is part of the MOTC, 
has been shown to mediate the initial step of nucleation (Raynaud-Messina et al.,  2007). 
Microtubules are in a process of ongoing renewal by which  polymers maintain a constant 
length. One process that  controls a constant  polymer length is  termed “treadmilling”  and 
includes growing of the plus end by the recruitment of heteromeric subunits on the one end 
and shedding of  subunits  from the minus end.  To ensure that  renewal  takes place in  a 
steady-state fashion, GTP hydrolysis along the way of incorporation of new subunits is a 
crucial  process.  The other  process,  called  dynamic  instability  describes  a mechanism in 
which the individual microtubule ends switch between a phase of relatively slow sustained 
growth and a phase of relatively rapid shortening (Margolis and Wilson, 1998).
Fig.  1-8 Structure of  microtubules and their  organisation.  The smallest  unit  within  a 
microtubule  is  a  heterodimer  consisting  of  one  α-  and  one  β-tubulin  protein.  Subunits 
oligomerise  in  a  nucleation  process  and are  stabilised by addition  of  further  subunits,  a 
protofilament  results.  13  parallel  protofilaments  build  a  hollow  cylindrical  tube,  one 
microtubule.
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1.4.2 Microtubule based motors and transport of cargo
Motor  proteins,  driving  the  movement  of  cargo along  microtubules,  are  members  of  the 
kinesin and dynein super families. Both are microtubule activated ATPases, which provide 
the driving forces along microtubular movements.
Kinesin  causes  movements  towards  the  microtubule  plus  end,  whereas  dynein  enables 
movements to the microtubule minus end. Kinesin is a hetero-tetramer composed of two 
alpha- and beta- subunits. The alpha-subunits contain ATP binding site in their N-terminal 
heads, whereas the tail domain mediates binding to membrane vesicles or other structures 
(Fig.1-7).
Cytoplasmic dynein consists of two heavy chains and multiple intermediate and one light 
chain. Dynein cannot  transport  cargo on its own, like kinesin does, but needs to build a 
complex with other proteins,  the so called dynactin-complex, that links vesicles to the motor 
protein. Kinesin and the dynein complexes are distinguished by the filament substrates, the 
direction of movements, the objects they move and the regulation of movement. Kinesin and 
dynein are not able to convert the ATP provided energy into movements themselves, but 
need  accessory  components,  the  microtubule  associated  proteins  (MAPs;  Schroer  and 
Sheetz,  1991).  MAPs  are  a  family  of  proteins  that  bind  to  and  stabilise  microtubules. 
Whereas some MAPs bind specifically to the microtubule plus ends or the minus ends, many 
MAPs bind along the microtubule lattice (Halpain and Dehmelt, 2006).
1.4.3 Actin organisation
In contrast to the organisation of microtubules where nucleation takes place mostly near the 
nucleus in  the cytoplasm, actin  filament  nucleation is  accomplished frequently below the 
plasma  membrane.  This  is  also  the  reason  for  observations  of  highest  actin-filament 
densities within in the cell. The area just below the plasma membrane is called cell cortex. Its 
function is to determine shape and movement of the cell surface and is involved in trafficking 
of scaffold proteins to the plasma membrane (Ross et al., 2008).
Actin  subunits  are  monomeric  globular  proteins  with  a  binding  capacity  for  ATP,  which 
provides energy for the process of actin filament formation. One actin filament consists of two 
parallel protofilaments that are twisted around each other in right handed helix, which provide 
flexibility to the filament. Those single filaments are crosslinked and bundled with each other 
within the cell. Actin needs several binding proteins that promote or inhibit polymerisation. 
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Treadmilling and dynamic instability also regulate the steady-state growth and shrinkage of 
actin-filaments as described for microtubules in section 1.4.1. with the difference, that ATP is 
the driving force in this process.
1.4.4 Actin based motors and transport of cargo
The large family of myosins has been implicated in movements of the actin cytoskeleton. 
This superfamily consists of 20 members among organisms (Krendel and Mooseker, 2000). 
The family members myosin I, myosin II, myosin V and myosin VI are the best investigated 
ones. Myosin II is involved in muscle contraction, whereas Myosin I, V and VI take part in 
cytoskeleton-membrane interactions like the transport of transport vesicles. 
Myosins consist  of  one or  two heavy chains and a different number of light  chains,  with 
regulatory functions. One characteristic of all myosins is a specialised head, neck and tail 
domain within all myosin heavy chains. All head domains are equipped with ATPase activity, 
which promotes the hydrolysis ATP that binds to the neck region. The tail region of myosins I 
V and VI  bind the plasma membrane or the membranes of  intercellular vesicles. Myosin 
movement is carried out towards the actin-filament plus end by most of the myosins, with the 
exception myosin VI, which moves to the minus end (Fig. 1-7; Ross et al.,2008).
1.5 Objective of research
Innexin2 as one representative member of the Drosophila melanogaster innexin gap junction 
family was investigated in this work to understand nature and assembly of  Drosophila gap 
junction  hemichannels  biochemically,  using  various  approaches  of  density  gradient 
centrifugation.  In  addition,  trafficking  of  innexin2  containing  hemichannels  to  the  plasma 
membrane was analysed by a combination of  experiments performed in  cell  culture and 
Drosophila.  Furthermore,  the  influence  of  innexin2  function  on  the  organogenesis  of  a 
specialised part of the posterior foregut of  Drosophila, the proventriculus, was investigated. 
Here,  the  influence  of  innexin2-dependent  gap  junctional  communication  on  paracrine 
signalling pathways was studied that are involved in morphogenetic movements and organ 
formation.
2 Material
2.1 Chemicals
All materials used are purchased with the quality grade pro analysi from Biomol, BioRad, 
Boehringer, Faust, Invitrogen, Macherey & Nagel, Promega, Pierce, Qiagen and Roth. 
2.2 Expendables
Common laboratory equipment Faust (Meckenheim), Schütt (Göttingen)
1,5ml / 2ml test tubes Roth
PCR-reaction tubes, thick-walled Eppendorf (Hamburg)
Plastic wares Greiner (Solingen)
X-ray films Fuji Medical X-Ray Film Super RX; BW Plus
2.3 Equipment
autoclave H+P Varioklav steam-sterilisator EP-2 with 
microprocessor
binocular Olympus S2X 12; 
Olympus S2 40
centrifuges Biofuge Pico, Heraeus
Eppendorf centrifuge 5415R; 
Hettich centrifuge Rotina 46R
confocal-laser scanning microscopes Leica TCS SP2, 
ZEISS LSM 710
electro-pipette Accu-jet; Brand
electrophoretic transfer cell Trans Blot, BioRad
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Fluorescence microscope Zeiss Axiovert M200 with ApoTome
gel-documentation system Biozym, Alpha Digi Doc
incubator for bacteria Memmert, Model 400
microwave Samsung, 1000W
nucleic acid electrophoresis PEQLAB
optical microscope Olympus Ax70 
with camera Olympus U-TVO.5xC-2;
Color View Soft Imaging System
PCR-Cycler MJ Research PTC-200 Peltier Thermal Cycler
photometer BioRad SmartSpec Plus
power supply unit Bio-Rad Power Pac 200
protein gel electrophoresis Mini-Protean 3 Cell, BioRad
scales Sartorius BL 150 S; 
Sartorius B211 D
test-tube rotator Snijders
thermo mixer Eppendorf Thermomixer comfort
ultracentrifuge Beckman Coulter OptimaTM LE-80 K
ultrasound device Bandelin SONOPLUS HD2070
vortexer Vortex Genie2 (Scientific industries)
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water bath Julabo TBW22
x-ray film developer Curix 60, AGFA
2.4 Standards and Kits
Company Item Purpose
BioRad All Blue prestained Protein Standard Molecular weight determination 
of proteins 
Boehringer / Roche DNA Molecular Weight Marker X 
PCR Nucleotide Mix 
Molecular weight determination 
of DNA-fragments;
PCR component
Macherey & Nagel Nucleospin Plasmid Midi Kit
NucleoSpin Extract II
NucleoSpin RNA II
Purification of plasmid DNA
Extraction and purification of 
DNA fragments
Extraction and purification RNA 
from tissues and cells 
Pierce ECL kit
Cell surface biotinylation kit
Detection  of  Western  Blot  via 
chemiluminescence
Biotinylation  of  cell  surface 
exposed proteins 
Promega Canine microsomal membranes
Rabbit Reticulocyte Lysate System, 
nuclease treated
Ribomax Large Scale RNA 
Production Systems
In vitro oligomerisation of 
proteins
in vitro translation from mRNA
in vitro transcription, mRNA 
synthesis
Qiagen QuantiTect Reverse cDNA-Synthesis
Transcription Kit 
cDNA synthesis
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2.5 Antibodies
2.5.1 Primary antibodies
Antibody Species Source Concentration
Armadillo mouse DSBH 1:5
BIP mouse S. Roth 1:1000
alpha-Spectrin mouse DSHB 1:10
DE-Cadherin goat Santa Cruz 1:30
Disc -large mouse DSHB 1:10
GFP (Fl) rabbit Santa Cruz 1:100
DIG sheep Boehringer/Roche 1:500
DIG-AP mouse Boehringer/Roche 1:2000
FasciclinII mouse DSHB 1:10
GFP (B2) mouse Santa Cruz 1:50
1:500 (WB)
Hedgehog rabbit T. Tabata 1:50
Innexin2-CS guinea pig Davids 1:50
Innexin2-CT (KLRH) rabbit Davids 1:40
1:400 (WB)
Innexin2-CT (REM) rabbit Davids 1:40
Innexin3-CS rabbit Davids 1:100
1:400 (WB)
Myc (9E10) mouse Santa Cruz 1: 200
1: 600 (WB)
Rab 5 rabbit M. Gonazales- 
Gaitan
1:50
1:200 (WB)
ß-galactosidase mouse Promega 1:500
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Antibody Species Source Concentration
ß -tubulin (E7) mouse DSHB 1.200
1:5000 (WB)
Sec6 guinea pig U. Tepass 1:100
Sxl mouse DSHB 1:10
Syx mouse DSHB 1:600 (WB)
(DSHB; Developmental Studies Hybridoma Bank; WB; Western Blot)
2.5.2 Secondary antibodies
Antibody Species Source Concentration
rabbit-HRP donkey Santa Cruz 1:15000 (WB)
mouse-HRP donkey Santa Cruz 1:15000 (WB)
guinea pig-HRP donkey Santa Cruz 1:15000 (WB)
rabbit-Cy3 donkey Dianova 1:200/1:300 (IF cells)
mouse-Cy3 donkey Dianova 1:200/1:300 (IF cells)
guinea pig-Cy3 donkey Dianova 1:200/1:300 (IF cells)
rabbit-Alexa 488 donkey Molecular Probes 1:100/1:200 (IF cells)
mouse-Alexa 488 donkey Molecular Probes 1:100/1:200 (IF cells)
guinea pig Cy2 goat Dianova 1:100/1:200 (IF cells)
Mouse-Alexa 633 goat Molecular Probes 1:100
rabbit-Alexa 633 donkey Molecular Probes 1:000
sheep-Biotin goat Sigma 1:300
(IF; immunofluorescent staining of cultured cells)
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2.6 Solutions
Agarose gel loading buffer (5x) 0.1% bromophenol blue, 0.1% xylene cyanol, 15% 
ficoll, 10% glycerine
Alkaline solution I (plasmid preparation) 50  mM glucose,  25  mM Tris-Cl  (pH  8.0),10  mM 
EDTA (pH 8.0)
Alkaline solution II (plasmid preparation) 0.2 N NaOH, 1% (w/v) SDS
Alkaline solution III (plasmid preparation) 60 ml 5 M potassium acetate, 11.5 ml glacial acetic 
acid, 28 ml A.bidest
Ampicillin 50 mg / ml ampicillin in A.bidest for stock solution, 
working concentration 50 µg / ml
AP-buffer 100 mM NaCl,  50  mM MgCl2,  1  M Tris;  pH 9.5, 
0.1% Tween-20
Apple juice agar 1  l  Apple  juice,  100  g  sugar,  85  g  agar,  40  ml 
nipagine (15%), 3 l A.bidest
Coomassie staining solution 0.25 g Coomassie Brilliant blue R-250 in 90 ml of 
methanol :  H2O (1:1, v/v) and 10 ml glacial acetic 
acid
EDTA (0.5M, pH 8.0) 186.1 g EDTA to 800 ml H2O .adjust pH to 8.0 with 
NaOH, autoclave
Homogenisation medium (cells/embryos) 10 mM HEPES, 25 mM EDTA, 100 mM NaCl, pH 
7.4
Hybridisation buffer 50%  deionized  formamide,  5  x  SSC,  100  µg/ml 
tRNA, Heparin 5 µg / ml, 0.1% Tween-20
Incubation buffer 136.8 mM NaCl, 5.36 mM KCl, 0.336 mM Na2PO4, 
0.345 mM KH2PO4, 0.6 mM MgSO4, 2.7 mM CaCl2, 
20 mM HEPES, adjusted to pH 7.5 (supplemented 
with 10 mM NEM and 200 µM PMSF)
Injection buffer 5 mM KCl, 0.1 mM NaPO4, pH 6.8
Nipagine-solution 147 ml ethanol, 63 ml A. bidest, 21 g nipagine
PBS (20x) 2.6 M NaCl, 10mM Na2HPO4, 60 mM NaH2PO4
PBT 1x PBS + 0.1% Tween 20
Proteinase K 20 mg / ml proteinase K in 50% glycerol, 10 mM 
Tris; pH 7.8, store at - 20°C
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RF-1 solution
(chemocompetent bacteria)
100 mM RbCl2;  50 mM MnCl2;  30 mM KOAc; 10 
mM CaCl2; 15% v/v Glycerin; pH 5.8
RF-2 solution
(chemocompetent bacteria)
10 mM Mops, pH 7,0; 10 mM RbCl2; 10 mM CaCl2; 
15% v/v Glycerin
RIPA buffer 100 mM NaCl,  1% IGEPAL CA-630,  0.5% DOC, 
0.1% SDS, 50 mM Tris (pH 8.0) + protease inhibitor 
cocktail
SDS gel-loading buffer 50 mM Tris-Cl  (pH 6.8),  100 mM DTT, 2% (w/v) 
SDS, 0.1% bromophenol blue, 10% glycerol
Solubilisation buffer 20 mM EDTA, 10 mM DTT, 2% (w/v) n-dodecyl ß-
D-maltoside, 20mM triethanolamine (TEA); pH 9.2
Sonication buffer 120  mM  potassiumglutamate,  10  mM  EDTA (pH 
8.5), 20 mM potassiumacetate, 4 mM MgCl2, 2 mM 
ATP, 0.5 mM DTT, 20 mM HEPES; pH 7.2
TAE-Buffer (50x) 2 M Tris-acetate (pH 8.0), 50 mM EDTA
TBS (10x) 0.5 M Tris-HCl, 1.5M NaCl; pH 7.5
TE 10 mM Tris-HCl, 1 mM EDTA; pH 8.0
TX-100 (20%) 2 ml TX-100 in 8 ml A.bidest.
Transfer buffer 25 mM Tris-base, 192 mM glycine, 10% methanol
Tris-glycine electrophoresis buffer 25 mM Tris-base , 250 mM glycine, 0.1% SDS
2.7 Enzymes and Buffers
Boehringer, Roche Complete, Protease-Inhibitor-cocktail
Alkaline Shrimp-Phosphatase (SAP)
DNase; RNase
10 x dephosphorylation buffer
T4-DNA ligase
10 x ligation-buffer
Restriction endonucleases
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Fermentas Restriction-endonucleases
Promega Pfu-Polymerase
Invitrogen SYBR green
2.8 Plasmids
Vector plasmid source
pAc/V5-His B Invitrogen, Karlsruhe
pBluescriptII Stratagene, Heidelberg
pCRII-Topo Invitrogen, Karlsruhe
pCS+ Dave Turner, Ralph Rupp
pMJ-Green AG Willecke, Bonn
pMT/V5-His B,C Invitrogen, Karlsruhe
pUAST AG AG Hoch (R. Bauer)
pWiz Carthew lab
pTOPO Invitrogen, Karlsruhe
2.8.1 LD clones
(from Berkeley Drosophila Genome Project)
Clone Gene Characteristics
SD03467 sec5 SD library; 
tissue source: Drosophila
Schneider L2-cells; 
vector: pOT2
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Clone Gene Characteristics
LD24661 sec6 LD library; 
tissue source: D.m.-embryo
(0-22 Std. old); 
vector: pBluescript SK(+/-)
RE55430 sec15 RE library; 
tissue source: D.m.-embryo
(0-22 Std. old); 
vector: pFLC-I
2.9 Oligonucleotides
2.9.1 Cloning primers
Primer name Sequence (5`->3´)
Melting 
temperature 
Tm (°C)
inx2NTstart-EcoRI GGA ATT CCA AAA TGT TTG ATG TCT TTG GGT 
CCG TC 68.3
inx2deltaCTmycstop
- XbaI
GCT CTA GAG CTT ACA GAT CCT CAG AGA TCA 
GTT TCT GCT CGA TAA GCG ATA 84.7
sec5T7RNAiF1 TAA TAC GAC TCA CTA TAG GGC AAG CTA CAC 
GGC AAT GAG 77.0 
sec5T7RNAiR1 TAA TAC GAC TCA CTA TAG GGA AAT GTC TGG 
CGA AAT GTC 76.0
sec6T7RNAiF1 TAA TAC GAC TCA CTA TAG GGC TTC AGC GCC 
TGT CAT A 77.0
sec6T7RNAiR1 TAA TAC GAC TCA CTA TAG GGA AGT TAT TGG 
GTC GCA GGT G 77.0
sec15T7RNAiF1 TAA TAC GAC TCA CTA TAG GGA ACA TTC CGT 
TCG ATC CTT G 76.0
sec15T7RNAiR1 TAA TAC GAC TCA CTA TAG GGC GAC GGA TGT 
TTT CCT TGA 76.0
inx2 start koz-EcoRI GGA ATT CCC ACC ATG TTT GAT GTC TTT GGG 
TCC 74.0
inx2stop-ApaI CGG GCC CGT TAG GCG TCG AAG GGC CGC TTG 
TG 83.0
inx2myc stop-ApaI CGG GCC CGT TACAGA TCC TCT TCA GAG ATG 
AGT TTC TGC TCG GCG TCG AAG GCC CGC TTG 
TG
92.0
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2.9.2 Sequencing-primers 
All sequencing analyses were done by 4Base lab GmbH, Reutlingen and GATC, Konstanz
The following oligonucleotides were used for sequencing:
Primer name Sequence (5`->3´)
CMV CAA ATG GGC GGT AGG CGT GTA
pCDNA3.1/BGH rev TAG AAG GCA CAG TCG AGG
pEGFP-RP AAC AGC TCC TCG CCC TTG
pUAST F1 GTG AAC ACG TCG CTA AG
pUAST R1 GCG GTT GCC TGC TGA GA
SP6 (Standard) ATT TAG GTG ACA CTA TA
T3 (Standard) ATT AAC CCT CAC TAA AGG GA
T7 (Standard) AAT ACG ACT CAC TAT AGG
2.9.3 RT-PCR primers
Primer name Sequence (5`->3`) Efficiency at 59°C annealing temperature
inx2-Sy-F1 CCT ACT CCG AGC CCG TTC C
100%
inx2-Sy-R1 TGC CCA GCT GAT AGA GCA GG
wg-Sy-F1 GTG CAA GCT GTG TCG GAC CA
100%
wg-Sy-R1 AGA ACG AAGAGG CCG GCT TC
hh-Sy-R1 CAA AGG GCT TGA ACTCGC C
98.3%
hh-Sy-R1 CAA AGG GCT TGA ACTCGC C
Dl-Sy-F1 GCT GTT TTC TCC GTTGCG AT
100%
Dl-Sy-R1 GCG TCG TCC TTT TCCTGA GC
rp49-Real- F1 GTG CAC CGC AAG TGC TTC TAA
100%
rp49-Real-R1 TGC TGC ACT CCA AAC TTC CAC
act-Sy-F1 GCT AAG CTG TCG CAC AAA TG
98.7%
act-Sy-R1 GTT CGA TCC GTA ACC GATGT
sec5-AV-F1 CAT CGA GCC CTC CAT GTA TCT 
100%sec5-AV-R1 CCA ACC AAA TTA TCG CAG CAC
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Primer name Sequence (5`->3`) Efficiency at 59°C annealing temperature
sec6-AV-F1 TTC TTT GAG AAA ATC GCG CC 
100%
sec6-AV-R1 ACG AGC AGT TCG ATA TCC GAG
sec15-AV-F1 CTG TGC CTG GTC TAA AGG AAG G 
90.9%
sec15-AV-R1 CAT GGA AAT ACG TGC TCC ATT C 
2.10 In situ probes
Name of probe Amount per reaction
innexin2 (pBluescript SK+)   4 µl
hedgehog (pBluescript KS+) 10 µl
otp (pBluescript KS+)   2 µl
2.11 Organisms
2.11.1 Bacterial strains
E. coli XL1 Blue MRF ∆(mcrA)183, ∆ (mcrCB-hsdSMR-mrr), endA1, gyrA96, lac(F−,  
proAB, lacIFqZ∆M15, TN10(tetr), recA1, relA1, thi-1 
(Stratagene, Heidelberg)
E. coli DH5α: F-, φ80dlacZΔM15, Δ(lacZYA-argF)U169, deoR, recA1, endA1, 
hsdR17(rk-, mk+), phoA, supE44, λ-, thi-1, gyrA96, relA1
(Invitrogen)
2.11.2 Fly strains
Fly strain genotype chromosome source
double balancer y w; Sp /CyO ftz lacZ; Dr / 
TM3; dominant marker Sp 
and Dr
II. +III. stock collection
hhIJ35 hhIJ35 / Ubx-lacZ III. stock collection
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kropf P(x)16 P(x)16/ FM7; kr::GFP X. stock collection
Gal4-strains genotype chromosome source
fkh-Gal4 w; p[14-3 Gal4, fkh1 e+2 ]/ 
TM3, Sb Ubx lacZ 
III. stock collection
hs-Gal4 P[GAL4-Hsp70];w X. stock collection
prd-Gal4 y w; p[w+;prd::Gal4]3 III. stock collection
twi-Gal4 P{GAL4-twi.2xPE}2 ,w III. Bloomington
twi-Gal4 P[GAL4-twi.G]108.4, w I. Bloomington
UAS-strains genotype chromosome source
UAS- WIZinx2ttt 5.1 w; P[UAS-inx2 dsRNA] III. diploma thesis
H. Lechner
UAS-inx2-1 w;P[UAS-inx2] II. stock collection
UAS-inx2∆CTmyc w;P[UAS-inx2∆CT] II. +III. produced during PhD
thesis
UAS-sec6 w;P[UAS-sec6]/TM3, Sb III. provided by U. Tepass
UAS-sec6 w;P[UAS-sec6]/SM6 II. provided by U. Tepass
UAS-wgHA w; P[UAS-UAS wg HA] II. stock collection
2.11.3 Cell lines
HeLa cells cell line derivative of cervical cancer explant, (source: Willecke lab, Bonn)
SL2 cells embryonic Drosophila Schneider cell line
SL2 inx2-myc embryonic  Drosophila Schneider  cell  line,  stably  transfected  with  
pMTVinx2myc for inducible over expression of innexin2 fusion protein with 
myc-tag
SL2 inx2-gfp embryonic  Drosophila Schneider  cell  line,  stably  transfected  with  
pMTVinx2GFP for inducible over expression of innexin2 fusion protein with 
gfp-tag
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2.12 Media for the cultivation of organisms
2.12.1 Media for bacterial cultures
LB-agar: 
10 g NaCl; 10 g tryptophan; 5 g yeast extract; 20 g agar; add 1 l A.bidest, adjust pH to7.0, 
with 5 M NaOH;  autoclave
LB-ampicillin-agar: 
1 l LB-agar autoclaved, cooled to 60°C, addition of 1 ml ampicillin (50 mg / ml sterile filtrated) 
LB-chloramphenicol-agar: 
1 l  LB-agar autoclaved, cooled to 60 °C ,  addition of 3 ml chloramphenicol (10 mg / ml; 
sterile filtrated)
2.12.2 Media for fly cultivation
2.12.2.1 Fly food (for 11 l)
90 g fiber-agar; 165 g yeast; 615 g maize flour; 1 l treacle; 200 ml 10% nipagine-solution. 
While dissolving fiber-agar in 8 l A.bidest, yeast and maize-flour are mixed with 3.3 l A.bidest, 
which is then applied to the dissolved agar and boiled. Treacle is added and the food is 
cooked for  15 min while  stirring.  After  that,  the food is  cooled down to 60°C ,  nipagine-
solution is added and the food is filled into food vials.
2.12.2.2 Apple juice agar plates
4 l A.bidest are boiled with 85 g agar and cooled down to 65° C. 1 l apple juice is mixed with 
100 g sugar and heated to 65°C. 40 ml nipagine-solution are added to the apple juice-sugar 
mixture  followed  by  the  combination  of  agar  and  apple-juice  mixture.  The  fluid  agar  is 
distributed on petri-dishes and cooled down at RT until the agar is solid.
3 Methods
3.1 Isolation of plasmids from E.coli
3.1.1 Analytical preparation
2 ml of rich medium (LB) containing the appropriate antibiotic are inoculated with a single 
colony  of  transformed  bacteria  and  are  incubated  in  the  culture  overnight  at  37°C  with 
vigorous shaking. 1.5 ml of the culture are filled into a microcentrifuge tube and centrifuged at 
maximum speed for 30 sec at 4°C in a microcentrifuge. The bacterial pellet is resuspended in 
100 µl ice cold alkaline lysis solution I by vigorous vortexing, followed by the addition of 200 
µl freshly prepared alkaline lysis solution II to each vial and mixing. The tubes are stored on 
ice for 2 min. After incubation 150 µl of alkaline solution III  are added and the mixture is 
stored on ice for further 5 min followed by centrifugation at maximum speed at 4°C. The 
supernatant is transferred to a fresh tube. The DNA is now either precipitated directly by the 
addition of  two volumes ethanol  (100%) at  RT and then pelleted by centrifugation,  or  is 
extracted from the solution using Phenol / Chloroform purification. The DNA pellet is washed 
with 1 ml of 70% ethanol and DNA is recovered after 2 min centrifugation at 4°C. After that, 
DNA is dried leaving the tube inverted at RT until the ethanol has evaporated.
3.1.2 Preparative scale
(Nucleo Bond® PC AX100 Kit (Macherey Nagel)
Quantitative plasmid preparations are carried out following the manufacturer´s protocol. An 
overnight culture of a single colony containing the plasmid of interest is set up with 50 ml of 
rich Medium (LB) supplemented with the adequate antibiotic and grown overnight at 37°C in 
a bacterial shaker. The culture is pelleted the following day by centrifugation at 4500 x g for 
15 min at 4°C. The supernatant is discarded and the pellet is dissolved in 4 ml S1 buffer 
containing RNAse A, followed by addition of 4 ml S2 to the suspension and inversion of the 
tube 6-8 times and 5 min incubation at RT for 2-3 min. Then, 4 ml of prechilled S3 buffer is 
added and the suspension directly mixed and incubated 5 min on ice. In between the column 
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is  equilibrated  with  2,5  ml  N2  buffer.  A  funnel  is  set  onto  the  column  containing  a 
NucleoBond® Folded  Filter  and  the  lysate  is  applied  onto  the  filter.  The  flow through  is 
discarded and the column washed with 10 ml N3 buffer. After discarding the flow through the 
column is set onto a fresh 50 ml tube and 5 ml Elution buffer N5 are added to the column. 
After elution of the purified plasmids, the DNA is precipitated by adding 3.5 ml isopropanol 
and centrifugation is carried out at 4500 x g for 60 min at 4°C. The DNA pellet is washed with 
5 ml 70% ethanol, centrifuged again for 15 min and is dried at RT after careful removal of the 
ethanol. Plasmids are later reconstituted by dissolving the pellet in A.bidest or TE buffer and 
the plasmid yield is determined by UV spectrophotometry.
3.2 Isolation of RNA from tissues
(Nucleospin RNA 2 Kit, Macherey & Nagel)
Isolation  of  total  RNA  from  embryos  and  cultured  cells  is  performed  according  the 
manufacturer instructions.  For isolation of RNA from embryos, specimen are collected in a 
close-meshed sieve, washed with PBS and transferred to a 2 ml microcentrifuge tube, the 
supernatant  is  discarded.  50-100  embryos  are  homogenised  in  600  µl  RA1  buffer 
supplemented with 6 µl ß-mercaptoethanol using an electrical homogenisation device. The 
suspension is loaded on a NucleoSpinFilter® and centrifuged for 1 min at 11000 x g at RT to 
reduce viscosity and clear the lysate. The flow through is transferred to fresh tube and mixed 
with 600 ml 70% ethanol. The suspension is transferred onto a NucleoSpin® RNA II Column 
and  further  processed  according  to  the  manual.  Purified  RNA is  resuspended  in  60  µl 
A.bidest devoid of RNAse and stored at -80°C. The concentration and quality of the isolated 
RNA is determined by agarose gel electrophoresis and UV spectrophotometry.
3.3 cDNA synthesis and qRT-PCR set up
3.3.1 cDNA synthesis
(Qiagen QuantiTect Reverse Transcription Kit)
Reverse transcription of mRNA into cDNA is performed using the Quantitect Kit purchased 
from Qiagen. Reactions are carried out as described in the manual. For one reaction only 
half the amount given in the protocol is used and RNA template input is 0.5 µg. Each cDNA 
reaction is diluted to a total volume of 50 µl with A.bidest prior analysis. For each isolated 
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RNA a control reaction is conducted where the transcriptase is substituted by A.bidest to 
exclude remaining DNA contaminations later on.
3.3.2 qRT-PCR analysis
For real-time PCR analyses each reaction consisted of cDNA template (1 µl of 1:100 diluted 
cDNA first strand reaction), forward and reverse primers (200 nM final concentrations, primer 
sequences see section 2.9.3) and iQ SYBR Green Supermix (BIO-RAD) in a total volume of 
25 µl. Three reactions per template are prepared in parallel and are repeated with isolated 
RNA samples from different egg collections. The experiments are performed with iQ5 Real-
Time  PCR  Detection  System  from  BIO-RAD.  Expressions  of  actin  5C  (Act5C,act)  and 
Ribosomal protein L32 (RpL32, rp49) are used as reference genes for normalisation (Fuss et 
al., 2006). Standard control PCR reactions are carried out to test for contaminations. Real-
time PCR is analysed using BIO-RAD iQ5 Optical System software (version 1.1.1442.OCR), 
following the instruction provided by the supplier, and Microsoft Excel. 
3.4 Agarose-gel electrophoresis
To separate DNA, 1% agarose is dissolved in 1x TAE buffer and boiled in the microwave until 
the agarose is melted completely. The fluid agarose is cooled down to 65°C and poured into 
a gel  slayer.  SYBR safe (Invitrogen).  A DNA/RNA intercalating  dye is  added to the fluid 
agarose at a concentration of 1 µg / ml and is distributed with a pipette tip throughout the 
agarose.  A comb is  inserted  into  the  slay  to  generate  slots.  After  hardening,  the  gel  is 
transferred into the electrophoresis chamber containing TAE buffer and the comb is removed. 
DNA, supplemented with loading dye is applied to one of the slots. After that, the chamber is 
voltage  connected  and  the  DNA is  separated  on  the  gel  at  constant  voltage.  Following 
separation of DNA, the gel is taken out and DNA, visible through SYBRsafe, is analysed with 
UV light.
3.5 Polymerase-chain-reaction (PCR)
PCR is an iterative process, consisting of three elements: denaturation of a template by heat 
(30 sec, 94°C), annealing of oligonucleotide primers to their single stranded target sequence 
(30 sec, 54°C - 59°C) and extension of annealed primers by a thermostable DNA polymerase 
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(1 - 2 min for a product length of up to 1.5 kb, 72°C) resulting in an amplification of template 
DNA (30 cycles).  Pfu-polymerase (Promega) is used to amplify DNA for molecular cloning. 
The following components are mixed in a 0.5 ml microcentrifuge tube:
10 x Pfu-polymerase buffer   5.0 µl 
20 mM dNTPs mix   2.0 µl
20 µM forward primer   2.0 µl
20 µM reverse primer   2.0 µl
Template DNA < 0,5 µg
Pfu -Polymerase (3 U / µl)   0.42 µl
A.bidest ad 50µl
3.6 Purification of DNA
3.6.1 Purification of DNA-fragments
(NucleoSpin Extract II, Macherey Nagel)
After PCR or restriction, DNA is purified from salts, oligonucleotides, enzymes or agarose. 
The purification is performed according to the user manual. Purified DNA is eluted from the 
column using 15 - 30 µl A.bidest.
3.6.2 Ethanol precipitation of DNA using sodium-acetate
Precipitation with ethanol is carried out to recover nucleic acids from aqueous solutions. DNA 
is precipitated by the addition of 1/10 volume 3 M sodium-acetate and 2.5 volumes of 100% 
ethanol followed by mixing of the solution and storage on ice for at least 15 min to allow the 
precipitate of DNA to form. DNA is recovered by maximal speed centrifugation at 4°C for 10 
min.  The  supernatant  is  aspirated  and  the  pellet  washed  with  70%  ethanol  and  re- 
centrifuged  for  2  min  at  maximum  speed  and  4°C.  The  DNA-pellet  is  air-dried  and 
resuspended in A.bidest or TE.
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3.6.3 Photometric determination of the DNA concentration
DNA quantification  is  performed using spectrophotometry.  Measurements of  1:25 or  1:50 
(DNA :  TE or  A.bidest)  dilutions are taken at  wavelengths of  260 nm and 280 nm.  The 
reading at 260 nm allows the calculation of DNA concentration. An OD of 1 corresponds to 50 
µg /  ml  for  double stranded DNA.  The ratio  between the readings at  260 nm :  280 nm 
provides to estimate the purity of the nucleic acid. Pure preparations should have values of 
approximately 1.8 - 2.0.
Calculation of the DNA concentration:
3.7 Molecular cloning of DNA-fragments
3.7.1 Restriction of DNA fragments and plasmids
Restriction enzymes are molecular scissors that cut DNA at specific sites. In order to cleave 
DNA the following set up is chosen: 1 µg DNA is mixed in a microcentrifuge tube with 2 µl of 
a  10  x  restriction  buffer  (enzyme  dependent)  and  3-5  U  of  the  corresponding  enzyme 
following incubation at 37°C for 2 - 3 h. After incubation the enzyme is heat inactivated for 15 
min  at  65°C.  For  double  digestions,  using  different  enzymes,  a  suitable  buffer  must  be 
chosen in which both enzymes are active.
3.7.2 Plasmid restriction and dephosphorylation
Integration  of  DNA fragments into plasmids  requires  the opening of  the double  stranded 
plasmid DNA. This is accomplished by restriction of  the plasmid of  interest with identical 
restriction  enzymes  used  for  DNA-fragment  cleavage.  To  avoid  closure  of  the  restricted 
plasmid,  dephosphorylation  of  overhanging 5`phosphate  residues is  carried  out  using an 
shrimp  alkaline  phosphatase  (SAP).  An  amount  of  100  ng  plasmid  DNA is  therefore 
incubated with 1 U / µl SAP in the corresponding reaction buffer in a volume of 20 µl and 
3 Methods 36
incubated 30 min at 37°C, followed by heat inactivation of the phosphatase at 65°C for 15 
min.
3.7.3 Ligation of DNA fragments
The T4 DNA ligase catalyses the formation of phosphodiester bonds between juxtaposed 5'-
phosphate and 3'-hydroxyl termini in duplex DNA or RNA with blunt or cohesive-end termini, 
to integrate restricted DNA fragments stably into plasmids, resulting in a closed ring structure 
which can be transformed into competent  bacteria  later  on for  amplification.  For  a 20 µl 
reaction, the ratio of input between vector DNA (100 ng) and insert DNA (300 ng) is 1 : 3. 2 µl 
of a 10 x ligation buffer and 1U of T4-DNA-ligase and the volume is adjusted to 20 µl with 
A.bidest. The reaction is incubated afterwards at 16°C over night.
3.7.4 TOPO cloning
(TOPO® PCR Cloning, Invitrogen)
TOPO® cloning uses the enzyme DNA topoisomerase I, which functions both as a restriction 
enzyme and as a ligase. Its biological role is to cleave and rejoin DNA during replication. 
Vaccinia virus  topoisomerase  I specifically  recognises  the  pentameric  sequence  5´-
(C/T)CCTT-3´  and  forms  a  covalent  bond  with  the  phosphate  group  attached  to  the  3´ 
thymidine.  It  cleaves  one  DNA strand,  enabling  the  DNA to  unwind.  The  enzyme  then 
religates the ends of  the cleaved strand and releases itself  from the DNA. To avoid the 
religating  activity  of  topoisomerase,  TOPO® vectors  are  provided  linearised  with 
topoisomerase I covalently bound to each 3´ phosphate. This enables the vectors to readily 
ligate DNA sequences with compatible ends. The ligation is complete in only 5 minutes at 
room temperature. For one reaction 0.5 µl DNA, 1 µl salt solution, 1 µl pCRII-TOPO-Vector 
and 2.5 µl A. bidest are mixed by pipetting and the mixture incubated for 5 min at RT. 2 µl of 
this reaction are mixed to 100 µl of “One Shot” competent bacteria and are incubated 20 min 
on ice followed by a heat shock at 42°C for 30 sec for the transformation of bacteria. To 
amplify bacteria, 250 µl preheated LB medium is added to the tube and incubated at 37°C for 
1h. In the meantime LB-agar- plates containing the appropriate antibiotic are covered with X-
Gal solution, a substrate for ß-galactosidase encoded by the lacZ gene in the vector, and the 
plates are dried at 37°C. After that 50 µl of the transformed bacteria are streaked on each 
plate and the plates cultured over night at 37°C. At the next day, white colonies, where the 
lacZ gene of the vector is deleted by the insert DNA, can be picked an analysed further.
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3.7.5 Preparation and transformation of chemocompetent bacteria
3.7.5.1 Preparation of chemocompetent bacteria
10 ml LB-medium are inoculated with a single colony of  bacteria  (strain DH5α)  and are 
incubated overnight at 37°C in a bacteria shaker. A volume of 2 ml of this preparatory culture 
are transferred to 50 µl of fresh LB-medium and incubated at 37°C in the shaker until the 
optical density (OD at 550 nm) has reached 0.5. Bacteria are pelleted by centrifugation (15 
min, 1000 x g, 4°C). The pellet is resuspended in 1/3 of initial volume ice cold RF-1 solution. 
This suspension is incubated for 15 min on ice before centrifugation at 1000 x  g and 4°C. 
The pellet is resuspended in 1/12 of initial volume RF-2 solution and incubated for 15 min at 
4°C. Bacteria are divided in portions of 200 µl in microcentrifuge tubes and stored at -80°C.
3.7.5.2 Transformation of chemocompetent bacteria
For one transformation reaction of 100 ng plasmid DNA into chemocompetent bacteria, an 
amount of 100 µl of  chemocompetent bacteria are thawed at 4°C and mixed in a 1.5 ml 
microcentrifuge tube with the DNA by pipetting followed by incubation on ice for 30 min. 
During this step plasmids adsorb to the bacterial membranes. Afterwards a heat shock at 
42°C is applied for 2 min, which results in plasmid acceptance through instable bacterial 
membranes. Next, the transformed bacteria are cooled down on ice and 1 ml of preheated 
LB-medium is added. The tube is incubated shaking (800 rpm) at 37°C allowing the bacteria 
to amplify. After incubation, the bacteria are pelleted by centrifugation at 13000 x  g for 10 
sec,  supernatant  is  discarded  and  bacteria  are  resuspended  in  the  reflux.  The  whole 
suspension is streaked on LB-agar plates containing the suitable antibiotic. The plates are 
cultured at 37°C over night.
3.8 Biochemical Methods
3.8.1 Cell culture
3.8.1.1 Cultivation of HeLa cells
HeLa  cells  are  cultured  in  75  ml  cell  culture  flasks  in  DMEM  (low  glucose)  medium 
supplemented with 10% FCS and 1% antibiotic (penicillin/streptomycin) at 37°C and under 
7% CO2  gassing. They are splitted twice a week in a 1:3 ratio. Therefore cells are washed 
twice with PBS followed by the addition of 1 ml trypsin and incubation for several minutes 
until cells loose adhesion to flask bottom. Cells are harvested by several strikes against the 
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flask and dilution in fresh medium.
3.8.1.2 Cultivation of SL2 cells
SL2 cells are cultured in 75 ml cell culture flasks in Schneiders Mediums containing 10% 
FCS and  1% penicillin/streptomycin.  Cells  are  splitted  twice  a  week in  a  1  :  5  ratio  by 
exchange of medium and knocking off cells from the flask bottom.
3.8.1.3 Transient transfection of HeLa cells
HeLa cells are sowed one day before transfection in the appropriate density in 6 -, 24 - or 6 - 
well  plates  or  on  100  mm  dishes.  All  transfections  are  done  with  Lipofectamine  2000 
(Invitrogen) in OPTIMEM (Invitrogen). Each transfection reaction is set up as described in the 
manual. After 6 h incubation the transfection medium is aspirated and fresh DMEM + 10% 
FCS is added. Cells are harvested for further analyses 24-48 h post transfection.
24 well 6 well 100mm
plating density 2 x 105 5 x 105 2 x 106
DNA 0.1-0.8 µg 1-4 µg 15-20 µg
DNA : Lipfectamine 
ratio
1:2 - 1:3 1:2 - 1:3 1:2 - 1:3
3.8.1.4 RNAi treatment of cultured SL2 cells
Knock down experiments using RNA interference (RNAi) is a successful tool to specifically 
reduce transcripts levels in cells. One advantage is that Drosophila uses this mechanism to 
defend against pathogens in nature. Therefore, RNAi treatment of Drosophila cells is an easy 
approach and double  stranded RNA is  applied directly to  the cells  without  the usage of 
transfection agents. For the accomplishment of RNAi experiments SL2-inx2 myc cells are 
plated in a density of 1 x 106 cells on 6 - well dishes containing a coverslip in serum free 
medium. Cells are allowed to deposit on the surface of the dish for 2 h. After that, double 
stranded RNA (double stranded RNA synthesis is described in section 3.8.10.1) is applied. 
The amounts that are used vary between 30-50 µg per sample. After incubation for 30 min at 
25  °C medium containing  FCS is  added  the  incubation  is  carried  out  for  3  days.  After 
incubation the coverslip is carefully taken out and cells grown the coverslip are fixed with 4% 
PFA followed by immunhistochemistry. The remaining cells are harvested using a cell scraper 
and are transfered to a 1.5 ml  microcentrifuge tube following RNA extraction in  order to 
analyse the knock down efficiency by qRT-PCR.
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3.8.2 Immunohistochemistry of cultured cells
Antigens of fixed cultured cells are commonly detected by detection with antigen specific 
antibodies (primary antibodies), which are later visualised by secondary antibodies coupled 
to a fluorescent dye. The detection of fluorescent  immuno-complexes is accomplished by 
imaging with  a confocal  microscope or  conventional  fluorescence microscopy.  Therefore, 
cells cultured on coverslips are fixed for 10 min at RT in 4% PFA followed by 2 x 5 min 
washes  with  PBS.  Accessibility  of  the  antibodies  to  the  antigens  is  enhanced  by 
permeabilisation with 0.2% TX-100 in PBS for 5 min at RT. Further washes of the cells with 
PBS follow to remove the permeabilisation solution. Next, blocking of cells in PBS + 1%BSA 
for 20 min is carried out. After removal of the blocking solution, primary antibody dilutions (in 
blocking solution) are applied on the coverslips and antibodies are incubated for 30 min at RT 
on a rocking table following 2 x 5 min washes in PBS and 2 x 10 min washes in PBS + 1% 
BSA. Now cells can be incubated with the secondary antibody, which is diluted in blocking 
solution. Incubation is carried out in the dark for 30 min on a rocking table. Several washes 
with PBS follow the antibody incubation. After that, coverslips are mounted on microscopy 
slides with Vectashield Hard Set (with or without DAPI, as a nuclear probe).
3.8.3 Preparation of protein extracts
3.8.3.1 Preparation of protein extracts from cultured cells (native and denaturing)
Cells are washed twice with PBS before further processing. Cells are harvested from 100 
mm plates with a cell scraper, transferred to a falcon tube and pelleted at 1000 x g at 4°C for 
10 min. The supernatant is discarded and the pellet homogenised in homogenisation medium 
or RIPA buffer (depending on whether native or denaturing conditions are chosen) using a 
tight fitting Dounce Homogenisator. RIPA extracts are further treated for 1 min in a ultrasound 
bath until the lysate becomes clear. Extracts are centrifuged at 10000 x g for 10 min at 4°C to 
pellet debris. The resulting supernatant, containing cellular proteins is stored at -80°C until 
further usage.
3.8.3.2 Preparation of protein extracts from D. melanogaster embryos
Embryos  are  collected  in  a  close-meshed  filter,  washed  with  PBS and  transferred  to  a 
prechilled Dounce Homogenisator with a brush and the appropriate homogenisation medium 
is added. The lysate is prepared with 15 - 20 strokes with a tight fitting pestle. RIPA extracts 
are  further  treated  for  2  min  in  a  ultrasound  bath  until  the  lysate  becomes  clear.  The 
homogenate is transferred into microcentrifuge tube and centrifuged at 10000 x g for 20 min 
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and 4°C. The supernatant is transferred to fresh microcentrifuge tube and further fractionated 
or stored at -80°C.
3.8.3.3 Dephosphorylation of proteins
Calf  intestine  alkaline  phosphatase  is  used  for  dephosphorylation  serine,  threonine  and 
tyrosine residues in proteins. For the dephosphorylation of proteins,  Drosophila embryonic 
extracts  (without  phosphatase  inhibitor)  are  incubated  with  the  calf  alkaline  shrimp 
phosphatase (CIAP, Roche) following the manufactures protocol for at least 30 min at 37°C. 
The reaction is stopped by the addition of SDS gel-loading buffer and heating of the sample 
for 5 min at 96°C.
3.8.4 Identification of protein concentration using BCA-Test
(BCA Protein Assay, Pierce)
The BCA Protein Assay is used to determine the protein concentration of protein extracts. It 
combines the reduction of Cu2+ to Cu1+ by protein in an alkaline medium with the highly 
sensitive and selective colorimetric detection of the cuprous cation (Cu1+) by bicinchoninic 
acid. The first step is the chelation of copper with protein in an alkaline environment to form a 
blue-colored complex. In the second step BCA, a highly sensitive and selective colorimetric 
detection reagent  reacts  with  the cuprous cation  (Cu1+)  that  is  formed in  step one.  The 
purple-colored reaction product is formed by chelation of two molecules of BCA with one 
cuprous  ion.  The  BCA/copper  complex  is  water-soluble  and  exhibits  a  strong  linear 
absorbance  at  562  nm  with  increasing  protein  concentrations.  Reactions  and  standard 
curves for different buffers are carried out as described in the manual using half the volume 
given  for  one  reaction.  950  µl  of  working  reagent  is  diluted  with  either  50  µl  of  the 
homogenisation  buffer  (blank  value  determination)  or  46  µl  homogenisation  buffer 
supplemented with 4 µl of the protein extract (equals a 12.5 fold dilution). After incubation for 
30 min at 37°C protein contents are calculated from spectrophotometry measurements at 
562 nm. 
3.8.5 Gel electrophoresis and transfer of proteins
3.8.5.1 SDS-PAGE and native PAGE 
Proteins  are  usually  separated  on  polyacrylamide  gels.  Polyacrylamide  can  be  used  in 
different  concentrations resulting in  variable pore sizes  to efficiently separate  proteins  of 
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different sizes. In this thesis, the acrylamide concentration of the resolving gel varied from 6 
to  15% depending  on  the  protein  analysed.  SDS-PAGE is  carried  out  when  denaturing 
conditions are required to separate proteins according their size. Basic native PAGE, where 
no  SDS is  added  to  the  gel  and  proteins  are  separated  according  to  their  charge  and 
hydrodynamic  size,  is  used  to  analyze  the  composition  of  oligomeric  acidic  and  neutral 
proteins (protocol by Lebendiker, 2000). Here the pH of the running buffer is adjusted to 8.9 
and SDS is exchanged by A.bidest. Electrophoresis is carried out at 80 - 150 V.
Composition / resolving gel
(5 ml)
SDS-acrylamide-gel (10%) Native gel (10%)
H2O 1.9 ml 1.95 ml
30% acrylamide mix 1.7 ml 1.7 ml
1.5 M Tris pH 8.8 1.30 ml 1.3 ml
SDS (10% stock) 0.05 ml --------
APS 0.05 ml 0.05 ml
TEMED 0.003 ml 0.006 ml
Composition / stacking gel
(1 ml)
SDS-acrylamide-gel (5%) Native gel (5%)
H2O 0.68 ml 0.69 ml
30% acrylamide mix 0.17 ml 0.17 ml
1.5 M Tris pH 6.8 0.13 ml 0.13 ml
SDS (10% stock) 0.01 ml --------
APS 0.01 ml 0.01 ml
TEMED 0.001 ml 0.002 ml
3.8.5.2 Staining polyacrylamide gels with Coomassie Brilliant Blue
Polyacrylamide gels with electrophoretically separated proteins are immersed in 5 volumes 
of staining solution for at least 4 h at RT followed by removal of stain and destaining by 
soaking gel  in  methanol  :  acetic  acid  solution  without  the  dye for  further  4 -  8  h.  Now, 
destaining of the gels follows: the destaining solution is exchanged 3-4 times after 15 min 
incubation. After destaining, gels are stored in A.bidest in a sealed plastic bag or dried under 
vacuum with heat (65°C) on whatman paper for 2 h.
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3.8.5.3 Western Blotting using a tank system
In  order  to  make  proteins  accessible  for  antibody  detection,  separated  proteins  on  a 
polyacrylamide  gel  are  transfered  to  a  membrane  made of  nitrocellulose  or  PVDF.  The 
membrane,  moistened with methanol  (PVDF) or  water  (nitrocellulose)  and equilibrated in 
transfer buffer, is placed on the gel and is layered in between a stack of whatman papers and 
two foam pads moistened in transfer buffer in between a tank transfer cassette holder. The 
membrane is oriented to the anode, whereas the gel is oriented to the cathode. Then the 
holder and an ice-block are placed in the tank blotting apparatus and the tank filled with 
transfer buffer. Electro blotting is carried out at 100 V for 1 – 2 h depending on protein size. 
After that, the transfer efficiency of total protein is analysed by Ponceau S (Sigma-Aldrich) 
red staining of proteins on the membrane and discoloration with TBST. 
3.8.5.4 Antibody binding and ECL detection
After transfer of proteins to the PVDF or nitrocellulose membrane, incubation with 5% milk 
powder in TBST is carried out for at least 2 h, followed by over night incubation with the 
primary antibodies diluted in TBST at 4°C. Next day, the membrane is washed several times 
for 5 min in TBST before incubation with the second antibody for 1 h at RT, recognising the Fc 
region of the bound first antibody. After antibody incubation, the blot is washed several times 
with TBST. The second antibody is coupled to HRP that produces chemiluminescence when 
converting an ECL substrate. The signal becomes visible when X-ray films are laid onto the 
membrane in the dark for different exposure times (20 s - 10 min) . X-ray films are developed 
in a Curix60 developer.
3.8.6 Co-Immunoprecipitation
(Immunoprecipitation Starter Pack, GE Healthcare)
Immunoprecipitation is a highly specific and effective technique for analytical separation of 
target  antigens  from  cell  homogenates  with  the  help  of  Sepharose  A/G  beads.  Co-
immunoprecipitation means that interacting proteins of the pulled antigen can be identified by 
antibody detection in addition using Western Blot analysis. Cell- or embryonic RIPA- extracts, 
a highly stringent homogenisation medium. Per reaction 300 - 500 µg of the protein lysate 
are diluted in 500 µl RIPA buffer. In parallel, sepharose beads are prepared as described in 
the manual. In the next step, the lysate is precleared by the addition of 50 µl sepharose and 
mixing for 1 h at 4°C. Beads are precipitated by centrifugation at 12000 x g at 4°C for 20 sec. 
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The supernatant is transferred to a fresh microcentrifuge tubes and the antibody is added at 
a concentration between 1 - 4 µg per reaction. As a control reaction, the appropriate normal 
IgG antibodies of different species are applied in parallel samples at the same concentration. 
Samples are incubated for 3 h at 4°C. The resulting immune complex is precipitated by the 
addition  and  incubation  of  40  µl  beads  and  incubation  for  2  h  at  4°C  followed  by 
centrifugation to pellet beads with the bound immune complex. The pellet is washed three 
times with 1 ml lysis buffer and centrifuged at 12000 x g for 20 sec between each wash. The 
final pellet is suspended in 30 µl sample buffer, heated for 3 min at 95°C and pelleted again. 
The supernatant is analysed by SDS-PAGE and Western blot.
3.8.6.1 Co-immunoprecipitation with crosslinked antibody sepharose complexes
To  prevent  that  IgG  chains  from  the  precipitating  antibody  become  visible  after 
immunoblotting,  antibodies  can  be  coupled  to  the  used  sepharose  with  the  help  of 
dimethylpimelimidatdihydrochlorid (DMP), a crosslinking agent. To perform crosslinking, 60 µl 
of sepharose beads are washed 3 times with 0.1 M sodium-phosphate buffer (pH 7.0) and 
are pelleted after each wash by centrifugation (see above). The antibody is diluted in 500 µl 
sodium-phosphate buffer, added to the sepharose and the mixture is incubated rotating for 
1h  at  4°C.  After  that,  the  complexes  of  antibody  and  sepharose  are  sedimented  by 
centrifugation (30 sec at, 12000 x g, 4°C) and are washed with 300 µl 0.2 M triethanolamine 
(pH 8.2). For the following crosslinking procedure, the complexes are incubated in 500 µl 20 
mM DMP in 0.2 M triethanolamine (pH 8.2) for 45 min at RT followed by one wash in 0.2 M 
triethanolamine and three additional washes in RIPA buffer. Now, the RIPA protein extract is 
added as described in section 3.8.6 and incubated over night. The following washing steps 
are done also as described above. The final pellet is suspended in 30 ml sample buffer and 
heated for 10 min at 65°C.
3.8.7 Cell surface biotinylation and pulldown assay
(Cell surface biotinylation kit, Pierce)
Expression  of  proteins  at  the  plasma  membrane  can  be  assayed  using  cell  surface 
biotinylation when lysines are exposed at the cell surface. Adherent cells are first labeled with 
Sulfo-NHS-SS-Biotin, a cleavable biotinylation reagent. Efficient labeling requires accessible 
lysine residues, sufficient sequence with extracellular exposure and minimal steric hindrance. 
The cells are subsequently lysed with a mild detergent and then labeled proteins are isolated 
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with the help of  column containing NeutrAvidin Gel.  The bound proteins are released by 
incubating the resin with SDS-PAGE sample buffer containing 50 mM DTT. The reducing 
agent  cleaves  the  disulfide  bond  within  the  biotin  label,  and  nearly  100% of  the  bound 
proteins are recovered. Isolated proteins are analysed by Western blot.
The  biotinylation  procedure  of  SL2  cells  expressing  inx2-myc  for  48  h  is  performed  as 
described in the manual using half of the amounts given for one reaction.
3.8.8 Fractionation of cells via density gradient centrifugation
Density gradient centrifugation is applied to separate different organelles in order to study 
their subcellular contents and to separate different oligomeric assemblies from each other. In 
this thesis different approaches are undertaken that applied density gradient centrifugation. 
Subcellular fractionation of organelles using discontinuous systems is accomplished in order 
to enrich different kinds of cellular membranes. For this purpose, protocols by Quigley (1976) 
and Love and colleagues (1998) are followed in order to separate a cytoplasmic fraction from 
a plasma membrane (PM), endoplasmic reticulum (ER) and vesicle fraction to study innexin2 
localisation.  In  order  to  isolate membranes of  PM and ER,  a total  membrane fraction  is 
isolated from SL2 cells (4 confluent 100 mm dishes), obtained by high speed centrifugation 
and separation in  a discontinuous sucrose gradient  (20%, 40%, 60% (w/v)  sucrose) and 
centrifugation at 100000 x g , 3 h. The fresh lysate is centrifuged 8 min at 600 x g and 4°C to 
remove cell debris and nuclei. The postnuclear supernatant is used for the isolation of the 
total membrane fraction and centrifuged at 100000 x g for 90 min and 4°C. The supernatant 
constitutes  the  cytoplasmic  fraction,  whereas  the  pellet  contains  all  membranes.  The 
resulting membrane pellet  is suspended in homogenisation medium and layered onto the 
discontinuous gradient  followed by centrifugation at  100000 x  g for  3  h at  4°C.  Discrete 
bands of subcellular membranes are removed from the gradient between two sucrose layers, 
diluted with homogenisation medium and washed by centrifugation at 100000 x g for 1h. 
Pellets are dissolved in homogenisation medium or sample buffer, followed by SDS-PAGE 
and  Western  blot  analysis.  Cloudy  membrane  accumulations  corresponding  to  the  PM 
fraction float  between 20% and 40% sucrose,  whereas the ER / mitochondrial  fraction is 
harvested between 40-60% sucrose. Vesicles float to the top of the gradient.
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Fig.  3-1  Schematic  drawing  of  endoplasmic  reticulum  and  plasma  membrane 
fractionation (after Quigley, 1976).
A second approach to isolate vesicles is a carried out using a discontinuous gradient made 
with Optiprep (Love et al., 1998). Cells (2 ml of a SL2 cell pellet) are washed in PBS and ST- 
(0.2 M sucrose, 10 mM Tris, pH 7.2) buffer, resuspended in 4 ml of ST per 1 ml of cell pellet, 
frozen in liquid nitrogen, and kept at -80°C until needed. Cells are thawed in a water bath at 
room temperature and transferred on ice immediately after thawing. 
Fig. 3-2 Schematic drawing of vesicle purification (after Love et al., 1998).
Permeabilised cells are pelleted by 5 min of centrifugation at 1,000 g at 4°C. Vesicles remain 
in  the  supernatant.  To  separate  vesicles  from  cytosol,  all  membranes are pelleted  by 
ultracentrifugation (90 min at 100000 x g) and are resuspended in 0.8 ml KHM buffer (150 
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mM KCl, 10 mM Hepes, pH 7.2, 2.5 mM MgOAc). 1.2 ml of 50% iodixanol ("optiprep") in HM 
(10 mM Hepes, pH 7.2, 2.5 mM MgOAc) is added, and the mixture is overlaid in an SW55 
tube (Beckman) with 2 ml of 25% iodixanol in KHM and 1 ml of  10% iodixanol in KHM. 
Vesicles are floating to the 10% / 25% interface during a 3 h centrifugation at 55,000 rpm in 
an SW55ti swing out rotor (Beckman Coulter) at 4°C. The vesicle membrane fraction isolated 
using a syringe from the interface. 
3.8.9 TX-100 solubilisation and continuous density gradient centrifugation
3.8.9.1 TX-100 solubilsation
Acquisition of Triton X-100 insolubility is a useful assay for gap junction channel assembly of 
different connexins (VanSlyke and Musil, 2000). The ability to separate plasma membrane 
integrated  gap  junctions  from  native  forms  of  connexin  oligomers  by  this  method  is 
dependent  on the detergent,  temperature and the buffer  composition of  the solubilisation 
reaction. For this reason the protocol by VanSlyke and Musil is carried out strictly. 
Production  of  a  protein  lysate  from  embryos  or  cultured  cells  is  accomplished  using 
incubation buffer and a Dounce Homogenisator (see 3.8.2). After that, 20% TX-100 is added 
to the the suspension to a final concentration of 1% and the tube is vortexed vigorously. The 
sample is incubated for 30 to 40 min at 4°C. Half the volume is removed from the sample and 
reserved  as  a  sample  of  total  lysate  (=  TX-100  soluble  +  insoluble).  The  remaining 
homogenate is spun at 100000 x g for 50 min at 4°C (36800 rpm in a 70Ti rotor, Beckman). 
The TX-100 solubilised extract is collected without disturbing the pellet. The pellet containing 
the TX-100 insoluble membrane fraction is  resuspended with 50-100 µl  incubation buffer 
depending on the pellet size. Its is homogenized with a micro pistil or a 26 gauge needle 
attached to a 1 ml syringe. Different protein fractions are kept at -80°C.
3.8.9.2 Velocity sedimentation of innexins in sucrose gradients
This procedure to fractionate innexin oligomers along sucrose gradients  is  adopted from 
studies about the assembly of the nicotinic acetylcholine receptor by Koval and colleagues 
(Koval et al., 1997) and from assembly studies of connexins (VanSlyke and Musil,  2000). 
Two stock solutions of sucrose are premixed with incubation buffer (5% and 20% w/v). 2 ml 
of each of the premixed solutions are added to the appropriate chamber of a gradient maker 
and continuous 5-20% sucrose gradients are prepared and chilled to 4°C. Gradients are 
overlaid with 0.5 ml - 0.75 ml (0.5 - 1 µg / µl) of TX-100 solubilised extract and gradients are 
spun  at  250000  x  g for  12  h  in  an  SW55 swinging  bucket  rotor.  In  parallel,  additional 
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gradients  are  loaded  with  100  µg  of  purified  ovalbumin  (45  kD)  or  catalase  (250  kD), 
purchased  from  Sigma  to  assess  their  sedimentation  as  markers  for  monomeric  or 
hexameric  assemblies,  respectively.  After  centrifugation,  fractions  of  500  µl  volume  are 
collected from the top of the gradient, following sucrose concentration measurement with a 
refractometer.  Protein  is  precipitated  from  each  fraction  using  methanol/chloroform 
precipitation.
3.8.9.3 Precipitation of Proteins using methanol / chloroform extraction
(after Wessel and Fluegge)
Quantitative precipitation of dilute protein samples, containing salts and detergents as TX-
100, for immunoblotting analysis is done by the dilution of the protein sample with 4 volumes 
methanol and vortexing of the mixture followed by the addition of 1 volume chloroform and 
vortexing. Finally, 3 volumes of A.bidest are added and the mixture is vortexed another time. 
Next,  centrifugation  is  carried out  at  4500 x  g for  15 min.  The precipitated proteins  are 
discovered  in  the  interface  between  two  phases.  The  upper  phase  is  discarded  and  3 
volumes of methanol are added following mixture of the sample and centrifugation at 4500 x 
g for 15 min to pellet the precipitated proteins. The supernatant is removed completely and 
the pellet is dried under vacuum at 37°C for 5 min. The purified and concentrated protein can 
be further analysed by immunoblot analysis.
3.8.9.4 Oligomerisation assay
Sodium dodecyl  sulfate  (SDS)  is  a  detergent,  which  is  commonly  used  to  resolve  non-
covalent bindings in and between proteins. In the oligomerisation assay TX-100 solubilised 
protein-lysates are incubated with various concentrations of SDS, which leads to the decay 
of oligomeric proteins into their monomeric form (Diez et al.,  1999). In this thesis SDS is 
applied to the TX-100 solubilised lysates at concentrations between 0.6% and 2% (w/v) for 1 
h at RT followed by velocity sedimentation in sucrose gradients and Western blot analysis. 
Results are compared to untreated controls.
3.8.10 In vitro transcription and translation
3.8.10.1 In vitro transcription
(RIBOMAX large scale , Promega)
To generate  mRNA for  in vitro translation experiments or to synthesis of double stranded 
RNA, 5 µg of a linearised plasmid (e.g. pBSinx2full) containing T7, SP6 or T3 promotor 5`-
prime of the inserted cDNA are mixed with 30 µl rNTP Mix, 20 µl 5 x transcription buffer, 10 µl 
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enzyme Mix T7, T3 or SP6, filled to 100 µl with A.bidest and are incubated for 4 h at 37°C. In 
the following step DNA digestion is carried out with 4.5 U DNase RQ1 for 15 min at 37°C and 
phenol/chloroform extraction of the synthesised mRNA. The resulting RNA pellet is dried and 
suspended in 80 µl RNAse free A.bidest.
For  the  generation  of  double  stranded  RNA for  RNAi  treatment  of  SL2  cells,  the  DNA 
digestion  is  stopped  by  5  min  incubation  at  70°C  after  in  vitro transcription  following 
refrigeration of the sample at RT, resulting in annealing of double stranded RNA.
3.8.10.2 In vitro translation and oligomerisation of proteins
(Rabbit Reticulocyte Lysate System, Nuclease Treated, Canine Microsomal
Membranes; Promega)
Rabbit  reticulocyte  lysate  translation  systems  are  utilised  in  the  identification  of  mRNA 
species, the characterisation of their protein products and the investigation of transcriptional 
and translational  control.  Rabbit  reticulocyte  lysate  is  prepared from New Zealand  white 
rabbits. After the reticulocytes are lysed, the extract is treated with micrococcal nuclease to 
destroy  endogenous  mRNA and  thus  reduce background translation  to  a  minimum.  The 
lysate contains the cellular components necessary for protein synthesis (tRNA, ribosomes, 
amino acids, initiation, elongation and termination factors). Microsomal vesicles are used to 
study co-translational and initial post-translational processing of proteins and has been used 
successfully for in vitro assembly of different connexin isoforms (Ahmad et al., 1999; Falk et 
al., 2001). The following components are mixed for one reaction: 
17.5 µl Rabbit reticulocyte lysate
0.5 µl Amino acid mix without methionine
1.8 µl Microsomal membranes
1-3 µl mRNA
2.0 µl 35 S Methionine (1,200 Ci / mmol at 10 mCi / ml)
ad 25.0 µl H2O
The sample is  incubated at  30°C over  night.  Analyses  are carried out  using SDS-PAGE 
followed by autoradiography and density gradient centrifugation followed by liquid scintillation 
counting or SDS-PAGE.
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3.8.10.3 Solubilisation of microsomal membranes
Solubilisation of microsomal membranes is done to release inserted proteins and analyse 
their contents (Ahmad et al., 1999). After the synthesis of innexin2 protein with the help of 
reticulocyte lysate and in the presence of microsomes, the translation mixture is incubated 
for 2 h in a solubilisation buffer. Samples are centrifuged at 12000 x g at 4°C for 15 min and 
the supernatant is subsequently loaded on preformed 5–20% (w/v) linear sucrose gradients 
prepared in 20 mM EDTA, 10 mM DTT, 0.2% n-dodecyl ß-D-maltoside and 20 mM TEA (pH 
9.2). After centrifugation at 150000 x g for 18 h at 4 °C, ten 0.5 ml fractions are collected and 
proteins dialysed against water in Microcon filter devices.
3.9 Drug treatment of Drosophila ovaries and cells
Ovaries of 24 h fertilised female flies are dissected in Schneiders Medium. Drugs are added 
at the appropriate concentrations (Colchicine or BFA: 20 µg / ml) and incubated at RT while 
rotating as required (Colchicine for 30 min, BFA for 4 h). In parallel, controls are incubated 
with the solvents only, that are used to dissolve the drug, to exclude unspecific effects during 
incubation. The treatment is stopped by fixation in formaldehyde.
3.10 Membrane sheet preparation from HeLa cells
Membrane sheets from basal cell membranes can be obtained by applying an ultrasound 
pulse  to the  cultured cells  on a coverslip  followed by and immediate fixation in  4%PFA. 
Therefore HeLa-cells are grown on 25 mm coverslips coated with poly-L-lysine. The coverslip 
is  transferred to  the  bottom of  a  dish  containing  sonication-buffer.  One pulse  (1 sec)  of 
ultrasound is applied and the coverslip is immediately fixed in 4% PFA for 90 min. After that, 
PFA is  removed and 50 mM NH4Cl2 is added for  20 min incubation,  followed by several 
washes with PBS (Sieber et al., 2007) The preparation can be used for conventional antibody 
staining of cells (see section 3.8.2).
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3.11 Fly work with Drosophila melanogaster
3.11.1 Fly stock keeping
Breeding  of  Drosophila melanogaster stocks  is  accomplished  using  standard  methods 
(Roberts et al., 1986).
3.11.2 Fixation of Drosophila embryos
Embryos are transferred from agar plates with A.bidest and a brush into a close mesh. The 
embryos are  dechorionated with  6% sodium-hypochloride,  washed with  A.bidest  and are 
fixed for 5 min in heptane : 37% formaldehyde (1 : 1). To remove the vitelline membrane, the 
lower phase of fixation solution is discarded and 10 ml methanol are added. The sample is 
mixed by vortexing for  1  min.  Fixed embryos sink  down to the  bottom of  the  vial.  After 
accumulation  of  fixed embryos at  the bottom of  the vial,  the whole solution is  aspirated 
carefully and embryos are washed twice with methanol. Fixed specimen can be stored at 
-20°C in methanol.
3.11.3 Antibody staining of Drosophila embryos 
An appropriate number of embryos is transferred into fresh 1,5 ml microcentrifuge tubes (this 
will be approximately 25-50 ml settled volume of embryos) and the methanol from surface of 
embryos  is  removed.  To rehydrate the  fixed embryos,  washes with  70%,  50% and 30% 
methanol (in PBS ) follow (5 min each). After that, embryos are washed twice with PBT for 10 
min before they are incubated in 2% donkey serum in PBT for 20 min to block unspecific 
antibody binding later on. The primary antibody is diluted in 2% donkey serum in PBT and 
incubated overnight at 4°C while rotating. The next day, primary antibody is removed and 
saved at 4°C (depending on the antibody titer, it can be re-used multiple times). The embryos 
are washed 4 x 10 min in PBT, followed by 20 min incubation in PBT+ 2% donkey serum. 
The second antibody (coupled to a fluorophor or an enzyme, which creates a signal when a 
substrate is added) is diluted in blocking solution and incubated 2 h at RT while rotating 
followed by 4 x 10min washes with PBT. Embryos are mounted in Gelmount on microscope 
slides and kept at 4°C until imaging.
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3.11.4 Antibody staining of Drosophila ovaries
Dissected ovaries are fixed in 4% PFA in PBT + 0.3% TX-100 for 30 min. The following steps 
are performed as described in section 3.11.3. with the exception that PBS is supplemented 
with 0.3% TX-100 instead of 0.1% Tween and mounting is done using Vectashield Hard Set 
with or without DAPI.
3.11.5 In situ hybridisation of Drosophila embryos (chemical)
In situ hybridisation is unique in its ability to reveal patterns of gene expression with cellular 
resolution. Embryos are fixed in such a way that all  mRNA being transcribed at the time is 
retained by hybridisation with a probe labeled so that it  can be detected by chromogenic 
stains or fluorescence.
In  a  first  step,  an  appropriate  probe  has  to  be  synthesised  that  is  able  to  specifically 
recognise corresponding mRNA fragments. To enable hybridisation of the probe to the target 
mRNA, a probe is designed in the antisense direction of the corresponding mRNA. As a 
control, a sense probe is also synthesised, which should not bind to the mRNA of interest.
For the synthesis of the probe the following components are mixed in a microcentrifuge tube:
1 µg   linearised plasmid containing cDNA 
2 µl   10 x transcription buffer
2 µl   10 x nucleotide mix (with digoxigenin-UTP)
20U   RNAse inhibitor
40 U  T7, SP6 or T3 polymerase
Incubation of the mixture is done for 2 h at 37°C followed by DNase I treatment (40 U) at 
37°C  for  15  min.  The  reaction  is  stopped  by  adding  2  µl  200  mM EDTA,  pH 8.0.  The 
synthesised  RNA is  precipitated  with  2.5  µl  M  LiCl  and  75  µl  pre-chilled  ethanol.  The 
precipitated RNA is spun down at 13000 x g for 10 min and redissolved in 100 µl of RNAse-
free water. The quality of the obtained RNA is checked on a 0.8% agarose gel in TBE. RNA 
probes are stored at -20°C until usage.
In situ hybridisation of the synthesised probe is accomplished as outlined below:
Embryos are fixed in 4% PFA following the protocol given in section 3.11.2., and rehydrated 
through 70%, 50%, 30% methanol in PBT. Incubation with a 1:800 dilution of a 20 mg/ml 
proteinase K stock for 2.5 min follows to make the tissue accessible for the RNA probe. After 
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this step, embryos are rinsed 2 x 1 min in PBT and fixed again for 5 min in 4% PFA, before 2 
x 1 min washes in PBT and a final wash in PBT : hybridisation buffer (1 : 1) follow. Pre-
hybridisation is done at 60°C in a water bath for at least 1 h in hybridisation buffer. After that 
the  buffer  is  removed  completely  and  exchanged  by  200  µl  fresh  hybridisation  buffer 
containing the heat denaturated probe (denaturation at 80°C for 5 min in a small volume 
hybridisation buffer). The probe is diluted depending on RNA amount between 1:100 and 
1:0000. Hybridisation is carried out over night at 60°C in a water bath.
Next  day,  the hybridisation buffer  containing the probe is  removed and the embryos are 
washed in fresh hybridisation buffer for 2 x 20 min ,1 x 20 min in PBT : hybridisation buffer 
(1 :1 ) at 60°C, followed by 5 x 20 min washes in PBT at RT.
Hybridised specimens are then incubated with anti-DIG antibody, diluted 1:2000 for 1 h. After 
removal of the antibody solutions, the embryos are washed 4 x 20 min in PBT followed by 
washes in AP buffer for 2 x 1 min. Next, 1 ml of AP buffer is mixed with 20 µl NBT / BCIP, a 
substrate  which  reacts  with  the  alkaline  phosphatase  coupled  to  the  anti-DIG  antibody, 
resulting in a blue precipitation at sites where the probe has bound. The solution is added to 
the embryos and the appearance of stain is monitored carefully using a binocular to avoid 
over-staining. The reaction is stopped with several rinses in PBT.
Dehydration of the stained embryos is carried out through 30%, 50%, 70% and 100% ethanol 
for 5 min each. Specimen are mounted in Canada-balm on a microscope slide and covered 
with  a  coverslip.  Hardening  of  the  sample  takes  12  -  24  h  before  analysis  with  a  light 
microscope is possible.
3.11.6 Fluorescence in situ hybridisation combined with antibody staining
Detection  of  mRNA  and  protein  in  the  same  embryo  can  be  accomplished  using  a 
combination of both techniques. For this purpose, embryos are treated during the first day of 
the experiment as outlined in section 3.11.5. After hybridisation of the probe with  mRNA, 
embryos are washed for 2 x 20 min at 60°C in hybridisation buffer : PBT (1:1) and for 4 x 20 
min in PBT to remove the unbound probe completely. Incubation with an anti-DIG antibody 
(sheep) is done for 1 h in PBT + 2% donkey serum followed by several washes with PBT (2 x 
5 min, 1 x 10 min, 2 x 5 min) and incubation with an anti-sheep-biotin antibody in PBT +2% 
donkey serum for 2 h. Extensive rinses in PBT follow (2 x 5 min, 1 x 10 min, 2 x 5 min). While 
rinsing the embryos, ABC reagent (Vectastain) is prepared by mixing 5 µl of component A 
with 5 µl of component B with 490 µl PBT and pre-incubation at RT follows for 30 min while 
rotating. After that, the ABC-mixture is applied to the the embryos and incubated 45 min on 
the rotating wheel and afterwards washed with PBT (as before).  Detection of the labeled 
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probe is performed by the addition of 100 µl TSA-Cy3 (1:250 in Amplification Diluent; Perkin 
Elmer) and a 20 min incubation following 4 x 10 min washes in PBT and blocking in PBT + 
2% donkey serum. Specimens are ready for fluorescent antibody staining as described in 
3.11.3. Secondary antibodies may not be coupled to Cy3.
3.11.7 Drosophila crossing experiments
In several experiments using Drosophila melanogaster, crossing of different strains has to be 
accomplished beforehand. To set these crossings only virgins of one strain are collected and 
crossed to males of a different strain. Identification of virgins is done time defined. A breeding 
vial with pupae is kept at 18°C and hatched female flies are collected within 18 h. The vial 
has to be screened for virgins every 4 h hours at 25°C. Virgins are collected in fresh breeding 
vials and are kept at 18°C until crossing.
3.11.8 The GAL4-UAS system in Drosophila melanogaster
The Gal4-UAS system is  an ectopic  expression  system to  overexpress  transgenes  in  a 
certain temporal and spatial manner in Drosophila (Brand and Perrimon, 1993). The coding 
sequence of a yeast transcription factor, Gal4, is cloned 3` prime of certain enhancers and is 
introduced stably in the fly via germ line transformation. Transgenic flies (activator strains) 
can be kept stably.  Another strain of flies (effector strain)  carries the upstream activation 
sequence (UAS) for Gal4 in front of a transgene. When both strains are crossed, Gal4 is 
expressed  and  binds  to  UAS,  which  leads  to  the  transcription  of  the  inserted  trangene 
3`prime of the UAS.
3.11.9 Germ line transformation
P-elements are mobile genetic elements in Drosophila that can be used genetically as tools 
to create transgenes and mutations. P-elements have a length of 2.9 kb and are flanked at 
their ends by repeated sequences of 31 bp, which encode for a transposase that catalyses 
the mobilisation and integration of P-elements into the genome. This kind of mobilisation is 
limited to the germ line cells because soma cells express an inhibitor of transposases due to 
differential splicing. Modified P-Elements are used as transformation-vectors for Drosophila. 
3 Methods 54
(Rubin and Spradling, 1982). Two differently modified P-elements are used in this case, one 
encodes  a  transposase  lacking  inverted  repeats,  which  prevents  the  integration  in  the 
genome and is  not  passed over to the next  generation (= helper plasmid).  A second P-
element containing the inverted repeats carries in between the gene of interest and a marker 
gene. The transposase of this P-element is deleted. To generate P-element transformed fly 
strains,  embryos  in  the  cellular  blastoderm  stadium  are  injected  with  a  mixture  of  both 
elements at  the  posterior  pole  plasma,  where  later  on the  precursors of  germ line  cells 
differentiate. After the pole cells have integrated both vectors, germ cells are transformed and 
the  progeny  of  those  flies  carries  the  transgene  in  all  cells.  Those  transgene  flies  are 
detected via a marker, usually a marker that results in a different eye color (in this thesis 
embryos from flies with white colored eyes (w- strain) are injected. white served as marker for 
transgenesis, resulting in red colored eyes after transformation). 
The mixture for injection contains 2.5 µg helper plasmid and 7.5 µg (precipitated with ethanol 
and sodium-acetate) of the vector with the gene of interest in 50 µl injection buffer.
4 Results
4.1 Drosophila gap junction hemichannel assembly
Vertebrate gap junction hemichannel formation has been studied extensively over the past 
years. Several  biochemical and functional studies showed the hexameric nature of  those 
channels (Van Slyke and Musil,  2000; Ahmad et al.,  2001). Non such studies have been 
undertaken to investigate the oligomeric status of Drosophila gap junction hemichannels. 
In  order  to  investigate  the  oligomeric  composition  of  Drosophila  innexin gap  junction 
hemichannels  that  do  not  exhibit  sequence  homology  on  the  amino  acid  level  to  their 
vertebrate connexin analogues, various biochemical approaches were undertaken to clarify 
the  issue  of  innexin  gap  junction  hemichannel  formation.  Innexin2  as  one  of  eight  gap 
junction constituting family members in Drosophila was used to analyse assembly of innexin 
hemichannels. 
Results presented on the investigation of oligomerisation of innexin2 in the first part of this 
doctorate thesis continued initial studies during the Diploma thesis (Lechner, 2004) and proof 
first evidence for the existence of hexameric hemichannels that contain innexin2.
4.1.1 Innexin2 is contained in hexameric  hemichannels that show  TX-100 
insolubility upon plasma membrane integration
Triton  X-100  (C14H22O(C2H4O)n)  is  a  nonionic  surfactant  that  is  used  routinely  to 
permeabilise eukaryotic cell membranes. It was used by Musil and Goodenough previously 
in  order  to  separate  phosophorylated  membrane  integrated  gap  junction  connexin43 
hemichannels from unphosphorylated native connexin43 hemichannels that have not been 
integrated  in  the  plasma membrane  yet  (Musil  and Goodenough,  1991).  For  this  assay, 
native protein-lysates of communication-competent normal rat kidney cells were incubated 
with 1% Triton X-100 (TX-100) for 30 min at 4°C in incubation buffer and were subsequently 
centrifuged at 100000 x g at 4°C. The resulting pellet contained mainly membranes enriched 
with TX-100 insoluble proteins containing hexameric connexons, whereas the supernatant 
comprised all solubilised proteins including native oligomers of connexin43 (Fig. 4-1)
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In order to study innexin oligomerisation and membrane integration such an experiment was 
done with Drosophila native embryonic lysates prepared from 0-16h old wild type specimen.
Fig.  4-1 Schematic  drawing  of  gap  junction  oligomerisation  and  TX-100  solubility 
characteristics. Newly synthesised and oligomerised connexins are soluble in 1% TX-100 at 
4°C,  whereas  membrane  integrated  hexamers  acquire  TX-100  insolubility  due  to  post 
translational modifications of connexin subunits.
First, a plasma membrane fraction was isolated from wild type embryonic extract by applying 
discontinuous density gradient centrifugation on 20%-60% sucrose step gradients. Plasma 
membranes were harvested from the interphase between 20-40 % sucrose (Quigley, 1976). 
To prepare plasma membrane fractions, total membrane fractions, obtained by differential 
centrifugation of wild type extracts for 90 min at 100000 x g were loaded onto the gradient 
and centrifugation was carried out at 100000 x g for 3 h at 4°C. Discrete bands of subcellular 
membranes  were  removed  from  the  gradient,  diluted  with  homogenisation  medium  and 
washed by centrifugation at 100000 x g for 1 h, followed by TX-100 solubilisation. Portions of 
harvested protein were separated on 6% basic native PAGE gels and innexin2 status was 
further analysed by Western Blot analysis.
Immunoblotting using an anti-innexin2 antibody (inx2KLRH) revealed a band corresponding 
to the size of approximately 250 kD in total embryonic extracts and in plasma membrane 
enriched fractions, corresponding to the size of innexin2 containing hexameric assemblies. 
The TX-100 soluble fraction prepared from total extracts contained an additional band which 
presents an oligomeric intermediate containing innexin2.
In  summary,  TX-100  solubility  studies  showed,  that  innexin2  containing  hexamers  are 
insoluble in TX-100 at chosen conditions as had been shown before for the vertebrate gap 
junction protein connexin43 (Fig. 4-2; Musil and Goodenough, 1991). Furthermore, the TX-
100 treated fractions and the plasma membrane contained only hexamers, whereas the TX-
100 soluble fraction showed an additional band, indicating that only the hexameric structures 
detected in this approach, acquired insolubility upon membrane integration.
“TX-100 soluble”
“TX-100 insoluble”
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Fig. 4-2 Native PAGE analysis of innexin2 (inx2) containing hemichannels after TX-100 
solubilisation.  Detection of innexin2 in the PM and in the TX-100 soluble fraction of total 
extracts reveals one protein band corresponding to the size of a hexameric form of innexin2 
in the insoluble fraction, whereas in the soluble fraction an additional band is detected with 
the innexin2 antibody (oligomeric intermediate).
4.1.2 Modifications of innexin proteins are crucial for the acquirement of 
TX-100 insolubility
To further characterise TX-100 insolubility of innexin2 containing hexamers, native embryonic 
extracts  solubilised  with  the  non-ionic  detergent  were  also  separated  under  reducing 
conditions  using  conventional  SDS-PAGE  with  Laemmli-buffer  (Gallagher,  2006).  This 
approach  was  chosen  to  figure  out  whether  modifications  on  innexin2  protein  could  be 
detected that distinguish innexin2 insoluble protein from soluble protein.
After  TX-100 solubilisation and centrifugation to separate soluble from insoluble proteins, 
innexin2 was detected again in both, the TX-100 soluble and insoluble fraction. The detected 
innexin2 protein bands showed differences in their molecular weight. A protein band at 42 kD 
was detected in the total and the TX-100 soluble fraction, corresponding to the full length size 
of  monomeric  innexin2 protein,  whereas a  protein  band of  higher  molecular  weight  was 
detected  in  the  total  and  the  TX-100  insoluble  fraction  (45  kD).  This  result  indicated 
modifications are introduced in  innexin2 containing  hexamers,  which  might  be a  general 
characteristic of TX-100 insolubility (Fig 4-3). 
inx2 containing hexamer
oligomeric intermediate
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Fig.  4-3  Innexin2-containing  hexamers  are  modified  before  membrane  integration. 
Innexin2 exhibits two major protein forms in total extracts and in a TX-100 soluble fraction. 
Only the higher molecular weight form of innexin2 protein is found in the TX-100 insoluble 
fraction, whereas the lower molecular weight form is absent, pointing to post translational 
modification of innexin2 upon membrane integration.
In  order  to  evaluate,  whether  modifications  of  innexins  are  a  general  prerequisite 
accompanied with TX-100 insolubility and membrane integration, the biochemical behaviour 
of another innexin isoform was investigated. 
Fig. 4-4 A modification of innexin3 protein is prerequisite for membrane integration. 
Innexin3 shows two major forms in total extracts and in a TX-100 soluble fraction. Only the 
higher molecular weight form of innexin3 protein is found in the TX-100 insoluble fraction, 
whereas the lower molecular  weight form is absent.  This suggests that  post translational 
modifications of innexins are prerequisite for membrane integration.
Fractionation of TX-100 solubilised embryonic extracts and detection with an anti-innexin3 
antibody also showed a higher molecular weight protein band in the insoluble fraction, which 
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was absent from the TX-100 soluble fraction, indicating that the introduction of modifications 
in innexin proteins is a necessity for TX-100 insolubility and plasma membrane integration of 
innexin hexamers (Fig. 4-4).
Investigations,  whether  phosphorylation,  as  one  possible  translational  modification,  is 
required for TX-100 insolubility and membrane integration, dephosphorylation reactions were 
carried  out.  Dephosphorylation  assays  of  embryonic  protein  extracts  using  calf  intestine 
alkaline phosphatase for 30 min at 37°C have been shown to reduce the upper protein band 
detected with the innexin3 antibody, arguing that phosphorylation is one modification involved 
in the acquisition of TX-100 insolubility (by B. Loer;  Fig. 4-5).  Dephosphorylation assays, 
followed by immunoblot detection of innexin2 did not show this clear effect, indicating that 
additional  modification  might  play  a  role  in  the  acquirement  of  TX-100  insolubility  and 
associated membrane integration.
Fig. 4-5 Phosphorylation is one post translational modification of innexin3. Treatment 
of embryonic extracts with calf intestine alkaline phosphatase (CIAP) leads to a decrease of 
the higher molecular weight protein band of innexin3 in favour of an increase in intensity of 
the lower innexin3 protein band.
4.1.3 Innexin2 is detected in different oligomeric forms
A common assay to study oligomerisation of proteins, besides native PAGE analysis used in 
the first section (4.1.1), is to separate oligomers of different sizes along density gradients 
following  fractionation  and  SDS-PAGE to  analyse  the  content  of  those  fractions.  In  this 
approach a linear 5 - 20% (w/v) sucrose gradient was chosen to separate different oligomeric 
assemblies of innexin2. To assess the sedimentation of different oligomeric proteins along 
the gradient, purified marker proteins of different molecular weights, namely ovalbumin (45 
kD) and catalase (250 kD) were centrifuged under the same biophysical conditions and their 
distribution along the sucrose gradient was analysed by Coomassie blue staining.
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Figure 4-6 shows that catalase with a molecular weight of 250 kD, corresponding to the size 
of  innexin2  containing  hexamers,  was  detected  in  fraction  between  14  -  19%  sucrose, 
whereas the smaller protein ovalbumin (45 kD) that was used to determine the sedimentation 
of monomeric innexin2 (42.49 kD), floated between 7 - 11% sucrose.
Fig.  4-6  Analysis  of  sedimentation  behaviour  of  the  marker  proteins  catalase  and 
ovalbumin in sucrose gradients. Coomassie blue-stained  SDS-polyacrylamide-gels after 
density centrifugation of purified catalase, 250 kD and ovalbumin, 45 kD on 5 - 20% sucrose 
gradients  and  fractionation.  Under  chosen  conditions,  catalase  sediments  in  fractions 
between 14 - 19% sucrose, whereas ovalbumin is detected in fractions containing 6 - 10% 
sucrose 
Consistently, accumulations of innexin2 protein were detected in fractions between 16 - 19% 
sucrose (Fig. 4-7), strengthening the evidence for hexameric isoforms that contain innexin2 
(section 4.1.1). In addition, an enhanced detection of innexin2 protein was detected also in 
the 7% sucrose fraction, indicating the presence of monomeric, unassembled protein (Fig. 4-
7, upper panel). The detected protein bands in between monomeric and hexameric forms 
were designated as oligomeric intermediates that have not reached the hexameric status yet. 
The hexameric form of innexin2-containing oligomers was termed “innexon” in analogy to the 
hexameric connexon. A control for the oligomerisation assay is to study the behaviour of 
oligomeric  proteins  after  dissolving  non  covalent  bonds,  which  mediate  adhesiveness  of 
proteins within an oligomer, by the addition of reducing agents. Analyses of such denaturated 
protein extracts were carried out under the same biochemical conditions that were used for 
TX-100 solubilised extracts.
4 Results 61
Fig.  4-7  Innexin2  forms  hexameric  hemichannels  and  oligomeric  intermediates. 
Addition of different concentrations of SDS (0.6% middle panel, 2% lower panel) to the TX-
100 soluble extract before centrifugation leads to the decay of innexin2 containing oligomers 
as compared to the untreated control (top panel). Analyses were done by continuous density 
gradient centrifugation of TX-100 solubilised extract on sucrose gradients and fractionation. 
In untreated controls, monomeric protein (accumulation in low percentage sucrose fractions 
between 7% - 9%) was separated efficiently from hexameric proteins (detected in fractions 
between 16% - 19% sucrose).
Applying  different  concentrations  (0.6  and  2%)  of  SDS,  which  works  by  disrupting  non-
covalent bonds in the proteins, causing the molecules to loose their native shape, to the TX-
100 solubilised lysate, resulted in a shift  of  innexin2 protein distribution to lower sucrose 
content fractions, indicating that innexin2 containing hexamers resolved into monomers and 
oligomeric intermediates under denaturating conditions (Fig. 4-7, middle and lower panel).
4.1.4 Innexin2 has the potential to form homomeric hemichannels in vitro
The preceding analyses of innexin2 oligomerisation were performed using whole embryonic 
extracts in the presence of all the other 7 innexin isoforms. In order to test whether innexin2 
holds the ability to form hexamers on its own and to exclude the influence of other innexin 
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proteins on the oligomerisation process, in vitro translation of full length innexin2 mRNA was 
carried out in the presence of canine microsomal membranes and the radioactive S35 epitope 
to  label  the  translated protein.  The described approach was  commonly used for  in  vitro 
assembly studies of connexin proteins (Falk,  2000).  Using this system and analysing the 
oligomerisation  ability  of  innexin2  by  liquid  scintillation  counting  of  integrated  S35  after 
separation  of  the  innexin2-oligomeric  forms  by  density  gradient  centrifugation  on  5-20% 
sucrose gradients followed by fractionation, revealed that innexin2 is to some extend able to 
assemble  into  hexameric  hemichannels.  However,  the  efficiency  of  in  vitro  translated 
innexin2  protein  in  building  hexamers  was  comparatively  low.  Only  22% of  total  protein 
relative to 100% monomers was found in  fractions between 18-19% sucrose,  which had 
been shown before to contain only hexameric innexin assemblies (Fig. 4-8). However, most 
of  the protein was detected in  fractions from 6-14%, containing innexin2 monomers and 
oligomeric intermediates.
Fig.  4-8 Innexin2 forms homomeric hexamers  in vitro.  Liquid  scintillation  counting  of 
incorporated S35 after in vitro oligomerisation of innexin2, density gradient centrifugation and 
fractionation. Only 22% of total protein is found in fractions designated to contain hexameric 
oligomers. Most of the protein accumulates in fractions between 6-14% sucrose containing 
monomers and oligomeric intermediates.
In order to evaluate this further, the  in vitro oligomerisation experiment was repeated and 
analysed  using  a  different  approach.  Fractions  containing  monomeric  and  oligomeric 
innexin2 were analysed by SDS-PAGE followed by autoradiography to verify that the signals, 
obtained by liquid scintillation counting, correspond to in vitro translated innexin2 protein and 
its oligomeric forms.
In fact, detection of a 42 kD protein band in different sucrose fractions corresponded to the 
size  of  monomeric  innexin2,  indicating  that  the  results  obtained  by  liquid  scintillation 
counting, resulted from the investigated protein (Fig. 4-9). Together, these data point to the 
ability of innexin2 to form homomeric hexamers in vitro, however to a quite low extent.
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Fig. 4-9 SDS-PAGE and autoradiography of in vitro oligomerised innexin2 protein after 
velocity sedimentation on sucrose gradients. A signal  at  42 kD corresponding to the 
protein  size  of  innexin2  protein  is  detected  in  fraction  between  7  -  19%  sucrose  with 
accumulation  of  protein  in  fractions  between  7  -  11%  (monomers)  and  19%  sucrose 
(hexamer containing fraction).
4.1.5 Overexpression of innexin2 in SL2 cells leads to plaque formation 
among neighbouring cells
Knowing that  innexin2 was able to form innexons,  which provide on half  of  gap junction 
channels, led to investigations of the resulting channels at the plasma membrane between 
adjacent cells that exhibit a typical plaque like structure in vertebrates.
Cell  culture  systems  are  often  used  to  perform  trafficking  assays  and  to  proof  plaque 
formation ability of gap junction proteins. In this thesis a system was used that enables an 
inducible overexpression of innexin2 in SL2 cells. 
SL2 cells, which are of Drosophila embryonic origin, naturally express innexins to a relative 
low extent.  These cells  do not  show gap junction typical  plaque like  structures between 
neighbouring cells, which is detectable by immunofluorescent staining (Bauer et al., 2006). 
To enhance and to differentiate ectopic from endogenous innexin2 expression in SL2 cells, 
an epitope-tagged version of innexin2 was introduced in these cells via stable transfection. 
SL2  cells  were  co-transfected  with  an  inducible  innexin2-myc  expression  construct 
(pMTVinx2-myc) and a vector that mediates resistance to the antibiotic hygromycin. Stable 
cells were selected by hygromycin addition to the medium at a concentration of 300 µg / ml. 
Overexpression of innexin2-myc protein in these stable cell line, inducible by the addition of 
copper sulphate, lead to the formation of gap junction typical plaques when cells were in 
direct contact to each other, even when no  DE-Cadherin was co-expressed as described 
previously (Bauer et al.,  2006; Fig. 4-10). Plasma membrane expression of innexin2 was 
verified, applying cell surface biotinylation of extracellularly exposed lysines and pull-down 
with avidin coated sepharose (Fig 4-11).
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Fig. 4-10 Overexpression of innexin2-myc in stable SL2 cells leads to gap junction 
plaque  formation.  Double  staining  of  innexin2-myc  (green)  and  innexin2  (red).  Over 
expression of innexin2-myc results in the formation of plaque like structures between two 
neighbouring cells (arrow).
Fig. 4-11 Innexin-2 myc is expressed at the plasma membrane of SL2 cells. Cell surface 
biotinylation of innexin2-myc. Biotinylation and pull-down of scintillated proteins with avidin 
coupled sepharose shows innexin2 (arrows) in the biotinylated fraction, whereas ß-tubulin 
was  found  only  in  the  flow through,  indicating  a  plasma  membrane  localisation  of  over 
expressed innexin2 protein.
Together,  these  results  showed that  the  generated  SL2  cell  line,  expressing  an  epitope 
tagged variant of innexin2, forms gap junction plaques at the plasma membranes between 
adjacent  cells.  The generated cell  line was used later  on for  the trafficking analysing of 
innexin2 containing gap junction plaques. 
4.2 Trafficking of innexin2 to the plasma membrane
After synthesis, transmembrane proteins have to travel to their final destination, namely the 
plasma membrane taking several routes. The well conserved secretory pathway is one of the 
major routes transmembrane proteins take to reach the plasma membrane. Different studies 
addressing exocytosis  of  vertebrate connexins showed that  the secretory pathway is  the 
main trafficking route for connexin oligomers and hemichannels for most of the investigated 
vertebrate gap junction proteins (Laird, 2006; Martin et al., 2001).
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4.2.1 Innexin2 is localised within compartments of the secretory pathway
In  a  first  approach,  addressing  the  issue  of  innexin2  trafficking,  subcellular  fractionation 
experiments were carried out in order to define the subcellular distribution of innexin2 protein 
within  different  cellular  compartments.  Differential  centrifugation  combined  with  density 
gradient centrifugation was used to isolate different membrane compartments of SL2 cells 
and to analyse them for  innexin2 content  using established protocols  for  fractionation of 
cultured cells (Quigely, 1976; Love et al., 1998).
Fig. 4-12 Innexin2 detection in different cellular compartments. Innexin2 is found in all 
membrane  fractions  (PM,  ER,  vesicle  fraction)  isolated  from  SL2  cells,  whereas  the 
cytoplasmic fraction is devoid of innexin2 protein.
Isolation of plasma membranes from discontinuous sucrose gradients (20 - 60% sucrose) 
from the 20% to 40% sucrose interphase,  followed by SDS-PAGE, Western Blotting and 
antibody  detection  of  innexin2  as  well  as  the  membrane  marker  syntaxin1A,  as  total 
membrane marker, showed that innexin2 was contained in the plasma membrane fraction. 
From same gradients a fraction at the interphase between 40-60% sucrose was isolated, 
designated  to  a  endoplasmic  reticulum  enriched  membrane  fraction  (Quigely,  1976).  As 
control,  BiP/Hsc70-3 protein, which encodes an  endoplasmic reticulum  located heat shock 
protein with ATPase activity (Elefant and Palter, 1999),  was found to be enriched in this ER 
enriched membrane  fraction.  Innexin2  was  also  found to  be  present  within  this  fraction, 
whereas its detection was absent from the isolated cytoplasmic fraction that was obtained by 
differential  pelleting  at  100000  x  g for  90  min.  The  cytoplasmic  fraction  was  free  of 
contaminating membranes indicated by the absence of the membrane marker syntaxin 1A. 
As a positive control that protein was present in the isolated fraction, the presence of ß-
tubulin as cytoplasmic protein was checked in the same fraction (Fig. 4-12). 
Furthermore,  a  total  vesicle  fraction  was  isolated  according  the  protocol  of  Love  and 
colleagues (Love et al., 1998). Due to their low density, vesicles float up in 10-40% iodixanol 
gradient and are harvested from the 10% - 25% iodixanol interphase. Analysis of the vesicle 
fraction revealed an accumulation of rab 5 in this fraction, a marker for early endosomes 
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(Wucherpfennig  et  al.,  2003).  Innexin2 protein  was  also  detected in  this  isolated vesicle 
fraction.
In  a  second  approach,  fluorescent  antibody  staining  of  the  epidermis  of  wild  type  and 
transgenic embryos that carry epitope-tagged markers (PDI-GFP; Golgi-CFP) for different 
organelles was carried out. Innexin2 localisation was analysed using confocal microscopy 
scanning through different focal planes of the embryonic epidermis.
Fig.  4-13  Partial  colocalisation  of  innexin2  and  different  subcellular  markers. Co-
immunostaining of innexin2 (red) and the plasma membrane marker spectrin (blue) of wild 
type embryonic epidermal cells (A).  Co-immunostaining of PDI-GFP (green) and innexin2 
(red)  of  epidermal  cells  (B)  and of  Golgi-CFP (green)  and  innexin2  (C)  from transgenic 
embryos (PDI-GFP and Hs::Golgi-CFP).
As described before, (Lehmann et al.,  2006, Bauer et al., 2004) innexin2 expression was 
found localised at the plasma membranes of epidermal cells (Fig. 4-13 A). Partial overlap 
with PDI-GFP, a GFP tagged variant of the disulphide isomerase that is ER located, points 
again  to  ER localisation  of  innexin2  (Fig.  4-13  B).  Another  transgenic  line  was  used  to 
analyse Golgi localisation of innexin2. Only some spots seemed to colocalise with the CFP-
tagged Golgi protein galactosyl-tranferase (Fig. 4-13 C). Results from co-immunostainings 
were consistent with previous finding of subcellular fraction studies, where innexin2 was also 
found in membrane fractions representing compartments of the secretory pathway.
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4.2.2 Brefeldin A treatment blocks endoplasmic reticulum exit of innexin2 
To  investigate  the  trafficking  route  of  innnexin2  further  and  to  clarify  whether  innexin2 
transport is indeed dependent on ER to Golgi transport, drug treatment experiments were 
carried out interfering with the early secretory pathway.
Brefeldin A is  known as fungal  lactone which interacts with  the anterograde transport  of 
proteins from the ER to the Golgi-apparatus (Klausner et al., 1992) by causing a breakdown 
of the Golgi apparatus and its redistribution into the ER. As a consequence proteins that are 
transported along the secretory pathway fail to reach their final destination and accumulate in 
the ER and the cytoplasm of brefeldin A treated cells. This assay was used in SL2inx2-myc 
cells and follicle cells of the Drosophila egg chamber to analyse whether innexin2 membrane 
trafficking is accomplished via the ER to Golgi trafficking route.
4.2.2.1 Brefeldin A treatment of SL2 cells
In  a  first  approach  brefeldin  A treatment  was  carried  out  in  cultured  SL2  cells,  stably 
expressing innexin2-myc under an inducible promotor. Applying brefeldin A at concentration 
of 20 µg / ml for 6 h to 40 h induced cells, resulted in the loss of plaque like structures at the 
membranes of adjacent cells as compared to the solvent (DMSO) treated controls (Fig. 4-
14).  Innexin2-myc  protein  is  found  strongly  colocalised  with  the  ER  marker  PDI  upon 
brefeldin A treatment, suggesting an ER exit block of innexin2-myc protein.
Fig. 4-14 Brefeldin A treatment results in a cytoplasmic accumulation of innexin2-myc 
in SL2 cells. Mock treated (DMSO) cells show plaque like structures between adjacent cells 
whereas no plaques are visible after BFA treatment (20 µg / ml) for 6 h. innexin2-myc protein 
(green) accumulates in the cytoplasm of BFA treated cells, colocalising with the ER marker 
PDI (red). Scale: 10 µm.
4.2.2.2 Brefeldin A treatment of the follicle cell epithelium of the Drosophila egg 
chamber
The follicle cell epithelium of the Drosophila egg chamber serves as and excellent system to 
study trafficking of  epithelial  membrane proteins (Fig.  4-15;  Horne-Badovinac  and Bilder, 
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2005).  These  cells  provide  a  highly  polar  organisation  and  imaging  can  be  easily 
accomplished.  Localisation  and  trafficking  of  various  membrane  proteins  has  been 
investigated successfully within this cellular system (Denef et al.,  2008, Tanentzapf et al., 
2000).  innexin2 mRNA expression  in  the  Drosophila ovary  has  already been  shown  by 
Stebbings  and  colleagues,  being  expressed  in  both,  the  germ  line  and  follicle  cells 
(Stebbings et al., 2002)
Fig. 4-15 Apico-basal polarity in the follicle cell epithelium. The drawing shows a stage 
8 egg chamber  with a magnified view of  two follicle  cells  and their  polarity showing the 
localisation of adherens and septate junctions along the apico-basal axis.
To  determine  the  protein  localisation  of  innexin2  in  the  follicle  cell  epithelium,  co-
immunostaining experiments were carried out with an anti-innexin2 antibody and an antibody 
recognising DE-cadherin, a Drosophila adherens junction core component, which marks the 
apico-lateral  membranes.  Detection  of  labelled  innexin2  protein  by  confocal  microscopy 
resulted in  the observation of  a  highly ordered expression pattern along the baso-lateral 
membrane (Fig. 4-16) of the follicle cell epithelium. DE-cadherin as adherens junction marker 
was found accumulating at the apico-lateral domain and with a weaker expression also at the 
lateral  membranes of follicle cells.  This highly ordered pattern made it  possible to detect 
changes in the localisation of innexin2 easily. 
Nurse cells
Oocyte
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Fig. 4-16 Baso-lateral localisation of innexin2 at the PM of follicle cells. Innexin2 (red) 
localisation at the baso-lateral membrane of follicle cells (fc) of the egg chamber, lateral view 
(left), top view (right) (A).  DE-cadherin (green) was co-stained as a marker for the apico-
lateral domains of the follicle cells epithelium. Lateral view (left), top view (right) (B). Merged 
pictures of DE-cadherin and innexin2 stainings in (C). Asterisks (*) mark the localisation of 
the oocyte.
Because of the clear expression pattern of innexin2 enriched at the baso-lateral membranes 
in follicle cells,  this system was used as an ex vivo model to study brefeldin A dependent 
changes of innexin2 localisation. 
Fig.  4-17 Brefeldin  A treatment  causes  innexin2 accumulation in  the cytoplasm of 
follicle cells.  Follicle cells of Brefeldin A (BFA) treated (right panel) and untreated ovaries 
(left  panel).  Whereas innexin2 was localised at  the plasma membrane of  solvent  treated 
control ovaries, localisation was shifted to the cytoplasm in BFA treated cells.
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Treatment of freshly isolated ovaries with brefeldin A at a concentration of 20 µg / ml for 4 h 
at  RT resulted in an accumulation of  innexin2 protein in the cytoplasm of  follicle cells in 
contrast  to  the  solvent  (DMSO)  treated  control  ovaries,  where  innexin2  localisation  was 
enriched at the plasma membrane, further indicating that the Golgi apparatus is an essential 
component on the trafficking route of innexin2 to the membrane (Fig. 4-17).
4.2.3 Innexin2 colocalises with ß-tubulin in the follicle cell epithelium
Gap junction  membrane trafficking  has  been shown to  be accomplished via  microtubule 
dependent trafficking in the vertebrate cells (Shaw et al., 2007, Guo et al., 2003, Giepmans 
et al., 2001). To check whether Drosophila gap junction proteins do also have the potential to 
interact with microtubules during trafficking and membrane integration, co-immunostainings 
of  ß-tubulin  and  innexin2  were  carried  out  in  the  follicle  cell  epithelium  of  the  ovary. 
Localisation of the fluorescently labelled proteins pointed to a spatial overlap of both proteins 
(Fig. 4-18).
Fig. 4-18 Innexin2, ß-tubulin and DE-Cadherin distribution in the follicle cell epithelium 
of  Drosophila egg  chambers.  DE-cadherin  (blue)  was  used  as  a  membrane  marker. 
innexin2 (red) and β-Tubulin (green) colocalise in the cytoplasm and predominately at lateral 
membranes. Asterisk (*) marks the oocyte.
4.2.4 Innexin2 interacts with ß-tubulin
Proteins showing a close spatial vicinity within a cell, may interact with each other directly or 
may be a part of a protein complex with other proteins. Therefore, the interaction potential of 
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innexin2 and ß-tubulin was investigated by co-immunoprecipitation experiments using whole 
embryonic extracts, where colocalisation of both proteins was also detected in the epidermis 
by co-immunostaining of innexin2 and ß-tubulin (Fig. 4-19). Embryonic extracts were used 
for the co-immunoprecipitation experiment for the reason that the preparation procedure of 
whole embryonic extract was much easier compared to the collection of extracts from pure 
ovaries.
Fig.  4-19 Innexin2 and ß-tubulin colocalise in the epidermis of  wild type embryos. 
Antibody staining  of  innexin2 (red)  and ß-tubulin  (green)  showed a  partial  colocalisation 
especially at the segment boundaries and the anal pads (merge).
Precipitation  was  carried  out  on  the  one  hand  with  an  anti-ß-tubulin  antibody  and  an 
unspecific mouse IgG antibody in the control reaction, followed by immunoblotting with an 
anti-innexin2 antibody.  On the other hand immunoprecipitation reactions were carried out 
using an anti-innexin2 antibody and an unspecific rabbit IgG control reaction, followed by 
immunoblotting  with  an  ß-tubulin  antibody.  The  different  approaches  resulted  in  the  co-
immunoprecipitation of both proteins, indicating that both proteins are contained within the 
same complex (Fig. 4-20).
Fig. 4-20 Innexin2 and ß-tubulin interaction. ß-tubulin was able to pull down innexin2 and 
vice versa, arguing for the existence of both proteins in a complex. IP with an anti-innexin2 
antibody as precipitating antibody was done by crosslinking of the antibody to the sepharose 
beads to avoid the presence of IgG heavy chains in the immunoblot (*), which have a similar 
size (52 kD) to ß-tubulin (55 kD).
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4.2.5 Transport  of  innexin2  containing  hemichannels  to  the  plasma 
membrane is dependent on microtubules 
Co-immunostainings  and  co-immunoprecipitation  experiments  point  to  an  interaction  of 
innexin2 and ß-tubulin. To investigate this interaction in respect to innexin2 trafficking further, 
a series of drug treatment experiments was performed. In a first approach freshly dissected 
ovaries from fertilised wild type females were incubated for 1 h at RT in Schneiders Medium 
drugged with colchicine (20 µg / ml). Colchicine inhibits the polymerisation of microtubules by 
binding to  α-  οr β-  tubulin subunits,  which are the core constituents of  the microtubules. 
Control  ovaries  were  incubated  with  medium  containing  the  solvent  ethanol.  Co-
immunostainings of colchicine treated and solvent treated control ovaries were done with 
anti-innexin2 and anti-disc  large antibodies.  Disc  large,  a protein  of  the  septate  junction 
family, has been shown to be not affected upon treatment with tubulin depolymerising drugs 
(Iizuka-Kogo  et  al.,  2004) and  was  therefore  co-stained  as  a  control.  Imaging  of  the 
distributions of both proteins in the follicle cell epithelium by confocal microscopy, exhibited a 
clear delocalisation of innexin2 from the plasma membrane to the cytoplasm upon colchicine 
treatment, whereas the localisation of disc large was not affected (Fig. 4-21) compared to the 
solvent  treated control  (ethanol).  This  observation indicates that  the microtubule network 
provides  the  route  for  innexin2  containing  oligomers  to  the  plasma  membrane  and  /  or 
stabilises innexin2 localisation at the membrane. 
Fig.  4-21  Microtubule  disruption  affects  innexin2  membrane  localisation. Treatment 
with colchicine (B) alters the localisation of innexin2 (red), whereas the plasma membrane 
localisation of disc large (dlg; blue) is unchanged. Ethanol treated control cells show innexin2 
localised at the PM of the follicle cell epithelium (A).
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In a second approach SL2-cells that stably express innexin2 fused to a myc epitope-tag were 
analysed to support the data obtained from ovary treatments with colchicine. In this approach 
nocodazole,  as  another  microtubule  polymerisation  interfering  agent  was  used.  After 
induction of innexin2-myc expression with copper sulphate for 40 h, nocodazole (5 µg / ml) 
was added to the cells. DMSO was added to control cells in parallel. After 1 and 2 hours 
incubation,  cells  were  fixed  and  innexin2-myc  expression  was  detected.  Imaging  of  the 
treated cells revealed an increasing loss of  innexin2 expression at the cell  membrane in 
favour of an accumulation of innexin2 within the cytoplasmic part of cell over the time (Fig. 4-
22).
This result proved the latter observations from colchicine treatments of dissected ovaries and 
indicates a turn over rate of gap junction plaques of 1 - 2 h in SL2 cells.
Fig.  4-22 Nocodazole treatment affects gap junction plaque assembly in SL2 cells. 
Treatment of induced Sl2 cells expressing innexin2-myc (green) with nocodazole for 1 h (B) 
or 2 h (C) leads to a time dependent loss of gap junction plaques at the plasma membrane in 
comparison to the solvent (DMSO) treated control (A). Nuclei were stained with DAPI (blue).
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4.3 The exocyst complex is involved in innexin2 hemichannel 
membrane targeting
The exocyst complex has been investigated in Drosophila and mammalian cells extensively 
in recent years. It serves as a platform that enables vesicle fusion at the plasma membrane 
by binding to secretory vesicles that deliver membrane proteins. Different studies showed an 
involvement of members of the exocyst complex in membrane trafficking. One example is 
that the introduction of antibodies against the exocyst subunit sec8 into oligodendrocytes, 
MDCK (Madin–Darby  canine  kidney)  and  acinar  cells  has  been  found  to  inhibit  plasma 
membrane protein transport and plasma membrane addition (Anitei et al.,  2006) and that 
sec8 antibodies inhibit delivery of LDL receptor to the baso-lateral membrane (Grindstaff et 
al., 1998). Another example is that knockdown of exocyst subunits sec6, sec8 and exo70 
resulted  in  a  decreased  level  of  type 4  glucose-transporter  at  the  plasma membrane  in 
adipocytes (Inoue et al., 2006).
Knowing that members of the exocyst complex have such a strong impact on targeting of 
plasma  membrane  designated  proteins,  various  approaches  were  undertaken  to  gather 
information whether membrane targeting of innexin2-containing gap junction hemichannels is 
mediated by members of the exocyst complex.
4.3.1 Innexin2 and sec6 are detected in close vicinity at the cellular cortex 
of epidermal cells
Vesicle fusion at the plasma membrane takes place just beneath the plasma membrane in 
the cortical region of a cell. To investigate whether innexin2 localisation can be detected in 
this region, co-immunostaining experiments of innexin2 and sec6, one crucial component of 
the exocyst complex, were carried out (Fig.4-23).
Immunofluorescent stainings of embryonic epidermal cells point to a partial colocalisation of 
both proteins in embryonic epidermal cells in the cortical region (Fig. 4-23 A). To define the 
place of colocalisation within the the cell,  the plasma membrane marker spectrin was co-
stained and localisation of sec6 and innexin2 relative to the membrane marker assayed. 
Whereas innexin2 colocalised mainly with the plasma membrane, a significant amount of 
protein was detected also at the cellular cortex beneath the plasma membrane (Fig. 4-23 C), 
sec6  protein  expression  was  found  accumulated  at  the  cellular  cortex  in  the  cytoplasm 
(Fig.4-23 B).
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Fig.  4-23 Innexin2 and sec6 are localised in close vicinity at  the cellular  cortex of 
epidermal  cells.  Innexin2 (red)  and sec6 (green)  show a partial  overlap  in  cells  of  the 
embryonic  epidermis  (A).  To  assess  the  precise  region  of  overlap,  co-staining  with  the 
membrane marker spectrin was done, revealing a cortical accumulation of sec6 relative to 
the  membrane  marker  (B).  Innexin2  was  found  localised  to  the  plasma  membrane  of 
epidermal cells and was also detected at the cellular cortex, shown in (C).
Partial  colocalisation  of  innexin2  and  the  exocyst  component  sec6  near  the  plasma 
membrane  was  a  first  evidence  for  the  involvement  of  sec6  in  inx2  plasma  membrane 
targeting. To follow this evidence, gain and loss of function experiments were carried out in 
embryos and SL2 cell culture.
4.3.2 Overexpression of sec6 recruits innexin2 into vesicles and the 
plasma membrane
In a first approach gain of function studies were carried out in embryos. Overexpression of 
sec6 was accomplished in  Drosophila embryos and innexin2 distribution was monitored by 
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subcellular fractionation experiments of plasma membranes and total vesicle fractions using 
the protocols for cell fractionation presented before. For the overexpression experiment a 
heat shock inducible Gal4-driver line was crossed to an UAS-sec6 effector line and embryos 
were collected for subcellular fractionation of plasma membranes and a total vesicle fraction. 
As controls, the heat shock inducible driver line was crossed to wild type flies that do not 
contain the UAS responsive element. The heat shock to activate overexpression of sec6 was 
applied for 2 h at 37°C on 0-6 h old embryos of both crossings, following 4 h incubation at RT 
and subsequent homogenisation of the specimen.
Subcellular fractionation and Western blot analysis of the plasma membrane fraction and the 
total vesicle fractions from embryos that overexpressed sec6 and control embryos showed 
that  the  innexin2  protein  content  was  increased  in  fractions  deriving  from  the  se6 
overexpressing embryos in comparison to the control sample (Fig. 4-24). As a loading control 
the membrane marker syntaxin 1A was used.  Interestingly,  the vesicle fraction contained 
innexin2  protein  in  two  forms  that  are  described  in  section  4.1.1,  whereas  the  plasma 
membrane fraction only contained the higher molecular weight form of innexin2 protein.
Fig.  4-24  Overexpression  of  sec6  recruits  innexin2  into  vesicles  and  the  plasma 
membrane. Plasma membrane fractions of wild type control extracts were compared to the 
equivalent fraction isolated from embryonic extracts, in which sec6 had been overexpressed. 
innexin2 shows an enhanced expression in the sec6 overexpressed sample (compared to 
syntaxin  (syx)  as  loading  control,  left  panel).  The  same  result  was  obtained  analysing 
differences of innexin2 expression intensity in vesicle fractions (compared to the membrane 
marker syx, right panel).
Loss of function experiments carried out in embryos did not show clear results. Therefore, 
additional RNAi approaches on different components of the exocyst were performed in SL2 
cells, stably expressing innexin2-myc. As shown before, gap junction plaque assembly at the 
plasma membrane of adjacent cells takes place in those cells. The formation of innexin2 
positive plaque-like structures was taken as a readout system to study exocyst involvement 
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in innexin2 membrane targeting.
One advantage of this loss of function approach is that several components of the exocyst 
complex  could  be  investigated  in  parallel  approaches.  First,  double  stranded  RNA was 
generated against the exocyst components sec5, sec6 and sec15 by  in vitro transcription. 
The purified double strand RNA was applied afterwards and incubated on SL2inx2-myc cells 
for three consecutive days. Innexin2 expression in the SL2 cells was induced at the second 
day of RNAi treatment with copper sulphate followed by an incubation for 40 h. After that, 
cells were analysed by immunhistochemistry of inx2-myc. The knock down efficiencies of the 
different double stranded RNAs were determined in parallel by quantitative real-time PCR 
analysis.
Fig. 4-25 Knock down of exocyst components affects innexin2 plaque formation in SL2 
cells. Knock down of  mRNA levels  of  various  exocyst  components by dsRNA treatment 
results in a decreased detection of innexin2-myc positive plaques (B-D) in contrast to the 
untreated  control  (A),  where  innexin2  positive  plaques  are  clearly  visible  between 
neighbouring cells  (arrows).  The knock down efficiency of  applied dsRNA was monitored 
using qRT-PCR analysis from cells of same sample in parallel (E).
Upon an RNAi mediated knock down of  mRNA expression of various exocyst (sec5, se6, 
sec15) components, transport of innexin2 proteins to the plasma membrane was diminished, 
as assayed by observation of a decreased number of gap junction plaque like structures at 
the plasma membrane between adjacent cells, as shown in Fig. 4-25.
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Together, these data provide first evidence for the importance of sec6 and other members of 
exocyst complex in membrane targeting of innexin2 containing hemichannels.
4.4 Expression of innexins in vertebrate cells
In  order  to  establish  another  cellular  system for  the  biochemical  analysis  of  Drosophila 
innexin gap junction hemichannel formation and transport on the one hand, and to proof the 
functionality of resulting innexin2 gap junction channels by dye-coupling experiments on the 
other  hand,  mammalian HeLa cells were chosen and innexin expression tested in  those 
cells.  An advantage of this mammalian cell  line  the possibility to express Drosophila gap 
junction proteins in an otherwise innexin free background. In addition, this cell line had been 
used successfully in the past to investigate trafficking of the vertebrate gap junction proteins 
and protocols for various approaches are established (Falk et al., 2001; Thomas et al., 2005).
Evidence, that vertebrate cells have the potential  to be used as a testing system for the 
expression of  invertebrate gap junction  proteins,  came from studies  in  coupled  Xenopus 
oocytes that  have been used successfully in the past for the expression and analysis of 
connexins, pannexins and innexins (Bahima et al., 2006; Bruzzone et al., 2003; Stebbings et 
al., 2000) with regards to study and proof their ability to form functional gap junction channels 
between adjacent cells. One of the mentioned studies showed that Drosophila innexin2 and 
innexin3 were able to form functional gap junction when co-expressed in  Xenopus oocytes 
and that  expression of  the innexin2 isoform alone lead to homomeric  channel  formation 
(Stebbings et al., 2000). 
4.4.1 Analysis of innexin2 expression in HeLa cells
HeLa  cells,  which  are  commonly  used  to  study  vertebrate  gap  junction  assembly  and 
coupling assays (Elfgang et al., 1995), were transfected with different constructs containing 
innexin2 cDNA. The vertebrate Kozak-core (CCACC) sequence was cloned 5`-prime of the 
start  codon in  the  pMJgreen vector  to  enhance the  translation  efficiency.  Cloning of  the 
optimal  vertebrate  Kozak-sequence  in  front  of  the  open  reading  frame  was  carried  out 
because expression efficiencies of constructs just containing the cDNA sequence were in 
general  very low.  Aim of  these expression studies was to analyse innexin2 behaviour  in 
vertebrate cells in regards to “plaque”-formation in those cells.
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To determine best  conditions  for  the  transfection  of  HeLa cells  with Drosophila innexin2 
constructs, cells were transfected with various ratios of DNA to Lipofectamine. Transfectants 
were harvested and analysed 24 - 30 h later. At this time, cells begun to round up and to 
loose  their  matrix  adhesion  finally  ending  in  up  in  cell  death.  The  obtained  transfection 
efficiencies  of  innexin2  constructs,  were  in  general  much  lower  (approx.  10-20%)  as 
compared  to  transfection  controls.  For  control  transfections  the  same  plasmid  lacking 
innexin2 cDNA, but containing an open reading frame for GFP expression was used which 
resulted in 90% of the cells expressing the reporter (pMJgreen; empty). The low transfection 
efficiency using innexin constructs made the analyses of large scale approaches difficult. 
Best transfection rates were obtained using a ratio of 1 : 2 ratio of DNA to Lipofectamine.
However, expression analysis of a innexin2-myc construct shows both, cytoplasmic and also 
membrane  localisation  of  innexin2,  observed  by  double  immunostaining  with  the  anti-
innexin2 and the epitope-tag antibody myc to verify fusion-protein expression (Fig. 4-26). 
Innexin2-myc protein expression of was also confirmed by Western blot analysis, detecting 
innexin2-myc only in the transfected sample (Fig. 4-27).
Fig. 4-26 Expression of innexin2-myc in HeLa cells.  Double immunostaining of innexin2 
(red) and myc (green) showed innexin2-myc expression in the cytoplasm and presumably at 
the plasma membrane.
Fig. 4-27 Western Blot analysis of HeLa cells transfected with innexin2-myc. Detection 
of  innexin2 protein expression from lysates of transfected cells and untransfected control 
cells revealed the detection of a clear protein band at 42 kD, corresponding to the size of 
innexin2-myc.
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Several transfection approaches using an innexin2-myc construct, lead to the formation of 
gap junction typical  plaque-like structures between plasma membranes of  adjacent  cells, 
observed 26 - 28 h after transfection (Fig. 4-28 A). The same result was obtained using an 
innexin2 construct without a tag fusion (Fig. 4-28 B).
Fig.  4-28  Localisation  of  innexin2-myc  and  inx2stop  in  gap  junctional  plaque  like 
structures  at  the  plasma membrane  of  adjacent  HeLa  cells. Innexin2  expression  is 
detected in a gap junction typical plaque-like structure at the membranes of two adjacent 
HeLa cells. Ectopic expression of innexin2-myc is shown in (A), expression of an untagged 
innexin2 variant is shown in (B). DIC was used to assess membrane-localisation. Scale in 
(A) 20µm.
In addition to plaque formation between two adjacent cells, a distinct membrane localisation 
of innexin2 became also visible at membranes of cells that do not have direct contacts to a 
neighbouring cell  (Fig.  4-29),  arguing for  the existence of  hemichannel  accumulations  in 
addition.
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Fig. 4-29 Expression of inx2stop in HeLa cells results plaque like structures at plasma 
membrane of single cells. Cells were transfected with pMJinx2stop and fixed 26 h later 
following immunofluorescent staining of innexin2 (green). Membrane localisation of innexin2 
arranged as plaque like structure in single cells is a frequent finding. DIC was used to assess 
membrane-localisation.
Together, expression analyses of innexin2 in HeLa cells indicate, that innexin2 forms gap 
junction typical  plaque like structures between neighbouring cells  to a low extent.  These 
findings suggest  the formation of  homomeric,  homotypic  gap junctions and in  vertebrate 
cells. In addition, observations of innexin2 localisation of at membranes of single cells, point 
to the formation of unopposed hemichannels in HeLa cells.
4.4.2 Innexin2 is integrated in plasma membranes of transfected HeLa cells
Various experiments using immunofluorescent staining combined to differential interference 
contrast (DIC) microscopy point to the localisation of innexin2 positive gap junction plaques 
at plasma membranes of transiently transfected HeLa cells. To further confirm the membrane 
integration of innexin2, a different approach was used to study membrane localisation of 
proteins. 
The plasma membrane sheet  assay is a unique tool  for  studies of  the organisation and 
function of membrane proteins using microscopic methods (Lang et al., 2003). An additional 
advantage of this method is the fact that the amount of transfected cells needed for analysis 
is very low in comparison to the amount needed for subcellular fractionation approaches and 
that it can be carried out quickly. 
With the help of a short ultrasound pulse cells, cultured on coverslips, can be “unroofed”, 
meaning, only the basal membranes remain on the coverslip that can be fixed and stained 
with  antibodies  against  the  protein  of  interest  (Fig.  4-30;  Lang,  2003).  The  generated 
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membrane sheets are co-stained with a probe against lipids of the inner plasma membrane 
leaflet (TMA/DPH).
Fig.  4-30  Scheme  of  plasma  membrane  sheet  preparations  from  cultured  cells. 
(Modified after Lang, 2003).
Analysis of membrane sheets produced from innexin2 and innexin3 transfected HeLa cells 
(Fig. 4-31 A-C) verified the observation of former experiments that innexins are inserted in 
the plasma membrane of those cells whereas control stainings of untransfected cells did not 
show a signal (Fig. 4-31 D).
Fig. 4-31a Detection of innexin2 in plasma membrane sheets of transfected HeLa cells 
28 h post transfection. Detection of innexin2 (red) and myc (green) showed co-localisation 
of both antibodies after transfection of pMJinx2myc (A), detection of innexin2 (green) after 
transfection of pMJinx2stop (B).
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Fig. 4-31b Detection of innexin3 in plasma membrane sheets of transfected HeLa cells 
28  h  post  transfection. Detection  of  inx3GFP with  an anti-GFP antibody in  membrane 
sheets (C), untransfected controls stained with secondary antibodies used in A-C showed no 
unspecific signals (D), scale: 10 µm.
Together,  these  data  provide  evidence  for  membrane  insertion  and  plaque  formation  of 
invertebrate  innexins  in  vertebrate  cells,  which  do  not  express  connexins,  indicating  a 
conserved mechanism of plaque formation between adjacent cells between analogous gap 
junction proteins.
4.4.3 Oligomerisation of innexin2 in HeLa cells
Assembled  innexin2  hemichannels  acquire  TX-1000  insolubility  upon  plasma membrane 
integration and plaque formation in Drosophila as shown in section 4.1. The observation of 
innexin2 plaque formation in transfected HeLa cells therefore also lead to the biochemical 
investigation of innexin2 in extracts of transfected HeLa cells with regards to oligomerisation 
and the acquirement of TX-100 insolubility.
TX-100 solubilisation was carried out with extracts from transfected HeLa cells, to determine 
whether  innexin2  is  found  in  the  TX-100  insoluble  fraction  upon  plasma  membrane 
integration. Fig. 4-32 shows that a significant amount of innexin2 protein was detected in the 
TX-100 insoluble fraction, revealing a faint band of higher molecular weight in contrast to the 
total lysate and the TX-100 soluble fraction, where both forms are detected. 
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Fig. 4-32 Innexin2-myc acquires TX-100 insolubility in HeLa cells. TX-100 solubilisation 
of  extracts  from of  HeLa cells  transfected with  innexin2-myc,  results  in  the detection  of 
innexin2-myc in the TX-100 insoluble fraction.
To determine  whether  innexin2  oligomerisation  occurs  in  innexin2-myc  transfected HeLa 
cells, velocity sedimentation of TX-100 soluble extracts of innexin2-myc transfected cells was 
performed. Fractions of 5 - 20% sucrose gradient were analysed in the same way as done 
for the analysis of oligomerisation in embryos in section 4.1.3.
Fig. 4-33 Innexin2 oligomerises in HeLa cells. The status of oligomerisation of innexin2 in 
vertebrate cells was detrmined by velocity sedimentation on 5 - 20% (w/v) sucrose gradients, 
resulting in the detection of innexin2 protein in high percentage sucrose fractions. Addition of 
SDS  prior  velocity  sedimentation  shifts  innexin2  detection  to  low  percentage  sucrose 
fractions, indicating the decay of oligomeric assemblies.
Figure 4-33 shows that innexin2 was detected within fractions that had been designated to 
contain hexameric proteins after fractionation of TX-100 soluble extracts from innexin2-myc 
anti-myc
4 Results 85
transfected cells by continuous sucrose gradients and Western blot analysis. Treatment of 
TX-100  solubilised  extracts  with  2% SDS  prior  velocity  sedimentation,  led  to  a  shift  of 
innexin2  distribution  to  lower  percent  sucrose  fractions,  suggesting  that  innexin2 
oligomerised  in  HeLa  cells  to  some  extent.  It  is  noteworthy,  that  under  non-denaturing 
conditions (- SDS) most of the protein is detected in higher percentage sucrose fractions 
from 12.5-19.5% sucrose,  indicating  that  monomers  seem to  be directly  assembled  into 
oligomers in HeLa cells.
Together,  data  collected  from expression  analyses  by  immunohistochemical  stainings  of 
innexin2 and innexin3 in transfected HeLa cells revealed that innexins are able to traffic to 
the plasma membrane of HeLa cells and to form gap junction typical plaque like structures 
between adjacent cells. Initial biochemical approaches also point to the ability of innexin2 to 
oligomerise and to integrate into the plasma membrane, which mediates TX-100 insolubility.
4.5 Cross regulation of innexin2 and major signalling 
components during organogenesis of the posterior foregut
Investigations on the assembly and transport of Drosophila innexin2 containing gap junction 
hemichannels revealed that oligomerisation of  hexameric innexons, which are assembled 
and transported to the plasma membrane along the secretory pathway via microtubules, is a 
crucial process for gap junction plaque formation. 
The functional role of thus assembled gap junctions during organogenesis was addressed in 
the second part of this thesis. Analyses on the physiological impact of innexin2 containing 
gap  junctions  during  development  concentrated  on  the  posterior  foregut  of Drosophila 
embryos.  The  posterior  foregut  constitutes  in  general  a  center  of  cell  signalling  and 
morphogenetic movements (Grapin-Botton and Melton, 2000), where cellular boundaries are 
created, resulting in the development of gut accessory organs (Ramalho-Santo et al., 2000). 
The creation of cellular boundaries in this compartment of the gut primordium enables the 
morphogenesis  of  gut  accessory  organs. The  accessory  organ  that  is  derived  from the 
posterior foregut in Drosophila is the proventriculus, a valve like structure that serves as a 
regulator for the food passage from the fore-into the midgut in larvae and adults. It develops 
during early embryogenesis at the junction of the ectodermal foregut and the endodermal 
anterior midgut primordia (Bauer et al., 2004).
The proventriculus organ is formed by subsequent foldings of ecto- and endodermal tissue 
layers resulting in a cardia shaped organ in the end of embryogenesis at stage 17. It starts 
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with an evagination (at stage 11) and constriction (at stage 13) of the ectodermal tissue layer 
followed by an inward movement of the ectoderm into the endoderm in stage 15 (Fig. 4-34). 
The establishment of two rows of cells, the anterior and posterior boundary cells have been 
found to be crucial for the morphogenetic endo- and ectodermal movements (Fuss et al., 
2004).
Fig.  4-34  Scheme of  proventriculus morphogenesis.  The proventriculus  is  formed by 
subsequent  foldings  of  ecto-  (green)  and endodermal  (violet)  tissue layers  resulting  in  a 
cardia shaped organ in the end of embryogenesis (st. 17) starting with evagination (at st. 11) 
and constriction (at st. 13) of the ectodermal tissue layer following inward movement of the 
ectoderm into the endoderm (st. 15). The anterior (ac) and posterior cells (pc) are labelled in 
red. (Modified after Lechner et al., 2007)
Development of the proventriculus has been studied extensively in our laboratory over the 
last  years.  Various  studies  identified  different  signalling  pathways  that  take  part  in  the 
morphogenetic  movements  during  proventricular  development.  All  mutants  of  different 
signalling proteins isolated, revealed a similar phenotype. It manifests itself by the failure of 
inward movement and folding of the ectodermal proventricular cells (Lechner et al., 2007; 
Fuss et al., 1998, 2004; Josten et al., 2004; Pankratz and Hoch, 1995).
In the context of morphogenetic movements, the importance of the above mentioned two 
rows of cells in the ectodermal tissue layer, the anterior and posterior boundary cells, were 
studied. It could be shown that the specification of both cell rows is dependent on the activity 
of the juxtacrine Notch signalling pathway, which is activated by its ligands Delta or serrate, 
in  cooperation  with  the  JAK/STAT signal  transduction  cascade  (Fuss  et  al.,  2004).  The 
interplay of both pathways was shown to be crucial for the expression of the cytoskeleton 
crosslinking protein short stop, a member of the spectraplakin protein family. (Gergory and 
Brown 1998; Röper, 2002). Short stop stabilises the cytoskeleton in the posterior boundary 
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cells  to  provide a stiffness  function  essential  for  the invagination  of  the  anterior  cells  to 
invaginate. (Fuss et al., 2004; Josten et al., 2004). 
Furthermore,  the  expression  of  wingless,  as  the  activator  of  the  paracrine  signalling 
Wnt/wingless  pathway  was  shown  to  be  functionally  required  for  cell  migration  of 
proventricular  cells.  Wingless  protein  was  shown  to  be  initially  expressed  at  the  site  of 
ectodermal constriction at stage 13. Later on, wingless expression is detected in two more 
defined domains, in the anterior and posterior boundary cells (Pankratz and Hoch, 1995, 
Fuss and Hoch, 1998, Bauer et al., 2004)
Another study revealed that hedgehog expression, ligand of the well conserved hedgehog 
signalling  pathway,  is  required  for  the  expression  of  Notch and  wingless  in  the  anterior 
boundary cells (Lechner et al., 2007; Josten, PhD thesis). It could be shown in this thesis that 
hedgehog protein is expressed in wild type from early to late embryonic stages in a broad 
expression  domain  in  the  posterior  foregut.  Hedgehog  expression  covers  cells  of  the 
developing esophagus and all the ectodermal cells of the proventriculus primordium, which 
invaginate during formation of the multi layered organ (Fig. 4-35).
Fig.  4-35  Hedgehog  is  expressed  in  ectodermal  cells  of  the  embryonic  foregut. 
Hedgehog protein staining (green) overlaps with forkhead (red), an ectodermal marker, of 
Drosophila in early (A) and late (B) stages of proventriculus development. (ec, ectoderm; en, 
endoderm; fg, foregut). (Modified after Lechner et al., 2007).
Analyses of hedgehog mutants revealed a specific loss of wingless expression in the anterior 
boundary cells,  whereas the posterior  wingless domain was not  affected (Lechner  et  al., 
2007;  Josten,  PhD  thesis).  This  is  consistent  with  previous  findings  that  temperature 
sensitive wingless mutants show an invagination defect of the ectodermal proventricular cells 
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(Pankratz and Hoch, 1995), which is very similar to the phenotype observed in  hedgehog 
mutants.
Recently,  a  mutant  of  the  gap  junction  forming  protein  innexin2 was  identified  that  also 
showed severe defects in proventriculus organogenesis (Bauer et al., 2004). In the innexin2 
mutant it was observed that food could not be transported into the midgut, resulting in an 
engorged oesophagus. Therefore, the innexin2 mutant was named “kropf”. 
The fact that innexin2 was shown to be a direct target gene of wingless signalling (Bauer et 
al., 2004) and that its expression was missing in  hedgehog mutants (Josten, PhD thesis), 
suggested  a  dependency  of  gap  junctional  communication,  paracrine  and  juxtacrine 
signalling  pathways.  This  dependency was  analysed  in kropf mutants  to  understand  the 
impact of gap junctional communication during proventriculus development. 
Altogether, accumulating evidence points to the existence of a complex signalling and cell 
communication  network  that  is  involved  in  programming  the  morphogenetic  movements 
during proventriculus development (Fig. 4-36). 
Fig.  4-36  Schematic  representation  of  the  hedgehog  and  JAK/STAT  pathways 
controlling  ac  and  pc  allocation  and  proventriculus  morphogenesis. Hedgehog  is 
required for the expression of Notch target genes and of wingless in the anterior boundary 
cells, whereas JAK/STAT signalling induces the expression of Notch target genes such as 
short stop in the posterior boundary cells. (after Lechner et al., 2007)
4.5.1 Innexin2 is expressed in the ecto- and endodermal part of the 
developing proventriculus primordium
The observation that  kropf mutants showed proventricular defects, prompted us to have a 
closer look at  innexin2 expression in  the proventriculus and to determine the subcellular 
distribution of innexin2 in the different tissue layers that build the folded organ.
Using fluorescent in  situ  hybridisation and antibody staining,  innexin2 mRNA and protein 
expression  was  monitored  in  the  developing  proventriculus  to  assess  the  distribution  of 
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innexin2 within the two different tissue layers that are involved in folding processes of the 
proventriculus organ. Detection of innexin2 mRNA with an innexin2 specific antisense probe 
showed expression in both, the ectodermal and endodermal tissue layer. Co-immunostaining 
with  anti-forkhead  antibody marks  the  ectodermal  tissue layer  (Fig.  4-37  A).  Protein  co-
staining with the fasciclin II as membrane marker also pointed to ubiquitous expression of 
innexin2 protein in the two germ layers (Fig. 4-37 B).
Fig.  4-37  Innexin2 mRNA and  protein  is  expressed  in  both  the  ectodermal  and 
endodermal  tissue  layers  of  the  proventriculus.  Fluorescent  in  situ hybridisation 
combined with antibody staining of st. 13 proventriculi showed that innexin2 mRNA (A), (red), 
is  expressed  in  both  the  ectodermal  and  endodermal  tissue  layer  co-stained  with  the 
ectodermal marker forkhead (green). Innexin2 protein was also found in both tissue layers 
(B), co-stained with fasciclin II (green) as membrane marker (en, endoderm ec, ectoderm).
Together,  these results indicate that  innexin2 expression might  be crucial  for  intercellular 
communication  within  the  endo-  and  ectodermal  tissue  layer  of  the  proventriculus 
primordium.
Earlier findings revealed that hedgehog mutants lack, in addition to their invagination defect, 
wingless and innexin2 expression in the proventricular primordium.  In  hedgehog mutants, 
innexin2 expression is specifically lost in the proventriculus whereas it is still present in the 
salivary glands of the embryo (Lechner et al., 2007; F.Josten, PhD thesis). In addition, it was 
found that  innexin2 is a direct target gene of the wingless signalling pathway (Bauer et al., 
2004).  Together,  previous  results  pointed to direct  dependency of  wingless  and innexin2 
expression  on  hedgehog  expression.  To  proof  this  findings,  a  rescue  experiment  was 
performed  to  investigate  the  observed  cross  regulatory  effects.  In  this  experiment,  the 
expression of  innexin2 should be reestablished by the over expression of wingless protein, 
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activating the wingless signalling cascade that regulates innexin2 expression. 
In fact, expression of  innexin2 transcripts could be rescued by overexpression of wingless, 
using  the  Gal4/UAS  system  in  the  hedgehog mutant  background.  Wingless  protein 
expression  was  monitored  by  an  anti-hemaglutinin-tag  (HA)  antibody  recognising  the 
overexpressed wingless-HA fusion protein. On the one hand, the obtained result argues for 
innexin2 being a downstream target of wingless and hedgehog signalling. On the other hand, 
it  revealed that expression of wingless and innexin2  in the  hedgehog mutant background 
abolished in addition the invagination phenotype of hedgehog mutants (Fig. 4-38), resulting 
in a properly folded organ in these embryos (inset  in Fig.  4-38).  The above data clearly 
implicate that hedgehog activates wingless, which in turn regulates innexin2 expression.
Fig. 4-38 Innexin2 mRNA expression is rescued by overexpression of wingless protein 
in  hedgehog mutants. Fluorescence  in  situ  hybridisation  of  innexin2  mRNA  (green) 
combined with antibody staining against wgHA (blue) and Fkh (red). Inset in merged picture 
shows  magnification  of  the  invaginated  proventriculus.  The  asterisk  (*)  marks  the 
proventriculus. 
4.5.2 Kropf and hedgehog mutants show reduced cell communication 
between proventricular cells
Cell-cell  communication  is  a  prerequisite  for  the  spatial  and  temporal  coordination  of 
patterning and morphogenesis. Gap junctions play an important role here, enabling the direct 
communication between adjacent cells within a tissue or  organ.  The analysis of  coupling 
between  cells  of  an  organ  or  tissue  is  a  key  experiment  to  assay  gap  junctional 
communication.  Injection of the fluorescent dye Lucifer yellow into cells that express gap 
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junctions has become a versatile tool to study intercellular communication between coupled 
cells (Weir et al., 1982; Huang et al., 2005). In hedgehog mutants, innexin2 expression was 
specifically lost in the proventriculus, however it was still detectable in the salivary glands of 
the  embryo.  Therefore,  we  analysed  whether  innexin2  dependent  gap  junction 
communication was affected in  hedgehog  mutants by using the described coupling assay. 
Consistent with the above data, which showed a clear dependency of wingless and innexin2 
on hedgehog expression,  dye  diffusion  was  reduced between cells  of  the proventriculus 
primordium  of  kropf  and  hedgehog  mutants  (F.  Josten,  PhD  thesis).  This  pointed  to  a 
defective communication between cells (Fig. 4-38; Lechner et al., 2007), suggesting that gap 
junctional communication is disturbed in the absence of innexin2 protein. In summary, these 
data provide evidence that hedgehog activates wingless and innexin2 expression and affects 
thereby also  the  innexin2  dependent  gap  junction  activity.  These data  are  also  in  good 
agreement with the fact that  hedgehog, wingless  or  innexin2  mutants display very similar 
invagination defects.
Fig. 4-39 Statistic of reduced dye coupling between proventricular cells of wild type a 
kropf and hedgehog mutants. Lucifer yellow (LY) diffusion through wild-type proventricular 
(blue bar) cells compared to diffusion through proventricular cells of kropf mutants (red bar) 
and hedgehog mutants (yellow bar) 4 h after injection. Dye diffusion was strongly decreased 
in  proventriculi of both mutants. (After Lechner et al., 2007).
4.5.3 Innexin2-dependent alterations of hedgehog, wingless, and Delta 
transcription in the proventriculus primordium
Next, we wanted to understand whether innexin2 gap junctional communication is, in turn, 
crucial  for  the  expression  of  major  signalling  molecules  involved  in  proventriculus 
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morphogenesis.  A series  of  loss  and  gain  of  function  experiments  using  innexin2  were 
performed and the mRNA expression levels of hedgehog, wingless and Delta, encoding the 
ligand for the Notch receptor, were investigated by in situ hybridisation and quantitative real 
time PCR analyses.  In this context, previously performed immunofluorescent stainings and 
mRNA in situ hybridisation  in kropf mutants and in embryos overexpressing innexin2 have 
shown changes in protein or  mRNA expression levels of  wingless,  Delta,  and  hedgehog. 
These was already first evidence for an innexin2 dependent regulation of important signalling 
molecules (Lechner et al., 2007, PhD thesis F. Josten). 
For quantitative real time PCR (qRT-PCR ) analyses,  mRNA from stage 13 embryos, was 
isolated.  At  this  stage  of  embryogenesis  the  invagination  of  ectodermal  tissue  occurs 
(compare to figure 4-34). qRT-PCR analyses and normalisation of the obtained values to the 
housekeeping gene expressions of  actin and  ribosomal protein, revealed that upon loss of 
innexin2  expression  in  kropf mutants,  mRNA levels  of  Delta  (Dl), hedgehog  (hh)  and 
wingless (wg) dropped to various extents compared to the wild type control (Fig. 4-40 A). 
Fig. 4-40 Hedgehog,  wingless and Delta mRNA levels are altered upon innexin2 gain 
and  loss  of  function  experiments. Quantitative  real-time  PCR  demonstrating  the 
transcriptional  regulation  of  hedgehog (hh),  wingless  (wg)  and Delta (Dl)  in  response to 
innexin2 activity (A). Decreased expression of  hh,  wg and  Dl mRNA levels is observed in 
kropf  mutants  as  well  as  in  innexin2  RNAi  knock  downs  using  the  UAS-WIZinx2 in 
combination with hs-Gal4 or fkh-Gal4 driver lines. In contrast, overexpression of innexin2 by 
using UAS-innexin2 in combination with hs-Gal4 results in enhanced Dl,  wg and hh mRNA 
levels, as compared to the control (B).
This result was confirmed by innexin2 RNAi knock down experiments. Down regulation of 
innexin2 transcripts was accomplished by crossing a innexin2 RNAi fly line (UAS-WIZinx2) to 
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a heat shock-inducible Gal4 driver line (hs-Gal).  The heat shock was applied for 30 min at 
37°C, thereby activating innexin2 dsRNA expression that targets innexin2 expression. The 
following analysis of mRNA expression levels 2.5 h after the heat shock resulted again in a 
severe knock down of hedgehog (5 - fold reduction) and wingless (4 - fold reduction) mRNA 
expression, whereas  Delta expression was only reduced 1.25 - fold. Usage of a fkh-Gal4 
driver line, which drives the RNAi mediated knock down of innexin2 constitutively in most of 
the embryonic tissues, showed an even more dramatic effect on all three genes. In contrast, 
overexpression of innexin2 using a heat shock driver line, resulted in increased levels of all 
three transcripts (Fig. 4-40 B). These experiments indicate that innexin2 expression is crucial 
for  the  expression  of  major  signalling  components  showing  phenotypes,  similar  to  kropf 
mutants and validate previous findings which showed an innexin2 dependent regulation of 
gene expression. As controls wild type flies were crossed to the appropriate driver lines that 
were exposed to identical experimental procedures.
Consistently with these strong read outs from real time PCR analyses, whole mount in situ 
hybridisations  of  hedgehog mRNA  in  kropf mutants  showed  an  overall  reduction  of 
transcripts as compared to control embryos. The expression of orthopedia (otp), which was 
used as intestinal staining control was not altered (Fig. 4-41).
Fig. 4-41 Kropf mutant embryos show a reduced expression of hedgehog expression. 
In situ hybridisation of  wild type and kropf  mutant embryos using antisense probes against 
hh and the hindgut marker otp. Otp, marked with asterisk (*), served as a staining control. A 
significant reduction of hh expression in kropf mutants is visible.
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4.5.4 Importance of the innexin2 C-terminus for the transcriptional 
regulation of wingless, hedgehog, and Delta transcripts
A next approach aimed on understanding whether a special domain of the innexin2 protein 
might  be involved in  the observed effects  of  innexin2 on  hedgehog,  wingless and  Delta 
mRNA expression  (Fig.  4-42).  Evidence  for  the  importance  of  the  C-terminal  domain  of 
innexin2 in transcriptional regulation derive from motif-predictions in silico, where a nuclear 
receptor  box  motif  is  predicted  to  be  contained  within  the  terminal  domain  (Fig.  4-42). 
Proteins that exhibit this motif in their amino acid sequence have been shown to bind nuclear 
receptors,  which  in  turn  regulate  gene  expression  (Savkur  et  al.,.  2004,  Mahajan  and 
Samuels, 2005).
Fig. 4-42 The innexin2 C-terminus contains a nuclear receptor box motif.  The nuclear 
receptor  box  motif  (LXXLL)  confers  binding  to  nuclear  receptors,  which  modulate  gene 
expression. Prediction made by http://elm.eu.org/.
This prediction lead to the overexpression of a transgene that contain a innexin2 C-terminal 
deletion (see appendix)  with  a heat  shock inducible driver  line.  The truncated transgene 
misses amino acids 301-367 of the innexin2 protein. The result of this experiment was a 
similar downregulation of all three transcript levels as shown for the kropf mutant in figure 4-
40. This indicates the necessity of the full length protein expression or the C-terminal part of 
innexin2 itself for proper target gene expression.
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Fig. 4-43 Transcript levels of hh, wg, and Dl drop upon overexpression of an innexin2 
C-terminal truncated transgene. Overexpression of innexin2∆CT containing a C-terminal 
deletion (innexin2 aa 301–367) with a hs-Gal4 driver line results in a similar reduction of hh, 
wg and Dl mRNAs, as observed in kropf mutants (compare to Fig. 4-26).
4.5.5 Evidence for the existence of an innexin2 C-terminal fragment that is 
directly or indirectly involved gene expression
Observations in  cell  culture point  to the existence of  an innexin2 C-terminal  fragment  in 
addition to the full length protein that might be involved in the regulation of transcription. Co-
immunoprecipitation experiments and Western blotting analyses in cell  culture using SL2-
cells, where overexpression of C-terminal GFP tagged innexin2 resulted in a second product 
which corresponds to the size of a C-terminal fragment fused to GFP (Fig. 4-44). 
The detected fragment exhibits a molecular weight of 37 kD, indicating that the innexin2 C-
terminal fragment has a size of approximately 10 kD, whereas GFP contributes with a size of 
27  kD.  The innexin2 cytoplasmic  C-terminus has  a  predicted molecular  weight  of  9  kD, 
indicating that a part of the fourth transmembrane domain must be contained in the fragment 
in addition.
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Fig.  4-44 Detection of  a C-terminal  fragment of  innexin2 in SL2 cells.  Western Blot 
analysis of extracts from SL2 cells, stably expressing inx2gfp fusion protein (fp) resulted in 
the detection of an additional protein fragment that is fused to GFP with a size of 37 kD (A). 
The observed fragment was also precipitated with the innexin2 antibody and detected with 
the anti-GFP antibody. IgG chains are marked by asterisk (*; B).
This finding led to the hypothesis that the C-terminal domain of innexin2 might be directly or 
indirectly involved in the transcriptional regulation of the mentioned target genes.
5 Discussion
5.1 Analogous gap junction proteins show common 
features
Vertebrate gap junction channels are formed by two opposing hemichannels, each consisting 
of six connexin protein subunits. One hemichannel can be either formed by six connexin 
proteins of the same isoform or by connexin proteins of different isoforms. Hemichannels are 
termed homomeric when they are made up by one isoform only, heteromeric when more then 
one connexin isoform is involved in the composition of one half channel. The existence of 20 
connexin isoform in mouse and 21 isoforms in humans opens the possibility for a variety of 
resulting hemichannel assemblies. This diversity is limited by different expression patterns of 
connexin  isoforms  and  their  different  abilities  to  oligomerise  with  each  other.  Whereas 
connexin43 is the most abundant connexin in mice and its expression is widely distributed 
throughout  the  organism,  the  expression  of  other  connexins  like  mouse  connexin  46  is 
limited to the lens (Willecke at al., 2002).
Pannexins, a second group of gap channel forming proteins, that have been isolated initially 
from mice several years ago, are found to assemble also into hexameric hemichannels as 
shown  by  Boassa  and  colleagues  (Boassa  et  al.,  2007),  despite  of  lacking  sequence 
homology to the connexins. To date, this family consists of three members in rodents and two 
in humans (Litvin et al., 2006). The potential of pannexins in forming intercellular gap junction 
channels was shown by Bruzzone and colleagues, who co-expressed pannexin 1 and 2 in 
paired  oocytes  derived  from  Xenopus and  found  that  they  form  functional  gap  junction 
channels (Bruzzone et al., 2003). However, a functional gap junction channel was not formed 
between pannexin1 and pannexin3 as investigated by Penuela and coworkers (Penuela et 
al.,  2007).  In  fact,  the  finding  that  pannexins  become  glycosylated  could  argue  for  an 
additional  function  of  those  proteins,  namely  a  function  in  the  construction  of  functional 
hemichannels at the plasma membrane from cells. The existence of functional unopposed 
hemichannels  became a  highly  debated  topic  in  both  connexin  and  pannexin  research. 
Meanwhile a number of studies claim the existence of functional hemichannels that have 
additional  functions  to  their  conventional  role  as  one  half  channel  the  formation  of 
intercellular channels (Spray et al., 2006).
A third group of gap junction proteins are the invertebrate innexins. An interesting feature of 
innexins  is  that  parts  of  their  amino  acid  sequence  are  conserved  to  the  sequence  of 
vertebrate  pannexins.  The  region  of  strongest  similarity  between  vertebrate  pannexin 
proteins and invertebrate innexin proteins includes the first two transmembrane domains and 
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the intervening stretch of amino acids (Baranova et al., 2004).
In Drosophila eight members of the innexin protein family, sharing the same protein topology 
despite the lack of sequence homology to connexins, are known to form gap junctions. Their 
expression  has  been  found  in  overlapping  patterns  in  various  tissues  and  organs. 
Furthermore, on the genetic level, some of the Drosophila innexin encoding genes are found 
organised in clusters on one chromosomal region, which may indicate a common expression 
control. The phenomenon of chromosomal clustering has been also shown for connexins 
resulting in overlapping expression patterns of the clustered isoforms (Fig. 5-1; Bauer et al., 
2005; Willecke et al., 2002). 
Despite of the initial identification of gap junctional structures in invertebrates, no biochemical 
data  existed  to  date  about  the  composition  and  nature  of  gap  junction  channel 
subcomponents.  So  far,  evidence  of  a  conserved  protein  topology  among  innexins, 
connexins  and  pannexins  led  to  the  assumption,  that  independently  of  species  related 
differences  on  the  sequence  levels,  the  construction  mechanism  of  gap  junction 
hemichannels is the same.
Fig. 5-1 Overview of the clustered organisation of innexin genes in the  Drosophila 
genome.
A common feature of genes that encode for gap junction proteins is a clustered genomic 
organisation on different chromosomes. Genes encoding for Drosophila gap junction proteins 
inx1,  inx2  and  inx7  are  arranged  as  a  cluster  on  the  chromosomal  region  6E4  of 
chromosome I, whereas inx5, inx6 and inx8 are all  located on chromosome I, but with a 
greater distance to each other. The remaining innexin isoforms inx3 and inx4 are located on 
chromosome III (65B5-98E6). (After Bauer et al., 2005).
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5.2 Innexin2 is part of hexameric innexons
As already mentioned in the previous paragraph, is the predicted overall protein structure of 
innexin proteins comparable to the structures of connexins and pannexins. All three protein 
families  exhibit  four  transmembrane  domains,  two  extracellular  loops  with  conserved 
cysteine  residues  and  three  cytoplasmic  located  domains  C-and  N-termini  as  well  as  a 
cytoplasmic loop. In this thesis hemichannel assembly of innexin2 containing hemichannels 
was analysed using different biochemical approaches. 
The oligomeric structure of innexin2 containing hemichannels was studied, first by analyses 
of native protein extracts from embryos (section 4.1.1). Basic native PAGE was carried out to 
investigate the size of innexin hemichannels after TX-100 solubilisation. This method is used 
to separate oligomeric proteins with an isoelectric point (pI) < 7.0. The mobility of proteins in 
native gels depends on both, the protein charge and its hydrodynamic size. (Lebendiker et 
al., 2000). 
Separation of embryonic protein lysates by basic native PAGE revealed the presence one 
major signal at around 250 kD as determined by the molecular marker catalase having the 
size of 250 kD (Fig. 4-2).  The size of the detected oligomer was in line with the size of 
hexameric  innexin2  containing  structures  and  was  termed  innexon  according  to  the 
hexameric  hemichannel  of  vertebrates,  the  connexon.  This  first  result,  addressing  the 
oligomeric composition of  Drosophila innexin hemichannels, led to the conclusion that the 
largest oligomeric assembly containing innexin2 detected in 6% polyacrylamide gels displays 
the size of a hexamer (all innexin proteins exhibit a molecular weight in a range between 42 
and 55 kD, with 42.49 kD for innexin2 as the smallest innexin isoform) This is in accordance 
to earlier studies of gap junction channels in crayfish done by Perrachia showing an electron-
microsocopic picture of gap junction plaques detected in giant fibers (Perrachia, 1976) that 
clearly displays an hexagonal arrangement of gap junctions at the plasma membrane. 
The question about the quality of the intermediate protein oligomers that are formed before 
the hexameric innexon status is reached, is unclear. Only chemical crosslinking experiments 
performed before (H.  Lechner,  diploma thesis)  pointed to the existence of  dimers as the 
smallest  oligomeric  subunit,  suggesting  a  mechanism  for  the  assembly  of  hexameric 
innexons that proceeds from monomers to dimers, tetramers and finally to hexamers. The 
issue  of  the  oligomeric  intermediate  formation  of  connexins  was  addressed  by  several 
groups. Using in vitro oligomerisation studies they found dimers and tetramers as the most 
preferred intermediates (Ahmad et al., 2001). Other studies claimed the existence of trimeric 
and pentameric intermediates in addition (Diez et al., 1999). All observations concerning this 
question  rely  on  results  from  cross-linking  studies  using  different  agents.  Due  to  the 
ambiguity of these results the issue of intermediate formation was not addressed further and 
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is only mentioned here for sake of completeness. 
Further  experiments,  for  the  separation  of  different  innexin2  containing  oligomers  along 
continuous sucrose gradients using protocols by VanSlyke and Musil (VanSlyke and Musil, 
2000),  confirmed  the  existence  of  hexameric  proteins  that  co-sedimented  in  fractions 
together with the molecular weight marker catalase, that has a size of 250 kD. In addition, 
the sedimentation behaviour of innexin2 in linear sucrose gradients, that exhibits a similar 
protein size to connexin43, was also related to hexameric connexin43 protein, sedimenting in 
14% - 17% sucrose fractions,  whereas monomers sedimented between 7-9% sucrose at 
chosen centrifugation conditions. Oligomerisation of innexin2 containing hemichannels was 
further verified by SDS treatments of TX-100 soluble fractions prior velocity sedimentation, 
an experiment that has already been performed before to validate the existence of connexin 
oligomers (Diez et al., 1999). 
Treatments with different concentrations of SDS led to a clear decay of innexin2 containing 
hexameric assemblies in favor of an increased detection of monomeric innexin2 protein and 
intermediate oligomeric forms (Fig. 4-7). 
Comparison of  the oligomerisation results  of  innexin2 and connexin43,  reveal  only slight 
differences  in  the  sedimentation  behavior.  These  may  result  from  experimental  setup 
fluctuations  such  as  the  usage  of  different  rotors  where  centrifugation  speed  had  to  be 
adjusted or temperature fluctuations during measurements of the sucrose concentration of 
the different fractions by refractometry.
Nevertheless,  data  obtained  on  the  oligomerisation  of  innexin2  containing  hemichannels 
point to comparable biochemical characteristics of Drosophila innexin2 and connexin43 that 
show similar molecular weights of 42.49 kD (innexin2) and 43 kD (connexin43).
Together,  findings  that  innexin2  is  part  of  a  hexameric  innexon  as  shown  by  usage  of 
combined methods to study oligomeric proteins, suggest that the hexameric hemichannel 
structure of gap junction subunits is conserved among species despite the lack of sequence 
homology.
In  addition  to  the  biochemical  investigation  on  the  oligomerisation  process  of  innexin2 
containing  hemichannels,  further  studies  aimed  on  understanding  the  requirements  for 
membrane integration of assembled innexons.
The finding that innexin2 as well as innexin3 need to undergo post translational modifications 
before  acquirement  of  TX-100  insolubility  and  plasma membrane  integration,  is  in  good 
agreement with investigations of connexin43 and its acquirement of TX-100 insolubility (Musil 
and  Goodenough,  1991).  Phosphorylation  had  been  shown  to  be  the  prerequisite  for 
membrane integration of connexin43 and insolubility in 1% TX-100 at 4°C. 
Studies on the post translational modification of innexin3 showed that the higher molecular 
weight protein band, which was detected as the only form of innexin3 in the TX-100 insoluble 
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fraction,  could be diminished by treatment with  the calf  intestine alkaline phosphatase in 
favour of a slight increase of the lower innexin3 protein band. Such a clear result was not 
obtained for innexin2. Nonetheless, both proteins exhibit  several putative phosphorylation 
sites, containing sites for serine, tyrosine and threonine (section 7.3) that might be crucial for 
membrane integration of the hexamer.
An additional post translational modification that could lead to the biochemical characteristic 
of insolubility of innexins in non-ionic detergents at chosen conditions might be also be the 
attachment of carbohydrate chains to the hexamer in the Golgi network. Another explanation 
for  TX-100  insolubility  could  be  in  addition,  the  integration  of  hexamers  into  detergent 
resistant membranes, which are defined as microdomains, known commonly as lipid “rafts”. 
They are characterised by their resistance to solubilisation in cold nonionic detergents or to 
cold sodium carbonate extraction at high alkaline pH (Locke at al., 2005).  Since  rafts also 
selectively include and exclude specific proteins, rafts may also have functional relevance 
with respect to protein sorting of innexin hemichannels. 
5.2.1 Innexin2 forms homomeric and heteromeric hemichannels
The  existence  of  eight  innexin  isoforms  in  Drosophila  as  well as the  occurrence  of 
overlapping expression patterns of some family members point to the existence of various 
gap junction hemichannel assemblies.
The fact that innexin2 and innexin3 could be co-immunoprecipitated from whole oligomeric 
and dimeric fractions (11-13% sucrose) in addition, point to the existence of heteromeric gap 
junction hemichannels. This is in accordance with their overlapping expression patterns in 
Drosophila embryos,  GST-pull  downs and the finding that  the usage of  innexin2 specific 
aptamers inhibited innexin2 and inx3 C-terminal interactions (Lehmann et al., 2005; Knieps 
et  al.,  2007;  Fig.  5-2).  Whether  innexin2  can  form  additional  heteromeric  gap  junction 
channels  has  not  been  investigated  yet.  However,  co-localisation  studies  in  Drosophila  
embryos as well as co-immunoprecipitation experiments performed in transfected SL2 cells 
(J. Martini, PhD thesis), to analyse the interaction potential of innexin2 and innexin1, point to 
the existence of other heteromeric hemichannel combinations containing innexin2 protein.
5 Discussion 102
Fig. 5-2 Co-immunoprecipitation of innexin2 and innexin3 from oligomeric fractions. 
Oligomeric  fractions  from  TX-100  soluble  embryonic  lysates  were  pooled  and  co-
immunoprecipitation  was  carried  out.  For  co-immunoprecipitation  from  dimeric  fractions 
lysates  fractions  between  11-13% sucrose  were  pooled.  Both  experiments  confirmed  an 
interaction of innexin2 and innexin3.
Moreover, innexin2 is able to form homomeric hexamers, too. Both, cell free expression and 
oligomerisation  experiments  (section  4.1.4),  as  well  as  the  observation  of  plaque  like 
structures  after  transfection  of  HeLa  cells  with  innexin2  (section  4.4.1)  provide  strong 
evidence  that  innexin2  is  able  to  form homomeric  hemichannels  as  well  as  homomeric, 
homotypic plaques. 
The  inefficient  oligomerisation  process  that  was  observed  when  analysing  innexin2 
homomerisation  in vitro  (Fig. 4-8)  was also described for the in vitro assembly of connexin 
proteins.  In vitro oligomerisation of  connexin proteins has been conducted various times, 
indicating  that  oligomerisation  can  be  mimicked  in  a  cell  free  system  that  is  only 
supplemented  with  microsomal  membranes,  which  resemble  core  components  of  the 
endoplasmic reticulum (Ahmad et al., 2001, 2002; Falk, 2000). Several reports discuss the 
low  efficiency  of  the  oligomerisation  process  to  form  hexamers.  Most  of  the  protein 
translated, remained in its monomeric status and is not oligomerised. 
This inefficiency can be explained by the fact  that  the used microsomal membranes are 
missing crucial components that are provided in vivo, for example by the proteins residing in 
the Golgi compartment. According to this assumption Ahmad and co-workers showed that 
the efficiency of oligomerisation could be improved for connexin32 by the addition of isolated 
Golgi membranes to the system (Ahmad et al., 1999).
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Fig. 5-3 Innexin2 forms homomeric and heteromeric innexons.  Schematic drawing of 
homomeric  and  heteromeric  hemichannel  formation  by  innexin2  proteins  alone  or  with 
innexin3. Dimers are the smallest oligomeric subunit.
However, the finding that innexin2 is able to form homomeric hemichannels and homotypic 
gap junctions is also supported by previous coupling experiments in paired Xenopus oocytes. 
Expression  of  Drosophila innexin  mRNAs resulted  in  the  measurable  induction  of  gap 
junctional  communication when expressing innexin2  mRNA only (Stebbings et  al.,  2000). 
However, the reliability to induce of gap junctional communication was greater in oocytes that 
co-expressed  innexin2  and  innexin3.  In  contrast,  injection  of  innexin3  mRNA alone  and 
expression of innexin3 protein did not lead to the induction measurable currents between 
membranes of patch-clamped oocytes. This recent findings point to the fact that all innexin 
proteins are able to form functional homomeric gap junction channels.
5.3 Trafficking of innexin2 along the secretory pathway is 
dependent on microtubules and the exocyst complex
Another  part  of  this  work  aimed  on  the  elucidation  of  trafficking  of  innexin2  containing 
hemichannels.
The secretory pathway is the major trafficking route of transmembrane proteins after their 
translation in the endoplasmic reticulum. 
Subcellular  fraction  studies  combined  with  drug  treatments  experiments  and  antibody 
stainings of embryos, ovaries and cultured cells led to the conclusion that innexin2 containing 
hemichannels  are  transported  along  the  secretory pathway to  their  final  destination,  the 
plasma  membrane.  Evidence  for  that  conclusion  was  obtained  first  from  findings  that 
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innexin2 was found enriched in different membrane fractions from organelles, namely plasma 
membrane,  endoplasmic  reticulum and  vesicles.  The  dependency of  innexin2  containing 
hemichannels  on ER to  Golgi  apparatus  trafficking  was  further  confirmed by brefeldin  A 
treatments, which are classically conducted for the analysis of exocytosis of transmembrane 
proteins  (Klausner  et  al.,  1992).  Brefeldin  A treatments  of  ovaries  and SL2 cells,  stably 
expressing inx2myc, resulted in a failure in delivery of newly synthesised hemichannels to 
the plasma membrane. Simultaneously, an accumulation of innexin2 was observed at the 
endoplasmic reticulum, as shown by co-staining with the ER marker PDI in cultured cells in 
section 4.2.2.1. The observations are line with data obtained from rat tumor cell  line that 
showed a redistribution of transfected connexin 26 and 43 from the plasma membrane to the 
ER (Thomas et al., 2005) upon brefeldin A treatment.
5.3.1 Microtubule dependent transport of innexons
Microtubules provide one main trafficking road for newly synthesised proteins within cells. 
With the help of microtubule based motor proteins a directive transport of proteins is enabled 
in both directions along the tubules. Whereas kinesin ensures thetransport of cargo to the 
plus end direction of microtubules towards the cell periphery, dynamin takes over transport 
processes to the minus end of microtubules. 
Previous  investigations  of  connexin  hemichannel  dependent  transport  showed  the 
dependency on  microtubules.  As  a  first  evidence  for  possible  connexin  and  microtubule 
interactions, Giepmans and coworkers showed the direct interaction of connexin43 with both, 
α− and  β−tubulin  subunits  in  vitro (Giepmans  et  al.,  2001,  2003).  In  GST-pull  down 
experiments a tubulin binding site in the C-terminal region of connexin43 was identified, that 
showed no conservation within other connexin isoforms. 
Publications on a microtubule dependent connexin trafficking also argue for the existence of 
microtubule independent trafficking routes. For instance, treatment of the connexin isoform 
cx26 with nocodazole did not  have impact  on the plasma membrane integration of  cx26 
positive  plaques in  normal  rat  kidney cells,  whereas it  affected membrane integration  of 
connexin43 (Thomas et al., 2005). These findings suggest an isoform dependent regulation 
of trafficking, indicating that specific analyses on single isoforms are necessary and that all 
gap junction proteins do not obligatory exhibit the same characteristics. None such studies 
have been conducted to analyse innexin2 transport.
To address this question a combination of various in vivo and cell culture experiments were 
conducted in this work. Co-immunoprecipitation (Fig. 4-20) as well as co-immunostainings of 
wild type embryos (Fig. 4-19) and dissected ovaries (Fig. 4-18), resulted in the finding that 
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innexin2 is part of a complex with ß-tubulin, one of the two subunits that gives rise to the 
microtubule architecture. The identification of a tubulin binding motif was not possible due to 
the variability of potential binding site sequences among gap junction proteins (Giepmans et 
al., 2001).
Evidence  for  the  importance  of  microtubules  on  the  transport  of  innexin2  containing 
hemichannels was provided by the application of microtubule depolymerising agents, such 
as colchicine and nocodazole  to  cultured cells  and  Drosophila ovaries (Fig.  4-21;  4-22). 
Whereas the localisation of other membranes proteins such as the septate junction protein 
disc large was still intact upon treatment, innexin2 became redistributed to the cytoplasm of 
follicle cells. The effect of innexin2 redistribution to the cytoplasm was also obtained in SL2 
cell culture, where nocodazole as a second microtubule depolymerising agent was applied. 
These data argue for the importance of the microtubular cytoskeleton in trafficking and/or 
stabilising of innexin2 containing gap junctions.
Shaw and colleagues showed in  addition,  that  connexin  gap junction  plasma membrane 
trafficking is dependent on the microtubule associated plus end binding protein EB1 and on 
the formation of adherens junctions (Shaw et al., 2007). EB1 was identified as microtubule 
associated protein that binds to microtubule plus ends, regulating microtubule dynamics and 
perhaps cortical attachment. It was first identified as a binding partner of the human tumor 
suppressor  APC,  which  plays  distinct  roles  in  Wnt  signalling  and  cytoskeletal  regulation 
(Grevengoed and Peifer, 2003).
Several  studies  in  our  group  also  pointed  to  an adherens junction  based localisation  of 
innexin2 to the plasma membrane.  One example  is  the proven interaction between  DE-
cadherin, as a core component of adherens junctions, and innexin2 in embryos and SL2 
cells.  When  DE-cadherin  is  overexpressed  in  SL2  cells  enhanced  gap  junction  plaque 
formation is detected between adjacent cells (Bauer et al., 2006).
Interestingly, first double immunostainings of embryos, overexpressing EB1gfp ubiquitously, 
using  antibodies  against  innexin2  and  GFP revealed  partial  overlapping  regions  of  both 
proteins near the plasma membrane with innexin2 accumulating at the apico-lateral domain 
of epidermal cells (Fig. 5-4). 
However, co-immunoprecipitation experiments, which were carried out subsequently to this 
finding, did not point to a direct interaction of both proteins. The negative result obtained from 
co-immunoprecipitation may result from the fact that the GFP tagged variant of EB1 is unable 
to  bind innexin2 due to steric  hindrances.  An alternative approach would have been co-
immunoprecipitation using an EB1 antibody. This could not be done due to the unavailability 
of an Drosophila EB1 antibody working in immunoblot analysis.
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Fig. 5-4 Overexpression of the microtubule plus end binding protein EB1gfp resulted 
in an accumulated localisation of innexin2 at apico-lateral membranes of embryonic 
epidermal  cells.  Co-immunostaining  of  inx2  (red)  and  EB1gfp  (green)  are  detected  in 
overlapping expression patterns.
In summary, it could be shown that innexin2 is transported via the secretory pathway to the 
plasma  membrane  and  that  innexin2  containing  hemichannel  transport  is  mediated  by 
microtubules. Figure 5-5 summarises again the different approaches that were undertaken to 
clarify  innexin2  containing  hemichannel  assembly  and  trafficking  of  those  to  the  plasma 
membrane.
Fig.  5-5  Summary of  undertaken approaches providing evidence for  a microtubule 
dependent trafficking of innexin2 hemichannels along the secretory pathway. In vitro 
oligomerisation  approaches  that  used  canine  microsomal  membranes  resulted  in  the 
formation of hexamers indicating that endoplasmic reticulum membranes are sufficient for 
innexin2  hexamer  assembly.  Transport  of  innexin2  containing  hemichannels  from  the 
endoplasmic reticulum to the golgi apparatus was abolished by brefeldin A treatment. Finally, 
interference  with  microtubule  depolymerising  drugs  indicate  a  microtubule  dependent 
trafficking of innexin2 hemichannels to the plasma membrane. 
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5.3.2 Evidence for an exocyst dependent targeting of innexons
Targeting of transmembrane proteins to specific  domains at the cell membrane is a widely 
used  mechanism  for  the  establishment  of  cell  polarity.  The  spatial  specificity  of  vesicle 
trafficking is thought to occur at a late step in this process through the tethering of exocytic 
vesicles at defined membrane sites by the eight-subunit exocyst complex (Blankenship et al., 
2007).  The  exocyst  complex  was  initially  identified  in  a  screen  for  major  regulators  of 
exocytosis  in  yeast.  Ongoing  studies  on  the  exocytosis  in  polarised  cells  of  metazoens 
revealed the existence of such a complex also in higher eukaryotes and also in Drosophila. 
Members of  the exocyst  complex show a high sequence homology between investigated 
species, indicating an ancient mechanism that is involved in transport of membrane proteins 
to the plasma membrane throughout the animal kingdom. In addition, recent studies point to 
a  role  of  the  exocyst  complex  in  endocytic  events  within  a  polarised  cell.  The  exocyst 
subunits  sec6,  sec8,  and  exo70  were  localised  to  early  endosomes,  transferrin-positive 
common recycling endosomes, and rab11a-positive apical recycling endosomes of polarised 
MDCK cells, indicated that it may be involved in a broader range of trafficking events than 
originally proposed (Oztan et al., 2007).
Previous studies of the exocyst complex in  Drosophila enabled the access to a variety of 
tools, which allowed to start the analysis of exocyst mediated trafficking of innexin2. First 
hints that innexin2 trafficking might be influenced by members of the exocyst complex came 
from co-immunostainings with an anti-sec6 antibody. Co-immunostaining using this antibody 
in combination with an antibody against innexin2, revealed a clear overlap of the innexin2 
and sec6 expression patterns in the cortical region of cell in the embryonic epidermis (Fig. 4-
23).  Overexpression  analyses  in  vivo and  double  stranded  RNAi  treatments  of  various 
members  of  the  exocyst  complex,  performed in  insect  cell  culture,  point  to  the  exocyst 
dependent  delivery  of  innexin2  containing  hemichannels  to  the  plasma  membrane.  A 
preliminary result for a direct dependency of innexin2 on sec6 comes from clonal analysis of 
sec6 negative cells. Innexin2 is found highly accumulated in the cytoplasm of follicle cells of 
the Drosophila ovary devoid of sec6 expression, whereas sec6 expressing cells showed the 
normal innexin2 pattern with a prominent staining at cellular membranes of follicle cells. 
Ongoing genetic analyses using a recombinant inducible RNAi fly-line in combination with 
the eye specific driver line eyes absent-Gal4 that knocks down  innexin2 mRNA efficiently, 
revealed a small eye phenotype. This small eye-phenotype was enhanced when crossing an 
an sec6 RNAi line to the recombinant small eyed flies. Progeny of such crossings showed 
the  total  lack  of  one  eye  or  even  more  drastically,  the  complete  absence  of  the  head 
structures, finally resulting in pupal cell death.
5 Discussion 108
All together, the hypothesis that the exocyst complex might be involved innexin2 containing 
gap  junction  trafficking  is  strengthened  by  different  findings  and  should  be  investigated 
further.
This  could  also  contribute  to  elucidate  an  exocyst  dependent  trafficking  of  vertebrate 
connexins and pannexins.
5.4 Implications on conservation
Studies on the oligomerisation and trafficking of  innexin2-containing hemichannels  to the 
plasma  membrane  revealed  that  the  procedures  of  both,  hemichannels  assembly  and 
trafficking, is highly comparable to the assembly and trafficking data available for vertebrate 
connexin43.
The next question was whether the similarities found for oligomerisation and trafficking of 
connexins  and  innexins,  would  allow  to  express  innexins  in  vertebrate  HeLa  cells  and 
whether the expressed innexin2 protein would be transported to the plasma membrane in 
this heterologous cellular system. 
It was possible to detect plaque like structures between some of the transfected cells and 
first  biochemical  approaches  also  point  to  the  potential  of  innexin  oligomerisation  in 
vertebrate  cultured  cells  (Fig.  4-32).  Membrane  integration  of  innexin2  was  proven  by 
analyses of plasma membrane sheet preparations from transfected HeLa cells (Fig. 4-31). 
This indicates that innexin2 is integrated in the plasma membrane of vertebrate cells that do 
not express connexins. In addition, immunofluorescent stainings show that innexin2 able to 
form  plaque  like  structures  between  membranes  of  two  neighboring  cells,  but  to  very 
inefficient level (Fig. 4-28). Various attempts to gain high levels of innexin expression in these 
cells  failed,  and  transfection  of  innexin2  (and  innexin3)  resulted  in  increased  cell  death 
occurring soon after transfection. These circumstance made statements on the potential of 
innexin2 to form homomeric and homotypic plaques difficult. 
Due to the low efficiency of plaque formation and the observation of high cell lethality, this 
system could not be used for functional studies, namely dye-tracer injection experiments, 
which should have been used to show the functionality of generated plaques.
However,  altogether evidence  was  obtained  for  a  conserved  procedure  of  gap  junction 
hemichannel formation and trafficking to the plasma membrane.
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5.5 Cross  regulation  between  gap  junctions  and  major 
signalling pathways
A number  of  signalling  cascades  and  communication  mechanisms  are  implicated  in  the 
formation of  shaped tissues and organs during embryogenesis.  In this work the effect  of 
innexin2 mediated gap junction communication was studied using the proventriculus as a 
model for organ formation. The proventriculus develops at the junctions of posterior foregut 
and midgut. It is known that morphogenesis of the posterior foregut and midgut is under the 
control of regulatory networks involving hedgehog, wingless and Notch signalling. Mutants 
encoding genes of signalling components show similar phenotypes, namely a failure in the 
correct folding ectodermal and endodermal tissue layers, which normally results in a valve 
like structure that serves as a regulator for the food passage from the fore into the midgut 
(Fig. 5-6).
Fig. 5-6 Schematic drawing of the proventriculus formation in wild type and hedgehog 
mutants during embryogenesis. Whereas proventriculi of  wild type embryos construct a 
valve  like  structure  at  stage  17  of  embryogenesis,  a  failure  of  inward  movement  of 
ectodermal  tissue layer  is  observed in hedgehog mutants.(Modified  after  Lechner  et  al., 
2007)
Recent studies revealed that two groups of cells, the anterior and posterior boundary cells 
play an important role during proventriculus development. It has been shown that the inward 
movement of the ectodermal proventricular cells is controlled by the anterior boundary cells, 
in which the Notch signalling pathway is activated (Fuss et al., 2004; Josten et al., 2004). 
Furthermore, hedgehog signalling is involved in the invagination process of the ectodermal 
tissue layer and is crucial for the allocation of anterior boundary specification. Evidence for 
this  finding  is  that  Notch  signalling  activity  is  missing  in  the  anterior  boundary  cells  of 
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hedgehog mutants.  Interestingly,  wingless  expression is  lost  in  the  same row of  cells  in 
hedgehog  mutants  (Lechner  et.,  2007).  Moreover,  it  could  be  shown  in  our  laboratory 
recently, that innexin2 is a direct target of wingless signalling (Bauer et al., 2004). This led to 
the question how paracrine signals and gap junctional communication cooperate to regulate 
the coordinated behaviour of cells during patterning and morphogenesis, especially of the 
proventriculus. Analyses on innexin2 mRNA and protein expression, resulted in the detection 
of innexin2 expression in both, the ecto- and the endodermal tissue layer, arguing for the 
existence of innexin2-containing gap junction channels in both tissue layers (Fig. 4-37). 
Interestingly,  innexin2  protein  expression  was  lost  in  proventriculi  of  hedgehog mutants 
(Lechner et  al.,  2007),  which is in good agreement with innexin2 being a target gene of 
wingless,  as  wingless  expression  is  also  lost  in  hedgehog mutants.  Finally,  this  loss  of 
innexin2 expression in hedgehog mutants resulted in a reduced dye coupling between cells 
of  hedgehog mutant  proventriculi  (Fig.  4-38;  Lechner et  al.,  2007).  The observation of  a 
reduced dye transfer to an even stronger extent was also obtained in proventriculi of  kropf 
mutants. Therefore, dye tracer injection experiments suggest, that the direct coupling of cells 
via  innexin2-containing  gap  junctions,  which  are  induced  in  response  to  hedgehog  and 
wingless activities, is important for the coordinated movement of the ectodermal cell layer. It 
is known from extensive studies in mammals that the coupling of cells and tissues via gap 
junctions enables the diffusion of second messengers, such as Ca2+, inositol-trisphosphate 
(IP3)  or  cyclic  nucleotides  to  allow  the  rapid  coordination  of  cellular  behavior  during 
morphogenetic processes such as cell migration and growth control (Chen et al., 1995; Wei 
et  al.,  2004).  These  results  suggest  that  wingless  and  Notch  signalling  in  the  anterior 
boundary cells depend on hedgehog expression. This hypothesis was verified  in vivo by a 
rescue  experiment  resupplying  wingless  expression  with  the  twist-Gal4  driver  line  in 
hedgehog mutants. As a result, innexin2 mRNA expression, as direct target gene of wingless 
signalling, was restored in  hedgehog mutants (Fig. 4-39), pointing to the interconnection of 
major signalling cascades in the posterior foregut. Additionally, the invagination phenotype 
that can be observed in hedgehog mutants was rescued (Fig. 5-6).
Finally, the similarity of proventricular defects, which can be seen in hedgehog, wingless and 
in the innexin2  kropf mutants are in good agreement with the idea that hedgehog acts on 
wingless  thereby  regulating  innexin2  dependent  gap  junction  activity  required  for  the 
invagination of ectodermal foregut cells.
In  addition,  further  studies  revealed  that  innexin2  itself  is  indispensable  for  the  precise 
expression of components of the signalling cascades mentioned above. Innexin2 loss and 
gain of function analyses point to clear cross regulatory effects on the  mRNA expression 
levels of major regulatory components involved in proventriculus organogenesis as found out 
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by qRT-PCR analyses. Innexin2 loss of function experiments resulted in a severe reduction 
of  mRNA expression  levels  for  hedgehog,  wingless  and Delta transcripts,  whereas  the 
overexpression of innexin2 led to elevated levels for all three transcripts (Fig. 4-40). These 
findings support  observations of  fluorescent  antibody stainings and  in  situ hybridisations, 
which showed innexin2 dependent alterations in expression levels of all  three  mRNAs or 
proteins (Lechner et al., 2007; Josten, PhD thesis).
Together,  the  collected  data  point  towards  an  essential  requirement  of  gap  junction 
communication  for  the  transcriptional  activation  of  morphogen-encoding  genes  activating 
evolutionary conserved signalling cascades essential for patterning in animals  (Lechner et 
al.,  2007;  Serrano  and  O'Farrell,  1997).  The  question,  in  which  way  innexin2  mediates 
transcriptional control remains unclear. Several experiments in cell culture point to a innexin2 
C-terminus  dependent  mechanism.  Quantitative  real  time PCR analyses  on  mRNA from 
embryos,  where  a  truncated  form  the  innexin2  full  length  protein  was  overexpressed, 
resulted in  a comparable reduction of  hedgehog,  wingless,  and  Delta transcripts as was 
obtained when analysing transcript levels in kropf mutants (Fig.4 -40).
One hypothesis that was followed up to explain this result, is a potential involvement of the 
innexin2 C-terminal domain in the activation of transcription. In silico predictions point to the 
existence of a nuclear receptor binding site in the C-terminal part of the innexin2 amino acid 
sequence (Fig. 4-42). Nuclear receptors are known to mediate regulation of transcription. 
The regulation of gene expression by nuclear receptors only happens in the presence of a 
ligand,  a  molecule,  which  affects  the  behaviour  of  the receptor.  More  specifically,  ligand 
binding to a nuclear receptor results in a conformational change of the receptor leading to its 
activation  and up-regulation  of  gene expression.  The C-terminal  innexin2  domain,  which 
contains  a  predicted  nuclear  receptor  motif,  may  serve  as  such  a  ligand  for  a  nuclear 
receptor that is involved in the activation of target gene expression because it contains a 
predicted nuclear receptor binding motif (Fig. 4-43).
Further  evidence  for  the  existence  of  such  a  mechanism,  derives  from  biochemical 
experiments in Schneider cell culture. Overexpression of inx2-gfp resulted in the observation 
of an additional C-terminal fragment that could be immunoprecipitated with an anti-innexin2 
and  an  anti-GFP  antibody  (Fig.  4-44).  The  detection  of  an  additional  innexin2  protein 
fragment  also  implicates  the  existence  of  a  mechanism,  which  is  responsible  for  the 
generation  of  the  C-terminal  innexin2  fragment.  One  possibility  might  be  a  C-terminal 
cleavage  event  that  takes  place  upon  innexin2  overexpression  within  the  fourth 
transmembrane domain. Another possibility is the existence of an additional translation start 
codon, an internal ribosomal entry site (IRES), resulting in a truncated C-terminal innexin2 
fragment. The existence of IRES-sites could be shown the in different connexin mRNAs. For 
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example, the zebrafish connexin55.5 mRNA produces a C-terminal fragment, that was also 
found in  nuclei  of  transected NIH3T3 cells.  It  was shown that  the  generation  of  this  C-
terminal fragment is IRES mediated. IRES sites were also found for connexins43, 32 and 26 
(Ul-Hussain et al.,  2008). The impact of IRES mediated translation and the generation of 
additional connexin protein fragments is only poorly understood.
The existence of a an additional C-terminal fragment was also described for connexin43 in 
different cellular systems. The group around Steven Taffet identified a C-terminal connexin43 
fragment with a size of 20 kD in chinese hamster kidney cells (Joshi-Mukherjee et al., 2007). 
Another study reported the observation that a truncated C-terminal fragment of connexin43. 
This fragment was localised in the nucleus of HeLa cells and led to a reduced proliferation of 
cells expressing this C-terminal Cx43 protein fragment (Dang et al., 2003).
The direct association of a transcription factor with gap junctions has been recently proposed 
for the mouse homologue of ZO-1-associated nucleic acid-binding protein (ZONAB). This 
transcription  factor binds to ZO-1, which is associated with oligodendrocyte, astrocyte and 
retina gap junctions (Penes et al., 2005; Ciolofan et al., 2006). It is possible that innexin2-
dependent  transcriptional  regulation  may  involve  a  similar  type  of  mechanism:  A  still 
unknown transcriptional regulator associated with the C-terminus of innexin2-containing gap 
junctions could be released upon modulation of gap junction composition thereby modulating 
the transcription of innexin2-dependent target genes (Lechner et al., 2007).
Another explanation for the oberserved modulation of transcription by innexin2 could be a 
gap junction mediated signalling via second messengers that modulate the transcription of 
target  genes  in  response  to  gap  junction  mediated  intercellular  communication.  This 
assumption is supported by a study from Stains and colleagues who found a dependency of 
transcriptional activities of different osteoblast genes on gap junction expression. In Cx43 
loss  and  gain  of  function  experiments  an  altered  recruitment  of  ubiquitously  expressed 
Sp1/Sp3 transcription factors to the promoters of  these genes was observed.  This might 
represent a potential general mechanism for transcriptional control of target genes by signals 
passing through gap junctions (Stains et al., 2003).
It was found in the laboratory that upon loss of innexin2 expression in the proventriculus, the 
coexpressed innexins 1 and 3 are also down regulated on the transcriptional level (Martini, 
PhD thesis). This results in a severe loss of gap junction formation associated with a loss of 
direct  communication  via  heteromeric  gap  junction  channels.  Loss  of  direct  cell 
communication via second messengers that are normally transported through gap junction 
channels and control transcriptional control, argues also for the assumption of a modulated 
gene expression via an altered exchange rate of second messengers.
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5.6 Outlook
In  this  thesis,  methods for  the analysis  of  oligomerisation  and trafficking of  gap junction 
proteins were established that  led to the identification that  innexin2 is transported to the 
plasma membrane via the secretory pathway. These methods can be used in the laboratory 
to analyse oligomerisation and trafficking of other Drosophila gap junction isoforms.
Further studies on the potential of innexins in the formation of homo- or heteromeric gap 
junction channels  will  clarify whether innexin2 is able to form other types of  heteromeric 
hemichannels with the remaining members of the gap junction family or whether there is only 
a limited number of interaction partners as outlined for the connexins.
Another question that should be addressed, is whether innexin2 hemichannels can function 
besides their  involvement as gap junction constituents as autonomous channels by itself. 
Indication for the existence of unopposed hemichannels come from immunohistochemical 
stainings cells, where innexin2 was overexpressed in various cell culture systems and the 
fact that members of the pannexin and connexin family were also implicated in hemichannel 
function.
Concerning trafficking, it would be very interesting to follow evidences for the involvement of 
members  of  the  exocyst  complex  in  plasma membrane  trafficking  of  innexin2-containing 
hemichannels. An expansion of analyses concerning an exocyst dependent targeting also to 
the  connexin  field,  where  transport  mechanisms  between  TGN  sorting  and  plasma 
membrane integration are also unclear, would be an interesting topic.
Finally, further studies on the mechanism by which the gap junction protein innexin2 controls 
the transcription of major signalling proteins is an interesting issue that also might contribute 
to the understanding of the phenomenon of C-terminal fragments of connexins in nuclei that 
alter gene expression levels.
Altogether, findings of conserved gap junction hemichannel structures and trafficking routes 
to the plasma membrane open the possibility to screen for new interaction partners that are 
crucial for the formation and function of gap junction proteins for all three families of gap 
junction proteins.
6 Summary
Gap junctions channels serve as mediators for direct cell-to cell  communication between 
cells  of  different  tissue and organs by the exchange of  small  metabolites  and signalling 
molecules. They are formed by analogous protein families in vertebrates and invertebrates. 
The docking of two hemichannels leads to gap junction channel formation at the plasma 
membrane of two adjacent cells, resulting in so called “plaque like” structures that consist of 
accumulations of gap junction channels at contact sites.
Whereas  the  biogenesis  and  functions  of  vertebrate  gap  junction  channels  consisting  of 
connexins have been analysed in some detail, biochemical studies on innexin gap junction 
assembly and trafficking are lacking for any innexin known to date. 
The formation and trafficking of innexin2 containing gap junction hemichannels to the plasma 
membrane  was  analysed  in  Drosophila  melanogaster  and  cultured  cells  in  this  thesis. 
Analysis of innexin2 oligomerisation by biochemical approaches like velocity sedimentation 
of  different  oligomers  in  density  gradients  combined  to  cell-free  transcription/translation 
assays revealed the existence of  hexameric  innexin2 containing hemichannels  that  were 
termed innexons. It could be shown that the identified innexons formed by innexin2 can be 
either homomeric, meaning that they are composed of innexin2 subunits only, or heteromeric 
meaning  that  other  innexin  isoforms  are  part  of  one  hemichannel  in  addition. 
Immunohistochemical analysis of innexin2 expression in Drosophila ovaries, invertebrate and 
mammalian  cell  culture  as  well  as  biochemical  fractionation  experiments  indicate  that 
innexin2-containing oligomers are transported along the secretory pathway to the plasma 
membrane.  Moreover,  by  the  combination co-immunoprecipitation  and  drug  treatment 
experiments it could be demonstrated that innexin2-containing hemichannels are transported 
along the microtubule cytoskeleton to the plasma membrane with  an involvement  of  the 
exocyst complex taking part in the anterograde transport of gap junction hemichannels. 
These findings provide the first biochemical evidence that innexins form hexameric innexon 
hemichannels and suggest that the oligomerisation and trafficking of connexins and innexins 
may rely on a  common mechanism despite  lacking of  sequence similarity between both 
protein families. 
Investigation  of  the  innexin2  function  during  the  development  of  the  proventriculus,  an 
accessory organ of  the  Drosophila gastrointestinal  tract  that  is  formed during  Drosophila 
embryogenesis, pointed in addition to an innexin2 dependent gap junctional cross regulation 
of major signalling molecules like hedgehog, Delta and wingless which are crucial for the 
formation of shaped organs.
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8 Appendix
8.1 Functionality proof of the UAS-inx2∆CT fly strain
The functionality of the UAS-inx2∆CT transgene was tested and verified using in situ 
hybridization, detecting mRNA levels of the overexpressed transgene (prd-Gal4) with an 
inx2-antisense probe. inx2 mRNA expression was detected in enhanced stripes of the 
epidermis.
Fig.  8-1  In  situ hybridisation  of  innexin2 mRNA in  embryos  that  overexpress  the 
transgene inx2∆CTmyc.
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Amino acid-sequence inx2 full length
MFDVFGSVKGLLKIDQVCIDNNVFRMHYKATVIILIAFSLLVTSRQYIGDPIDCIVDEIPLGVM
DTYCWIYSTFTVPERLTGITGRDVVQPGVGSHVEGEDEVKYHKYYQWVCFVLFFQAILFYV
PRYLWKSWEGGRLKMLVMDLNSPIVNDECKNDRKKILVDYFIGNLNRHNFYAFRFFVCEAL
NFVNVIGQIYFVDFFLDGEFSTYGSDVLKFTELEPDERIDPMARVFPKVTKCTFHKYGPSGS
VQTHDGLCVLPLNIVNEKIYVFLWFWFIILSIMSGISLIYRIAVVAGPKLRHLLLRARSRLAES
EEVELVANKCNIGDWFLLYQLGKNIDPLIYKEVISDLSREMSGDEHSAHKRPFDA 
intracellular domain
transmembrane domain
extracellular domain
Amino acid- sequence inx2  ∆  CT:  
MFDVFGSVKGLLKIDQVCIDNNVFRMHYKATVIILIAFSLLVTSRQYIGDPIDCIVDEIPLGVM
DTYCWIYSTFTVPERLTGITGRDVVQPGVGSHVEGEDEVKYHKYYQWVCFVLFFQAILFYV
PRYLWKSWEGGRLKMLVMDLNSPIVNDECKNDRKKILVDYFIGNLNRHNFYAFRFFVCEAL
NFVNVIGQIYFVDFFLDGEFSTYGSDVLKFTELEPDERIDPMARVFPKVTKCTFHKYGPSGS
VQTHDGLCVLPLNIVNEKIYVFLWFWFIILSIMSGISLIY 
intracellular domain
transmembrane domain
extracellular domain
8.2 Phosphorylation - site predictions
Predictions were done using the following link: 
http://www.cbs.dtu.dk/services/NetPhos/
inx2
MFDVFGSVKGLLKIDQVCIDNNVFRMHYKATVIILIAFSLLVTSRQYIGDPIDCIVDEIPLGVMDTYCWIYSTFT
VPERL      
TGITGRDVVQPGVGSHVEGEDEVKYHKYYQWVCFVLFFQAILFYVPRYLWKSWEGGRLKMLVMDLNSPIVNDECK
NDRKK     
ILVDYFIGNLNRHNFYAFRFFVCEALNFVNVIGQIYFVDFFLDGEFSTYGSDVLKFTELEPDERIDPMARVFPKV
TKCTF     
HKYGPSGSVQTHDGLCVLPLNIVNEKIYVFLWFWFIILSIMSGISLIYRIAVVAGPKLRHLLLRARSRLAESEEV
ELVAN     
KCNIGDWFLLYQLGKNIDPLIYKEVISDLSREMSGDEHSAHKRPFDA
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Serine phosophorylation prediction
Threonine phosphorylation prediction
Tyrosine phosphorylation prediction
inx3
MAVFGMVSAVSGFIKIRYLLDKAVIDNMVFRCHYRITTAILFTCCIIVTANNLIGDPISCINDGAIPMHVINTFC
WITYT     
YTIPGQQHRQIGTDVAGPGLGNEYGQEKRYHSYYQWVPFVLFFQGLMFYVPHWVWKNMEDGKIRMITDGLRGMVS
VPDDY     
RRDRQDRILKYFVNSLNTHNGYSFAYFFCELLNFINVIVNIFMVDKFLGGAFMSYGTDVLKFSNMDQDKRFDPMI
EIFPR    
LTKCTFHKFGPSGSVQKHDTLCVLALNILNEKIYIFLWFWFIILATISGVAVLYSLVVIMMPTTRETIIKRSYRS
AQRKE     
IAGLVRRLEIGDFLILHFLSQNLSTRSYSDMLQQLCGLLGASRTPSAPSTLEMNRISHPIYPPVETFGGGKETET
Serine phosophorylation prediction
Threonine phosophorylation prediction
Tyrosine phosphorylation prediction
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8.3 Development of the Drosophila embryo
Fig. 8-2 Stages of embryonic development in  D.melanogaster.  All embryos are in lateral 
view  (anterior  to  the  left).  (Red)  Endoderm,  midgut;  (green)  mesoderm;  (purple)  central  nervous 
system; (blue) foregut,  hindgut;  (yellow) pole cells.  (amg) anterior midgut  rudiment; (br)  brain;  (cf) 
chephalic furrow; (cl) cypeolabrum; (df) dorsal fold; (dr) dorsal ridge; (es) esophagus; (gb) germ band, 
(go) gonads; (hg) hindgut; (lb) labial bud; (md) mandibular bud; (mg) midgut, (mt) Malphigian tubules; 
(mx) maxillary bud; (pc) pole cells; (pmg) posterior midgut rudiment; (pnb) procephalic neuroblasts; 
(pro)  procephalon;  (ps)  posterior  spiracle;  (pv)  proventriculus,  (sg)  salivary gland,  (stp)  stomodeal 
plate, (st) stomodeum; (tp) tracheal pits; (vf) ventral furrow, (vnb) ventral neuroblasts, (vnc) ventral 
nerve cord. (After Hartenstein, Drosophila Atlas)
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8.4 Crossing scheme for rescue of hedgehog mutants
P = parental generation
F = filial generation
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